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Two Malaysian plants viz., Leuconotis griffithii and Kopsia pauciflora, and one fungi 
strain (Penicillium sp. (CDA p48.3)) were investigated for their alkaloidal content and 
the results are summarized below (Table). A total of 107 alkaloids were isolated and 
characterized from these sources. Of these, 37 are new alkaloids. Leuconotis griffithii 
yielded a total of 24 new alkaloids, of which sixteen, viz., the tetracyclic ring-opened 
oxindole leucolusine (1), the strychnan alkaloids, leuconicines AG (28), the ring-C 
contracted rhazinilam alkaloid, nor-rhazinicine (22), the unprecedented 
eburnanequinoline dimer, leucophyllidine (36), the eburnanesarpagine bisindole, 
leuconoline (37), the aspidospermatanaspidospermatan bisindole, leucofoline (38), and 
the StrychnosStrychnos bisindoles, leucoridines AD (3942), are notable for 
incorporating novel or intriguing molecular skeletons. The stem-bark and leaf extracts 
of Kopsia pauciflora gave a total of 10 new alkaloids. These new alkaloids are the seco-
leuconoxine alkaloid, compound 62, the eburnane alkaloids, 6364, the corynanthean 
oxindole alkaloids, 6971, the corynanthean pseudoindoxyl alkaloid, 
tetrahydroalstonine pseudoindoxyl (73), the aspidofractinine alkaloid, 11,12-
dimethoxykopsinaline (77), and the andransinine alkaloids, andransinine (90) and 
compound 91. The culture broth extract of a Penicillium sp. (CDA p48.3) gave three 
new variotin derivatives, viz., compounds 101103. Among the new alkaloids, 5,21-
dihydrorhazinilam N-oxide (23), leucophyllidine (36), and leucoridine A (39) showed 
pronounced cytotoxic effects against human KB cells (IC50 0.572.95 g/mL), while 
leuconodine B (10), leuconodine D (12), nor-rhazinicine (22), leuconoline (37), 
leucofoline (38), and leucoridines BD (4042) showed only moderate to weak activity 
(IC50 7.0617.90 g/mL). Leuconicines AB (23), compound 70, and andransinine 
 iii 
(90) were found to be effective in circumventing MDR in vincristine-resistant KB cells 
(IC50 1.612.75 g/mL), while leuconicines CE (46),
 
leuconodine E (13), and 



















Abstrak (Versi Bahasa Malaysia) 
 
Dua jenis tumbuhan dari Malaysia iaitu Leuconotis griffithii, dan Kopsia pauciflora, dan 
sejenis kulat (Penicillium sp. (CDA p48.3)) telah dikaji dari segi kandungan 
alkaloidnya, keputusan yang diperoleh telah dirumuskan di dalam jadual seperti di 
bawah. Sebanyak 107 alkaloid telah diasingkan dan dicirikan dari sumber yang 
dinyatakan di atas. Dari jumlah tersebut, 37 alkaloid merupakan alkaloid baru. 
Sebanyak 24 alkaloid baru telah diasingkan dari Leuconotis griffithii, antaranya, enam 
belas memiliki rangka karbon yang menarik, iaitu leucolusine (1), leuconicines AG 
(28), nor-rhazinicine (22), leucophyllidine (36), leuconoline (37), leucofoline (38) dan 
leucoridines AD (3942). Ekstrak-ekstrak dari kulit-batang dan daun Kopsia 
pauciflora memberikan sejumlah 10 alkaloid baru. Alkaloid baru ini termasuklah 
sebatian 6264, 6971, tetrahydroalstonine pseudoindoxyl (73), 11,12-
dimethoxykopsinaline (77), andransinine (90) dan sebatian 91. Ekstrak dari supernatan 
Penicillium sp. (CDA p48.3) telah menghasilkan tiga terbitan baru variotin, iaitu 
sebatian 101103. Antara alkaloid baru ini, 5,21-dihydrorhazinilam N-oxide (23), 
leucophyllidine (36), dan leucoridine A (39), menunjukkan kesan sitotoksik yang kuat 
terhadap sel-sel KB (IC50 0.572.95 g/mL), manakala leuconodine B (10), 
leuconodine D (12), nor-rhazinicine (22), leuconoline (37), leucofoline (38), dan 
leucoridines BD (4042) menunjukkan kesan sitotoksik yang sederhana sahaja (IC50 
7.0617.90 g/mL). Leuconicines AB (23), sebatian 70, dan andransinine (90) 
memberikan kesan yang sangat kuat dalam memintasi ketahanan multidrug dalam sel-
sel KB vincristine-resistant (IC50 1.612.75 g/mL), manakala leuconicines CE (46),
 
leuconodine E (13), dan sebatian 62, 64, dan 91, hanya menunjukkan aktiviti yang 
sederhana sahaja (IC50 3.8618.13 g/mL). 
 v 
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Table: Alkaloid Composition of L. griffithii, K. pauciflora, and Penicillium sp. (CDA  
            p48.3) 
Plant Plant part Alkaloid 
L. griffithii (Plant) Stem-bark Leucolusine (1) [New] 
  Leuconicine A (2) [New] 
  Leuconicine B (3) [New] 
  Leuconicine C (4) [New] 
  Leuconicine D (5) [New] 
  Leuconicine E (6) [New] 
  Leuconicine F (7) [New] 
  Leuconicine G (8) [New] 
  Leuconodine A (9) [New] 
  Leuconodine B (scholarisine G) (10) [New] 
  Leuconodine C (11) [New] 
  Leuconodine D (12) [New] 
  Leuconodine E (13) [New] 
  Leuconoxine (14) 
  Leuconodine F (6-oxoleuconoxine) (15) 
  Mersicarpine (16) 
  Arboloscine (17) 
  3,14-Dehydroleuconolam (18) [New] 
  Leuconolam (19) 
  O-Methylleuconolam (20) 
  Epi-leuconolam (21) or 6,7-dehydroleuconoxine (21a) 
  Nor-rhazinicine (22) [New] 
  5,21-Dihydrorhazinilam N-oxide (23) [New] 
  5,21-Dihydrorhazinilam (24) 
  Rhazinilam (25) 
  Rhazinal (26) 
  Rhazinicine (27) 
  ()-Eburnamaline (28) [New] 
  ()-Eburnamonine (29) 
  ()-Eburnamenine (30) 
  O-Methylisoeburnamine (31) 
  O-Methyleburnamine (32) 
  ()-Isoeburnamine (33) 
  ()-Eburnamine (34) 
  (±)-Vincamine (35) 
  Leucophyllidine (36) [New] 
  Leuconoline (37) [New] 
  Leucofoline (38) [New] 
  Leucoridine A (39) [New] 
  Leucoridine B (40) [New] 
  Leucoridine C (41) [New] 
  Leucoridine D (42) [New] 
  Tetrahydroalstonine (43) 
  17(S)-Ajmalicinial (44) and 17(R)-Ajmalicinial (45) 
  Akuammidine (46) 
 vii 
Table, continued 
Plant Plant part Alkaloid 
  16(R)-19,20-E-Isositsirikine (47) 
  16(S)-19,20-E-Isositsirikine (48) 
  Z-Geissoschizol (49) 
  Fluorocarpamine (50) 
  Pleiocarpamine (51) 
  16-Hydroxymethylpleiocarpamine (52) 
  ()-Isovallesiachotamine (53) 
  ()-Isovallesiachotamine (53) and ()-Vallesiachotamine (54) 
  Norfluorocurarine (55) 
  12-Hydroxynorfluorocurarine (56) 
  Tubotaiwine (57) 
  Tubotaiwine N-oxide (58) 
  N(4)-Chloromethyltubotaiwine chloride (59)  
  Venoterpine (60) 
  Syringaresinol (61) 
   
K. pauciflora  Stem-bark Leuconoxine (14) 
(Plant)  Rhazinilam (25) 
  Compound 63 [New] 
  Compound 64 [New] 
  (+)-Eburnamonine (29) 
  (+)-Eburnamenine (30) 
  (+)-Isoeburnamine (33) 
  ()-Eburnamine (34) 
  19-Oxoeburnamine (66) 
  ()-19(R)-Hydroxyisoeburnamine (67) 
  ()-19(R)-Hydroxyeburnamine (68) 
  Tetrahydroalstonine (43) 
  11,12-Dimethoxykopsinaline (77) [New] 
  Pseudokopsinine (78) 
  Kopsinine (79) 
  Kopsamine (80) 
  N(1)-Decarbomethoxykopsamine (81) 
  Kopsilongine (82) 
  Paucifinine (83) 
  Kopsanone (84) 
  11,12-Methylenedioxykopsine (85) 
  Kopsifine (87) 
  N(1)-Decarbomethoxykopsifine (88) 
  Methyl 11,12-methylenedioxy-N(1)-decarbomethoxy-
chanofruticosinate (95) 
  Methyl 11,12-methylenedioxychanofruticosinate (96) 
  ()-Norpleiomutine (100) 
   
 Leaves Compound 62 [New] 
  Leuconoxine (14) 
  Leuconodine F (6-oxoleuconoxine) (15) 
 viii 
Table, continued 
Plant Plant part Alkaloid 
  Mersicarpine (16) 
  Leuconolam (19) 
  Rhazinilam (25) 
  Compound 63 [New] 
  Larutenine (65) 
  Compound 69 [New] 
  Compound 70 [New] 
  Compound 71 [New] 
  ()-Catharinensine (72) 
  Tetrahydroalstonine pseudoindoxyl (73) [New] 
  Tetrahydroalstonine (43) 
  16(R)-19,20-E-Isositsirikine (47) 
  ()-Aspidospermidine (74) 
  ()-1,2-Dehydroaspidospermidine (75) 
  ()-Quebrachamine (76) 
  Pseudokopsinine (78)  
  Kopsinine (79) 
  N(1)-Decarbomethoxykopsamine (81) 
  Paucifinine (83) 
  11,12-Methylenedioxykopsine (85) 
  12-Methoxykopsine (86) 
  Akuammicine (89) 
  Andransinine (90) [New] 
  Compound 91 [New] 
  Condylocarpine (92) 
  Precondylocarpine (93) 
  Stemmadenine (94) 
  Methyl 11,12-methylenedioxy-N(1)-decarbomethoxy-
chanofruticosinate (95) 
  Methyl 11,12-methylenedioxychanofruticosinate (96) 
  Methyl chanofruticosinate (97) 
  Methyl N(1)-decarbomethoxychanofruticosinate (98) 
  Methyl 12-methoxychanofruticosinate (99) 
   
Penicillium sp.  Culture broth Compound 101 [New] 
(CDA p48.3)  Compound 102 [New] 
(Fungi)  Compound 103 [New] 
  Variotin (104) 
  Viriditin (105) 
  cyclo (L-Phenylalanine-trans-4-hydroxy-L-proline) (106)  
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Plants and microorganisms provide a diverse and unique source of secondary 
metabolites (also known as natural products), which are biosynthetically derived from 
primary metabolites.
1
 The great majority of these substances do not participate directly 
in growth and development of an organism, and are often differentially distributed 
among limited taxonomic groups.
2-5
 Since the study of natural products began in the 
19th century,
6
 organic chemists have shown great interest in the investigation of these 
phytochemicals for their chemical structures, biogenesis, and chemical synthesis. As 
chemical and biological techniques improved,
7-19
 many complex chemical structures 
with intriguing skeletons were discovered from natural sources, and some of these 
substances were found to exhibit significant biological activities. In addition, an 
increasing number of natural product-based drugs were approved for therapeutic 
applications worldwide between 20052010.20-23 Natural products have therefore 
proven to be fertile sources for the discovery of new biologically active agents, which 
provide useful lead compounds for drug discovery and development.
6,21,23-38 
These 





















 Plants and microorganisms, therefore, represent a promising and still 
unexhausted source of potentially useful natural compounds. The rich natural resources 
available in this country
77
 present the opportunity for finding new natural products of 
interest from the viewpoint of chemistry (structure, biogenesis, etc.) as well as biology 
(biological activity, etc.). Two plants of the Malayan Apocynaceae (Leuconotis and 
Kopsia) and one unidentified fungal strain (Penicillium sp.) were chosen for 
investigation in the present study with emphasis on the discovery and structure 
elucidation of new natural products, and the evaluation of biological activity. 
 
 3 
1.2 The Alkaloids 
  
The isolation of morphine in 1805 by the German pharmacist, Friedrich Sertürner, 
marked the beginning of alkaloid chemistry. The term alkaloid, or ‘alkali-like’, was first 
proposed by another German pharmacist, W. Meissner in 1819. In 1983, S. W. Pelletier 
suggested a modern definition for alkaloids: An alkaloid is a cyclic compound 
containing nitrogen in a negative oxidation state which is of limited distribution in 
living organisms.
78-80
 However, after many years of alkaloid research, this definition as 
such is no longer appropriate as it was found that alkaloids occur in all types of living 
organisms. Hesse has presented a new definition for alkaloids: Alkaloids are nitrogen-





The total number of alkaloids so far isolated from various sources (plants, fungi, 
bacteria, marine organisms, mammals, etc.) is enormous.
81
 These alkaloids can be 
classified based on the immediate environment of the N-atom in the individual alkaloid. 
Essentially, five distinct alkaloid classes were put forward according to the position of 
the N-atom in the main structural element:
78-80
  
i. Heterocyclic alkaloids 
ii. Alkaloids with exocyclic N-atoms and aliphatic amines (e.g., cassaine, 
ephedrine) 
iii. Putrescine, spermidine, and spermine alkaloids (e.g., paucine, inandenin-12-
one, verbascenine) 
iv. Peptide alkaloids (e.g., integerrine, mucronine A) 





Among the five classes, the heterocyclic alkaloids constitute the largest group and in 
common usage, the term alkaloids usually refers to the heterocyclic alkaloids. These can 


























Quinoline   
 












The indole alkaloids of Apocynaceae constitute one of the largest groups of alkaloids 
and account for about 20% of all known alkaloids.
78-81
 This figure includes both those 
compounds that incorporate the actual indole chromophore and those containing its 
derivatives: namely indoline (dihydroindole), indolenine, hydroxyindolenine, -
methylideneindoline, pseudoindoxyl, and oxindole. Also members of this group are 
alkaloids in which the nucleus incorporates an additional benzene or pyridine ring, for 




1.3.2 Classification of the Indole Alkaloids 
 
The indole alkaloids are further subclassified according to their structural and 
biogenetic criteria. In general, the indole alkaloids can be divided into two main 
categories with respect to their structural features. The first comprises the simple indole 
alkaloids that do not present a structural uniformity, possessing only the indole nucleus 
or a direct derivative of it as a common feature (e.g., harmane). Indole alkaloids of the 
second category, which are known as the monoterpene indole alkaloids, contain two 
structural units, viz., tryptamine (or tryptophan) with the indole nucleus, and a C9- or 
C10-monoterpene moiety derived from secologanin. The majority of the indole alkaloids 




The monoterpene indole alkaloids shared a common precursor, namely strictosidine, 
which is a condensation product of secologanin and tryptamine.
82-84
 Indole alkaloids can 
be grouped into ten main skeletal types: corynanthean (C), vincosan (D), 
vallesiachotaman (V), aspidospermatan (A), strychnan (S), eburnan (E), plumeran (P), 
heynean (H), capuronan (K), and tacaman (T).
85-116
 Monoterpene indole alkaloids which 
do not present structural features that allow them to be accommodated in any of the ten 
main skeletal types considered above are listed as miscellaneous alkaloids. All indole 
alkaloids are biogenetically related and the biogenetic relationships of these alkaloids 
are given in Scheme 1.1.
78-80,108,112,114,116








Scheme 1.1: Biogenetic relationships of the ten main skeletal types of indole alkaloids 
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Scheme 1.2: Classification of indole alkaloids 
 10 
 
Scheme 1.2, continued 
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The genus Leuconotis belongs to the tribe Willughbeieae, subfamily Rauvolfioideae of 
the family Apocynaceae. This genus occurs only in tropical Asia, mainly in southern 
Thailand, Indonesia and Peninsular Malaysia.
117-122
 Leuconotis are usually woody 
climbers and all species have tetramerous flowers, which make this genus almost unique 
in the family. The leaves are usually petiolate, opposite to each other, blade elliptic or 
narrowly elliptic, with scattered black dots beneath, while the fruit is fleshy, 




Based on the most recent review of the genus by Middleton, a total of 4 species are 
recognized. The species are listed as follows:
118,120
  
i. L. anceps Jack 
ii. L. bullata Leeuwenb. 
iii. L. eugeniifolia (Wall. ex G. Don) A. DC. 
iv. L. griffithii Hook. f. 
 




1.4.2 Alkaloids of the Genus Leuconotis 
 
The alkaloidal composition of the genus Leuconotis bears a striking similarity to that of 
the genus Kopsia.
77
 Previous studies of the Malayan L. griffithii and L. eugenifolia 
provided kopsinine, eburnamine and a strychnan derivative (alkaloid 376), the ring-
opened alkaloids leuconolam, epi-leuconolam, rhazinilam and their derivatives,
124-127
 
while two yohimbines and the pentacyclic diazaspiro alkaloid leuconoxine, were 
subsequently reported from L. eugenifolia occurring in Indonesia.
128 
In addition to the 
indole alkaloids, ten new bisindole alkaloids (leucophyllidine, leuconoline, leucofoline, 
leucoridines AD, leucoridine A N-oxide, bisleucocurine A, and bisleuconothine A) 
have also been recently reported.
 
 
1.4.3 Occurrence and Distribution of Alkaloids in the Genus Leuconotis 
 
The occurrence of alkaloids in Leuconotis as reported in the literature (up to May 2012) 
is summarized in Table 1.1. 
 
Table 1.1: Occurrence of Alkaloids in Leuconotis 
Plant
a
 Plant part Alkaloid References 
L. eugeniifolia  Leaves Leuconolam (19) 128 
(Wall. ex G. Don) A. DC.  Leuconoxine (14) 128 
(L. eugenifolius DC.)  21-O-Methylleuconolam (20) 128 
(Indonesia)  Rhazinaline N-oxide (115) 128 
  Yohimbine (116) 128 
  -Yohimbine (117) 128 
    
 Stem Leuconolam (19) 128 
  Leuconoxine (14) 128 
  21-O-Methylleuconolam (20) 128 
  Yohimbine (116) 128 
  -Yohimbine (117) 128 
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Plant part Alkaloid References 
L. eugeniifolia  Bark Alkaloid 376 (= Leuconicine B) (3)
b
 124,126 
(Wall. ex G. Don) A. DC.  5,21-Dihydrorhazinilam (24)
b
 124-126 
(L. eugenifolius DC.)  Eburnamine (34) 124,126,127 
(Peninsular Malaysia)  Eucophylline (108) 129 
  Leuconolam (19) 124-127 
  Epi-leuconolam (21) 124-126 
  Leucophyllidine (36)
b
 129 
  Rhazinilam (25) 124-126 
    
    L. griffithii Hook.f. Leaves Anhydropereirine (110)
b
 130,131 
(L. griffithii (Retz.)   Bisleucocurine A (120) 130 
Gardner ex Thwaites)  Leucomidine A (111) 132 
  Leucomidine B (112) 132 
  Leucomidine C (113) 132 
  Leuconicine B (3)
b
 131 
  Leucoridine A (39)
b
 131 
  Leucoridine A N-oxide (119) 131 
  Melohenine A (114)
b
 131 
    
 Stem-bark Bisleuconothine A (118) 133 
  ()-Eburnamenine (30) 133 
    
    L. griffithii Hook.f. Stem-bark 5,21-Dihydrorhazinilam (24)
b, c
 124-126 
  ()-Eburnamaline (28)c 134 
  (+)-Eburnamenine (30)
c
 134 
  ()-Eburnamine (34)c 124,126,127,134 
  (+)-Eburnamonine (29)
c 
 134 
  (+)-Isoeburnamine (33)
c
 134 
  Kopsinine (79)
b
 124,126 
  Leucofoline (38)
c
 135 
  Leucolusine (1)
c
 136 
  Leuconicine A (2)
c
  134 
  Leuconicine B (= Alkaloid 376) (3)
c
 124,126,134  
  Leuconicine C (4)
c
 134 
  Leuconicine D (5)
c
 134 
  Leuconicine E (6)
c
 134 
  Leuconicine F (7)
c
 134 
  Leuconicine G (8)
c
 134 
  Leuconolam (19)
c
 124-127 
  Epi-leuconolam (21)
c
 124-126 
  Leuconoline (37)
c
 135 
  Leucophyllidine (36)
c
 137 
  Leucoridine A (39)
c
 138 
  Leucoridine B (40)
c
 138 
  Leucoridine C (41)
c
 138 
  Leucoridine D (42)
c
 138 
  O-Methyleburnamine (32)
c
 124,126,127 
  O-Methylisoeburnamine (31)
c
 124,126,127 
  Norfluorocurarine (55)
b, c
 124,126,127 
  Norfluorocurarine N-oxide (109)
b
 124,126,127 




 Classification according to Middleton
120
 with original attribution in parenthesis; 
b 
[]D not reported; 
c
 


















The genus Kopsia belongs to the tribe Vinceae, subfamily Rauvolfioideae of the family 
Apocynaceae.
139,140
 This genus is widely distributed in South East Asia
141-143
 and is 
most diverse in Peninsular Malaysia and Sarawak.
140





All Kopsia species are shrubs or small trees, occurring as part of the understory 
vegetation in forests, at forest edges, or in the open. Most of the species have young 
branchlets, and in some species the angles become so pronounced as to become wing-
like. The leaves are usually opposite to each other, and mostly petiolate. All species 
have a small to large gland right below the apex of the sepal. A unique peculiarity of 
most species of this genus is the nose-like ventral appendage of the mericarp which is a 




In the most recent revision of the genus by Middleton, a total of 24 species are 
recognized, two of which have two varieties each.
140,146
 Eighteen species occur in 
Peninsular Malaysia, while four are found in Malaysian Borneo (Sabah and 
Sarawak).
145
 They are listed as follows:
140,145
  
i. K. arborea Blume 
ii. K. dasyrachis Ridl. 
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iii. K. deverrei L. Allorge 
iv. K. fruticosa (Roxb.) A. DC. 
v. K. grandifolia D. J. Middleton 
vi. K. griffithii King & Gamble var. griffithii 
vii. K. griffithii King & Gamble var. pubescens D. J. Middleton 
viii. K. larutensis King & Gamble 
ix. K. macrophylla Hook. f. 
x. K. pauciflora Hook. f. var. pauciflora 
xi. K. pauciflora Hook. f. var. mitrephora (Sleesen) D. J. Middleton 
xii. K. profunda Markgr. 
xiii. K. rajangensis D. J. Middleton 
xiv. K. rosea D. J. Middleton 
xv. K. singapurensis Ridl. 
xvi. K. sleeseniana Markgr. 
xvii. K. tenuis Leenh. & Steenis 
xviii. K. teoi L. Allorge 
 
In Malaysia, the roots of K. larutensis, K. pauciflora, K. profunda (K. macrophylla), and 
K. singapurensis are used for poulticing ulcerated noses in tertiary syphilis.
145
 Under the 
name ‘somu’, K. flavida is used as a contraceptive in Vanuatu.145 While in China, K. 
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1.5.2 Alkaloids of the Genus Kopsia 
 
Plants of the genus Kopsia have proven to be prodigious sources of indole alkaloids 
with alkaloids of the aspidofractinine skeletal type predominating (Table 1.2). In 
addition to the known bisindoles, viz., kopsoffinol, (−)-norpleiomutine, (–)-
demethylnorpleiomutine, (+)-kopsoffine, tenuiphylline, nitaphylline, and the quasidimer 
buchtienine, a new bisindole of the corynantheaspidospermatan type, kopsiyunnanine 
A, was recently isolated from the aerial part of a Kopsia species.
149
 Several 
monoterpene alkaloids related to skytanthine (kinabalurines AG, kopsilactone, and 
kopsone)
 




1.5.3 Occurrence and Distribution of Alkaloids in the Genus Kopsia 
 
The occurrence of alkaloids in Kopsia as reported in the literature (up to May 2012) is 






Table 1.2: Occurrence of Alkaloids in Kopsia 
Plant
a
 Plant part Alkaloid References 
K. arborea Blume Leaves Arbophylline (137) 151 
(Peninsular   Methyl N(1)-decarbomethoxychanofruticosinate (98) 152 
Malaysia)  Methyl 11,12-methylenedioxy-N(1)-
decarbomethoxychanofruticosinate (95) 
152 
  Methyl 11,12-methylenedioxychanofruticosinate (96) 152 
  Methyl 11,12-methylenedioxy-N(1)-
decarbomethoxy-14,15-chanofruticosinate (308) 
152 
  Prunifoline A (296)  153 
  Prunifoline B (297) 153 
  Prunifoline C (298) 153 
  Prunifoline D (299) 153 
  Prunifoline E (300) 153 
  Prunifoline F (301) 153 
    
 Stem-bark Akuammidine (46) 154,155 
  Arboflorine (134) 154-156 
  Arboloscine (17) 155,157  
  Arboricine (135) 155,158  
  Arboricinine (136) 155,158 
  Aspidofractinine (200) 155 
  Dasyrachine (313) 155 
  N(1)-Decarbomethoxykopsamine (81) 155 
  5,21-Dihydrorhazinilam (24) 155 
  15-Hydroxykopsinine (190)  155 
  Kopsamidine A (192) 155 
  Kopsamidine B (193) 155 
  Kopsamine (80) 155 
  Kopsamine N-oxide (213) 155 
  Kopsanone (84) 155 
  Kopsifine (87) 155 
  Kopsiflorine (215) 155 
  Kopsilongine (82) 155 
  Kopsinidine A (277)   155 
  Kopsinidine B (278)  155 
  Kopsinine (79) 155 
  Leuconoxine (14) 155 
  Mersicarpine (16) 155,159 
  N(1)-Methoxycarbonyl-11,12-dimethoxykopsinaline 
(= 11-Methoxykopsilongine) (218)  
155 
  19(S)-Methoxytubotaiwine (161) 155 
  19(R)-Methoxytubotaiwine (162) 155 
  Methyl N(1)-decarbomethoxychanofruticosinate (98) 155 
  11,12-Methylenedioxykopsine (85) 155 
  O-Methylleuconolam (20) 155 
  Methyl 12-methoxychanofruticosinate (99) 155 
  Methyl 11,12-methylenedioxychanofruticosinate (96) 155 
  Methyl 11,12-methylenedioxy-N(1)-
decarbomethoxychanofruticosinate (95) 
155 
  Methyl 11,12-methylenedioxy-N(1)-
decarbomethoxy-14,15-chanofruticosinate (308) 
155 
  Norfluorocurarine (55) 155 
  Paucidactine B (275) 155 
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Table 1.2, continued 
Plant
a
 Plant part Alkaloid References 
  Paucidactine C (276)  155 
  Pericidine (158) 155,157 
  Pericine (159) 155 
  Pericine N-oxide (160) 155 
  Pleiocarpamine (51) 155 
  Prunifoline E (300) 155 
  Rhazimal (144) 155 
  Rhazinicine (27) 155 
  Rhazinilam (25) 155 
  Rhazinoline (143) 155 
  Tetrahydroalstonine (43) 155 
  Valparicine (157) 155,160 
  Venalstonidine (202)   155 
  Venalstonine (201)  155 
  Vincadifformine (186) 155 
    
    
K. arborea Blume Leaves Danuphylline B (320)   161 
(K. flavida)  Flavisiamine A (= Prunifoline D) (299) 162 
(Peninsular  Flavisiamine B (303) 162 
Malaysia)  Flavisiamine C (= Prunifoline F) (301) 162 
  Flavisiamine D (= Prunifoline E) (300) 162 
  Flavisiamine E (304) 162 
  Flavisiamine F (309)  162 
  12-Methoxykopsine (86) 161 
  Methyl 11,12-dimethoxychanofruticosinate (305) 163 
  Methyl 11,12-methylenedioxy-N(1)-decarbo-
methoxychanofruticosinate (95) 
163 
  Methyl 12-methoxychanofruticosinate (99) 163 
  Methyl 12-methoxy-N(1)-decarbomethoxy-
chanofruticosinate (306) 
163 
  Methyl 3-oxo-11,12-methylenedioxy-N(1)-decarbo-
methoxy-14,15-didehydrochanofruticosinate (311) 
164 
  Methyl 3-oxo-12-methoxy-N(1)-decarbomethoxy-
14,15-didehydrochanofruticosinate (312) 
164 
  Prunifoline C (298) 162 
 
    
    
K. arborea Blume  Leaves Kopsine (279)  165-168 
(K. albiflora, K.     
 pruniformis)     
(India)    
    
    
K. arborea Blume Leaves 14,15-Dehydrokopsijasminilam (329)   169 
(K. jasminiflora)  10-Demethoxykopsidasinine (323) 170 
(Thailand)  Deoxykopsijasminilam (328) 169 
  Fruticosamine (282)  169 
  Fruticosine (281) 169 
  Jasminiflorine (284)   169 
  Kopsijasmine (255)  169 
  Kopsijasminilam (327) 169 
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Table 1.2, continued 
Plant
a
 Plant part Alkaloid References 
K. arborea Blume Leaves  Kopsamine (80) 171,172 
(K. longiflora)  Kopsiflorine (215) 171,172 
(Queensland,  Kopsilongine (82) 171,172 
Australia)    
 Stem-bark Kopsamine (80) 171,172 
  Kopsilongine (82) 171,172 
  Kopsinine (79) 171,172 
    
    
K. arborea Blume 
(K. pitardii) 
Leaves  Methyl 11,12-methylenedioxy-N(1)-decarbo-
methoxy-14,15-chanofruticosinate (308) 
173 
(Vietnam)  Methyl N(1)-decarbomethoxychanofruticosinate (98) 173 
  Methyl 11,12-methylenedioxychanofruticosinate (96) 173 
    
    
K. arborea Blume  Leaves 11,12-De(methylenedioxy)danuphylline (319)  174 
(K. officinalis)  (+)-Eburnamonine (29) 174 
(China)  16-Hydroxyaspidofractinine (211) 174 
  ()-19(R)-Hydroxyisoeburnamine (67) 174 
  (+)-19(R)-Hydroxyeburnamine (68) 174 
  (+)-Isoeburnamine (33) 174 
  Kopsamine (80) 174 
  Kopsiflorine (215)  174 
  Kopsilongine (82) 174 
  Kopsinine (79) 174 
  Kopsinine N-oxide (189) 174 
  Kopsininic acid (203)  174 
  Larutenine (= Larutensine) (65) 174 
  11-Methoxykopsilongine (218)   174 
  12-Methoxykopsinaline (222) 174 
  Methyl 11,12-methylenedioxychanofruticosinate (96) 174,175 
  Methyl chanofruticosinate (97) 174,175 
  Methyl N(1)-decarbomethoxychanofruticosinate (98) 175 
  Methyl N(1)-decarbomethoxy-14,15-3-oxo-
chanofruticosinate (310) 
174 
  Rhazinicine (27) 174 
    
 Leave-twigs Methyl 5-oxo-chanofruticosinate (302)  176 
    
 Roots 5,22-Dioxokopsane (287) 147 
  ()-Isoeburnamine (172) 147,177 
  Kopsinine (79) 147,177 
  (+)-Kopsoffine (376) 177 
  N(1)-Methoxycarbonyl-11,12-dimethoxykopsinaline 
(= 11-Methoxykopsilongine) (218) 
147 




kopsinaline (= kopsamine) (80) 
147 
  12-Methoxykopsinaline (222) 147 
  11,12-Methylenedioxykopsinaline (81) 147 
  ()-Quebrachamine (76) 147 
  Tetrahydroalstonine (43) 147 
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Table 1.2, continued 
Plant
a
 Plant part Alkaloid References 
 Aerial Arboloscine (17) 178 
  Condylocarpine (92) 149,179 
  Condylocarpine N-oxide (166) 179 
  Eburenine (187) 180 
  ()-Eburnamenine (30) 180 
  ()-Eburnamine (34) 180 
  ()-Eburnamonine (29) 180 
  ()-Ethyleburnamine (= O-Ethyleburnamine) (174) 180 
  ()-Ethylisoeburnamine (= O-Ethylisoeburnamine) 
(175) 
180 
  Isocondylocarpine (168) 179 
  Isocondylocarpine N-oxide (169) 179 
  ()-Isoeburnamine (33) 180 
  Kopsiyunnanine A (381)  149 
  Kopsiyunnanine B (133) 149 
  Kopsiyunnanine C1 (= 5-Methoxymethylrhazinilam) 
(183) 
178 
  Kopsiyunnanine C2 (= 5-Ethoxymethylrhazinilam) 
(184) 
178 
  Kopsiyunnanine C3 (=5-Hydroxymethylrhazinilam) 
(185) 
178 
  Kopsiyunnanine D (180) 178 
  Kopsiyunnanine F1 (= 19S,20R-Epoxy-tubotaiwine) 
(163) 
179 
  Kopsiyunnanine F2 (= 19R,20R-Epoxy-tubotaiwine) 
(164) 
179 
  Kopsiyunnanine F3 (= 19R,20S-Epoxy-tubotaiwine) 
(165) 
179 
  Kopsiyunnanine G (188)  180 
  Kopsiyunnanine H (181) 180 
  Mersicarpine (16) 178 
  19(S)-Methoxytubotaiwine (161) 179 
  19(R)-Methoxytubotaiwine (162) 179 
  ()-Methyleburnamine (= O-Methyleburnamine) (32) 180 
  ()-Methylisoeburnamine (= O-Methyl-
isoeburnamine) (31) 
180 
  ()-Quebrachamine (76) 178 
  Rhazinilam (25) 178 
  Tetrahydroalstonine (43) 149 
  Tubotaiwine (57) 149 
    









  N(1)-Carbomethoxy-12-methoxykopsinaline (82)  181 




  Kopsamine (80) 181 
  Kopsamine N-oxide (213) 181 
  Kopsanone (84) 181 
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Table 1.2, continued  
Plant
a
 Plant part Alkaloid References 
  Kopsinilam (191) 181 
  Kopsinine (79) 181 
  Pleiocarpine (197) 181 
  Vincadifformine (186) 181 




  Kopsinine (79) 148 
  Kopsamine (80) 148 










    
    
K. arborea Blume Leaves  Flavisiamine A (= Prunifoline D) (299) 182 
(Indonesia)  Flavisiamine C (= Prunifoline F) (301) 182 
  Flavisiamine D (= Prunifoline E) (300) 182 
  Kopreasin A (307) 182 
  Methyl N(1)-decarbomethoxychanofruticosinate (98) 182 
  Methyl 12-methoxychanofruticosinate (99) 182 
  Methyl 12-methoxy-N(1)-decarbomethoxy-
chanofruticosinate (306) 
182 
  Methyl 11,12-methylenedioxychanofruticosinate (96) 182 
  Methyl 11,12-methylenedioxy-N(1)-
decarbomethoxychanofruticosinate (95) 
182 
  Methyl 11,12-methylenedioxy-N(1)-
decarbomethoxy-14,15-chanofruticosinate (308) 
182 
  Prunifoline B (297)  182 
    
    
K. dasyrachis  Leaves Danuphylline (318)   183-185 
Ridl. (Sabah, 
Malaysian 
 11,12-Dimethoxykopsamine (= 11-Methoxy-
kopsilongine) (218) 
183 
Borneo)  Kinabalurine G (127) 183 
  Kopsamine (80) 183 
  Kopsamine N-oxide (213) 183 
  Kopsidasine (258) 186 
  Kopsidasine N-oxide (259) 186 
  Kopsidasinine (321)  186 
  Kopsifine (87) 183 
  Kopsirachine (130) 183,187 
  12-Methoxypleiocarpine (194)  183 
  Methyl chanofruticosinate (97) 183 
  Methyl N(1)-decarbomethoxychanofruticosinate (98) 183 
  Methyl 11,12-methylenedioxychanofruticosinate (96) 183 
  Methyl 11,12-methylenedioxy-N(1)-decarbo-
methoxychanofruticosinate (95) 
183 
  Pleiocarpine (197)  183 
    
 Stem-bark N(1)-Carbomethoxy-5,22-dioxokopsane (288) 188 
  Dasyrachine (313) 188 
  Decarbomethoxykopsifine (88) 188 
  ()-Demethylnorpleiomutine (377) 188 
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Table 1.2, continued 
Plant
a
 Plant part Alkaloid References 
  (+)-Eburnamonine (29) 188 
  ()-19(R)-Hydroxyisoeburnamine (67) 188,189 
  (+)-19(R)-Hydroxyeburnamine (68) 188,189 
  16-Hydroxymethylpleiocarpamine (52) 188 
  (+)-Isoeburnamine (33) 188 
  Kopsamine (80) 188 
  Kopsamine N-oxide (213) 188 
  Kopsifine (87) 188,190 
  Kopsiflorine (215) 188 
  Kopsiflorine N-oxide (216) 188 
  Kopsilongine (82) 188 
  Kopsinarine (285)  188 
  Kopsine (279)  188 
  Kopsinine (79) 188 
  Kopsinine N-oxide (189) 188 
  (+)-Kopsoffinol (378) 188 
  Leuconoxine (14) 188 
  11-Methoxykopsilongine (218) 188 
  11-Methoxykopsilongine N-oxide (220)  188 
  12-Methoxypleiocarpine (194) 188 
  11,12-Methylenedioxykopsinaline (81) 188 
  11,12-Methylenedioxykopsine (85) 188 
  ()-Norpleiomutine (100) 188 
  Paucidactine B (275) 188 
  Pleiocarpamine (51) 188 
  Pleiocarpine (197) 188 
  Rhazinicine (27) 188,190 
  Tetrahydroalstonine (43) 188 
    
    
K. deverrei  Leaves 14,15-Dihydro-10-methoxykopsinone (208) 191 
L. Allorge  10-Methoxykopsinone (206)  191 
(Peninsular  12-Methoxykopsinone (207)  191 
Malaysia)    
 Stem-bark N(1)-Carbomethoxy-17-hydroxykopsinine (195) 192 
  N(1)-Carbomethoxy-17-hydroxy-14,15-kopsinine 
(196) 
192 
  Deacetylakuammiline (= Rhazimol) (145) 193 
  16-Epi-deacetylakuammiline (148) 193 
  14-Hydroxycondylocarpine (167) 193 
  16-Hydroxymethylpleiocarpamine (52) 193 
  N(1)-Methoxycarbonyl-11,12-methylenedioxy-
kopsinaline (80)  
192 
  N(1)-Methoxycarbonyl-12-methoxykopsinaline 
(82) 
192 
  Kopsinone (205)   192 
  Pleiocarpamine (51) 193 
    
    
K. fruticosa 
(Roxb.) A. DC. 
Leaves Fruticosamine (282) 141,162,194
-196 
(India, Indonesia,  Fruticosiamine A (283)  162 
Malaysia)  Fruticosine (281)  141,162,194
-196 
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Table 1.2, continued 
Plant
a
 Plant part Alkaloid References 
  Kopsine (279)  141,162,195
-202 
  Decarbomethoxykopsine (280) 202 
  Decarbomethoxyisokopsine (314) 202 
  Methyl decarbomethoxychanofruticosinate (98) 162 
    
    
K. grandifolia Stem-bark Epi-lapidilectinol (338) 203 
D. J. Middleton  Isolapidilectine A (335) 203 
(K. lapidilecta)  Lapidilectam (336)  203 
(Peninsular  Lapidilectine A (334) 203,204 
Malaysia)  Lapidilectine B (343) 203 
  Lapidilectinol (337) 203 
  Venalstonine (201)  203 
    
 Leaves Lapidilectine B (343) 203,204 
    
 Stem-bark
d
 Grandilodine A (331) 205 
  Grandilodine B (332) 205 
  Isolapidilectine A (335) 205 
  Kopsinine (79) 205 
  Lapidilectam (336) 205 
  Lapidilectine A (334) 205 
    
 Leaves
d
 Grandilodine C (333) 205 
  Lapidilectine B (343) 205 
    
    
K. griffithii  Leaves Buchtienine (380) 206 
King & Gamble 
(Peninsular 
 N(1)-Carbomethoxy-11,12-dimethoxy-kopsinaline 





  (+)-Eburnamonine (29) 206 
  Epi-leuconolam (21) 207 
  Harmane (131) 206 
  (+)-Harmicine (132) 206 
  16(R)-19,20-E-Isositsirikine (47) 206 
  Kopsamine (80) 206 
  Kopsamine N-oxide (213)  206 
  Kopsilongine (82) 206 
  Kopsinine (79) 206 
  Leuconolam (19) 206 




  12-Methoxy-10-demethoxykopsidasinine (322) 206 
  12-Methoxypleiocarpine (194) 206 
  6-Oxoleuconoxine (15) 208 
  Pleiocarpine (197)  206 
  Rhazimol (= Deacetylakuammiline) (145) 206 
  Tetrahydroalstonine (43) 206 
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Table 1.2, continued 
Plant
a
 Plant part Alkaloid References 
 Stem-bark Akuammiline N-oxide (149) 209 
  Buchtienine (380) 209 
  Deacetylakuammiline (= Rhazimol) (145) 209 
  ()-Eburnamine (34) 209 
  16-Epi-deacetylakuammiline (148) 209 
  16-Epi-deacetylakuammiline N-oxide (150) 209 
  Harmane (131) 209 
  Kopsinine (79) 209 
  Kopsinine N-oxide (189)  209 
  Leuconolam (19) 209 
  Leuconoxine (14) 209 
  11,12-Methylenedioxykopsinaline N-oxide (214)  209 
  Rhazinaline N-oxide (115) 209 
    
    
K. hainanensis  Leaves-  Kopsihainanine A (315) 210 
Tsiang (China) stems Kopsihainanine B (316) 210 
    




  (+)-Eburnamine (171) 211 
  ()-Isoeburnamine (172) 211 
  Kopsihainin A (317) 212 
  Kopsihainin B (198) 212 
  Kopsihainin C (199) 212 
  Kopsanone (84) 211 
  Kopsinilam (191) 211 
  Kopsinine (79) 211,212 
  Kopsininic acid (203) 211 
  Kopsinoline (= Kopsinine N-oxide) (189) 211 
  (+)-Kopsoffine (376) 211 
  Methyl N(1)-decarbomethoxychanofruticosinate (98) 212 
  (+)-Tubotaiwine (57) 211 
    
 Twigs- Kopsinine (79) 213 
 leaves Tubotaiwine (57) 213 
    
K. larutensis Leaves ()-Eburnamine (34) 214 
King & Gamble  (+)-Eburnamonine (29) 214 
(Peninsular   (+)-Eburnamonine N-oxide (173) 214 
Malaysia)  (+)-Isoeburnamine (33) 214 
  (+)-Larutenine/larutensine (65) 214 
    
 Stem-bark (+)-Eburnamenine (30) 215 
  ()-Eburnamine (34) 215,216 
  ()-Eburnaminol (177) 216 
  (+)-Eburnamonine (29) 215,216 
  (+)-Eburnamonine N-oxide (173) 215 
  ()-O-Ethyleburnamine (174) 215 
  (+)-Isoeburnamine (33) 215,216 
  Kopsinine (79) 215,216 
  (+)-Larutensine/larutenine (65) 215,216 
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Table 1.2, continued 
Plant
a
 Plant part Alkaloid References 
K. pauciflora Leaves Kinabalurine A (121) 217,218 
Hook.f.  Kinabalurine B (122) 218 
(Sabah, Malaysian   Kinabalurine C (123) 218 
Borneo)  Kinabalurine D (124) 218 
  Kinabalurine E (125) 218 
  Kinabalurine F (126) 218 
  Kopsamine (80) 219 
  Kopsamine N-oxide (213)  219 
  Lahadinine A (225)  220 
  Lahadinine B (226)   220 
  11-Methoxykopsilongine (218) 219 
  Paucidactine A (274) 221 
  Paucidactine B (275)  221 
  Paucifinine (83) 220 
  Paucifinine N-oxide (224) 220 
  Pauciflorine A (324)   222 
  Pauciflorine B (325) 222 
  Pauciflorine C (326) 219 
  Paucifoline (330) 219 
    
 Stem-bark ()-Demethylnorpleiomutine (377) 223 
  ()-Eburnamine (34) 224 
  (+)-Eburnamonine (29) 224 
  (+)-Isoeburnamine (33) 224 
  Kopsamine N-oxide (213) 224 
  Kopsinine (79) 224 
  (+)-Kopsoffine (376) 223 
  (+)-Kopsoffinol (378) 223 
  N(1)-Methoxycarbonyl-11,12-dimethoxykopsinaline 
(= 11-Methoxykopsilongine) (218) 
224 
  N(1)-Methoxycarbonyl-12-methoxy-16,17-kopsinine 
(261) 
224 




kopsinaline (= kopsamine) (80) 
224 
  12-Methoxy-10-demethoxykopsidasinine (322) 224 
  ()-Norpleiomutine (100) 223,224 
  (+)-19-Oxoeburnamine (66) 224 
  Pauciflorine A (324)  219 
    
    








  N(1)-Methoxycarbonyl-12-methoxy-16,17-kopsinine 
(261) 
225,226 







kopsinine N-oxide (263) 
225 
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Table 1.2, continued 
Plant
a
 Plant part Alkaloid References 
K. profunda  Leaves Kopsilactone (128) 227 
Markgr.  Kopsone (129) 227 
(K. macrophylla)    
(Peninsular  Stem-bark Akuammiline (146) 227 
Malaysia)  Deacetylakuammiline (145) 227 
  5,22-Dioxokopsane (287) 227 
  Dregamine (138)  227 
  (+)-Kopsoffine (376) 227 
  Norpleiomutine (100) 227 
  Tabernaemontanine (139) 227 
    
    
K. profunda  Stem-bark ()-Eburnamine (34) 228 
Markgr.   ()-Eburnaminol (177) 228 
(K.   (+)-Isoeburnamine (33) 228 
terengganensis)  (+)-Larutensine (155) 228 
(Peninsular   (+)-Quebrachamine (182) 228 
Malaysia)  Terengganensine A (178) 228 
  Terengganensine B (179) 228 
    
    
K. singapurensis  Leaves 16-Epi-akuammiline (147) 229 
Ridl. (1)  16-Epi-deacetylakuammiline (148) 229 
(Sample A)
e
  16-Epi-kopsinine (204)  229 
(Peninsular   Kopsidine D (269)   229 
Malaysia)  Kopsilongine (82) 229 
  Kopsilongine N-oxide (219) 229 
  Kopsiloscine A (228) 229 
  Kopsiloscine B (229) 229 
  Kopsiloscine C (230) 229 
  Kopsiloscine D (231) 229 
  Kopsiloscine E (232) 229 
  Kopsiloscine F (233)  229 
  Kopsingine (237) 229 
  Vincophylline (140) 229 
    
 Stem-bark Akuammidine (46) 229 
  Aspidodasycarpine (151) 229 
  Aspidophylline A (152) 229 
  16-Epi-akuammiline (147) 229 
  16-Epi-deacetylakuammiline (148) 229 
  17-Hydroxy-14,15-kopsinine (227) 229 
  Kopsaporine (238) 229 
  Kopsinganol (246) 229 
  Kopsingine (237) 229 
  Kopsinine (79) 229 
  Leuconolam (19) 229 
  Lonicerine (154) 229 
  Rhazinal (26) 229,230 
  Rhazinilam (25) 229 
  Tetrahydroalstonine (43) 229 
 
 30 
Table 1.2, continued  
Plant
a
 Plant part Alkaloid References 
K. singapurensis  Leaves Akuammidine (46) 231 
Ridl. (2)  16-Epi-akuammiline (147) 231 
(Sample B)
e
  16-Epi-deacetylakuammiline (148) 231 
(Peninsular   Kopsidarine (247) 231 
Malaysia)  Kopsidine A (265) 231 
  Kopsidine C (267) 231 
  Kopsidine C N-oxide (268) 231 
  Kopsimaline F (253) 231 
  Kopsinganol (246) 231 
  Kopsingine (237) 231 
  Kopsinitarine A (289) 231 
  Kopsinitarine B (290) 231 
  Mersingine A (294)  231 
    
 Stem-bark Akuammidine (46) 231 
  Aspidodasycarpine (151) 231 
  Aspidophylline B (153) 231 
  5,21-Dihydrorhazinilam (24) 231 
  16-Epi-akuammiline (147) 231 
  16-Epi-deacetylakuammiline (148) 231 
  17-Hydroxy-14,15-kopsinine (227) 231 
  Kopsiloscine C (230) 231 
  Kopsiloscine G (234) 231 
  Kopsinganol (246) 231 
  Kopsingine (237) 231 
  Kopsinine (79) 231 
  Lonicerine (154) 231 
  Rhazinilam (25) 231 
    
    
K. singapurensis  Leaves Akuammidine (46) 232 
Ridl. (3)   N(1)-Decarbomethoxykopsamine (81) 232 
(K. fruticosa)    5,21-Dihydrorhazinilam (24) 232 
(Peninsular   16-Epi-akuammiline (147) 232 
Malaysia)  16-Epi-deacetylakuammiline (148) 232 
  17-Hydroxy-14,15-kopsinine (227)  232 
  Kopsiloscine G (234) 232 
  Kopsiloscine J (245)   232 
  Kopsimaline A (248) 232 
  Kopsimaline B (249) 232 
  Kopsimaline C (250) 232 
  Kopsimaline D (251) 232 
  Kopsimaline E (252) 232 
  Kopsinicine (244)  232 
  Kopsofinone (210) 232 
  Mersinine A (354)   233,234 
  Mersinine B (355)  233,234 
  Mersinine C (356) 234 
  Mersiloscine (357)  233,234 
  Mersiloscine A (358) 234 
  Mersiloscine B (359) 234 
  Mersifoline A (360)  234 
  Mersifoline B (361) 234 
 31 
Table 1.2, continued  
Plant
a
 Plant part Alkaloid References 
  Mersifoline C (362) 234 
  Mersidasine A (363)  234 
  Mersidasine B (364)  234 
  Mersidasine C (365)  234 
  Mersidasine D (366)  234 
  Mersidasine E (367)  234 
  Mersidasine F (368)  234 
  Mersidasine G (369)  234 
  Mersiphylline A (370)  235,236 
  Mersiphylline B (371) 235,236 
  Mersilongine (374)  232,237 
  Mersirachine (372)  232,238 
  Mersinaline (373) 232,238 
  Rhazinilam (25) 232 
    
 Stem-bark Akuammidine (46) 232 
  Aspidodasycarpine (151) 232 
  Burnamine (155) 232 
  Deacetylakuammiline (145) 232 
  5,21-Dihydrorhazinilam (24) 232 
  16-Epi-akuammiline (147) 232 
  16-Epi-deacetylakuammiline (148) 232 
  14-Hydroxycondylocarpine (167) 232 
  16-Hydroxymethylpleiocarpamine (52) 232 
  Kopsiloscine H (235) 232 
  Kopsiloscine I (236)  232 
  Kopsinine (79) 232 
  Leuconolam (19) 232 
  Leuconoxine (14) 232 
  Lonicerine (154) 232 
  Mersicarpine (16) 159,232 
  Mossambine (170)  232 
  Picramicine (156) 232 
  Rhazinilam (25) 232 
  Tetrahydroalstonine (43) 232 
    
    
K. singapurensis  Leaves 15-Hydroxykopsinine (190)  239 
Ridl. (4)  Kopsifoline A (348)    239-241 
(K. fruticosa)   Kopsifoline B (349) 239-241 
(Peninsular   Kopsifoline C (350) 239-241 
Malaysia)  Kopsifoline D (351) 239,241 
  Kopsifoline E (352) 239,241 
  Kopsifoline F (353) 239,241 
  Kopsorinine (286)  239 
  Venacarpine A (256)   239 
  Venacarpine B (257) 239 
    
 Stem-bark Akuammigine (141) 239 
  16-Epi-deacetylakuammiline (148) 239 
  16-Epi-kopsinine (204) 239 
  15-Hydroxykopsinine (190) 239 
  16-Hydroxymethylpleiocarpamine (52) 239 
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Plant
a
 Plant part Alkaloid References 
  Kopsanone (84) 239 
  Kopsinine (79) 239 
  Kopsorinine (286)  239 
  Lonicerine (154) 239 
  Picramicine (156) 239 
  Pleiocarpamine (51) 239 
  Venalstonine (201) 239 
    
    
K. singapurensis Leaves 5,21-Dihydrorhazinilam (24) 242,243 
Ridl. (5)  Kopsifoline A (348) 244 
(Peninsular   Kopsininic acid (203)  244 
Malaysia)  11,12-Methylenedioxykopsaporine (241) 242,243 
  Rhazinilam (25) 242,243 
  Singaporentine A (347) 244 
    
 Stem-bark 11,12-Methylenedioxykopsaporine (241) 242 
  Singapurensine A (270) 242 
  Singapurensine B (271) 242 
  Singapurensine C (272) 242 
  Singapurensine D (273) 242 
    
    
K. singapurensis Leaves Kopsaporine (238) 245,246 
Ridl. (6)   Kopsingine (237) 245,246 
(Peninsular     
Malaysia)    
    
    
K. tenuis  Leaves Lundurine A (339) 247,248 
Leenh. & Steenis  Lundurine B (340)  247,248 
(Sarawak,   Lundurine C (341) 247,248 
Malaysian Borneo)  Lundurine D (342) 247 
  Tenuiphylline (379) 249 
  Tenuisine A (344)  247,249,250 
  Tenuisine B (345) 247,249,250 
  Tenuisine C (346)  247,249,250 
    
 Stem Kopsinine (79) 219 
  Kopsinine N-oxide (189) 219 
 
 
 Leuconoxine (14) 219 
  Tetrahydroalstonine (43) 219 
    
    
K. teoi L.  Leaves 11-Hydroxykopsingine (239) 251 
Allorge (1)  Kopsidine A (265) 251-253 
(Peninsular   Kopsidine B (266) 251-253 
Malaysia)  Kopsidine C (267) 251,253 
  Kopsidine D (269) 251,253 
  14,15--Epoxykopsingine (= Kopsimaline E) (252) 251 
  Kopsinganol (246) 251,252 
  Kopsingine (237) 251,252 
  Kopsinitarine A (289) 251,254,255 
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  Kopsinitarine B (290) 251,254,255 
  Kopsinitarine C (291) 251,254,255 
  Kopsinitarine D (292) 251,255 
  Mersingine A (294) 251,254,256 
  Mersingine B (295)  251,254,256 
  11-Methoxy-12-hydroxykopsinol (243) 251 
  11-Methoxykopsingine (240) 251 
  Nitaphylline (375)   251,257,258 
    
 Stem-bark
e
 Akuammiline (146) 251,252,259 
  Aspidodasycarpine (151) 251 
  16-Epi-deacetylakuammiline (148) 251 
  17-Hydroxy-
14,15
-kopsinine (227)  251,252,257
,259,260 
  Kopsaporine (238) 251,252,259
,260 
  Kopsinganol (246) 251,252,259 
  Kopsingine (237) 251,252,259
,260 
  Kopsinginine (223) 251,252,259
,260 
  Kopsinginol (212) 251,252,259 
  Kopsinol (242) 251,252,259 
  Lonicerine (154) 251 
  11,12-Methylenedioxykopsaporine (241) 251 
  Rhazimol (= Deacetylakuammiline) (145) 251,252,259 
  Rhazinilam (25) 251,252,259 
    
    
K. teoi L.  Stem-bark
e
 Akuammiline (146) 208 
Allorge (2)  Aspidodasycarpine (151) 208 
(Peninsular   Deacetylakuammiline (= Rhazimol) (145) 208 
Malaysia)  16-Epi-akuammiline (147) 208 
  16-Epi-deacetylakuammiline (148) 208 
  16-Epi-kopsinine (204)  208 
  17-Hydroxykopsinine (= Kopsiloscine G) (234) 208 
  16-Hydroxymethylpleiocarpamine (52) 208 
  Kopsamine (80) 208 
  Kopsidine A (265) 208 
  Kopsijasminine (254) 208 
  Kopsinganol (246) 208 
  Kopsingine (237) 208 
  Kopsinine (79) 208 
  Kopsinitarine E (293)  208 
  Kopsonoline (209)  208 
  Leuconoxine (14) 208 




  Pleiocarpamine (51) 208 
  Tetrahydroalstonine (43) 208 
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K. teoi L.  Leaves Kopsingine (237)  261 
Allorge (3)   11,12-Methylenedioxykopsaporine (241) 261 
(Peninsular     




  Kopsingine (237) 261 
  Lonicerine (154) 261 
  Rhazinilam (25) 261 
a 
Classification according to Middleton
140
 with original attribution in parenthesis; 
b 
[]D not reported; 
c 
Plant part not specified; 
d 
Reinvestigation of plant material collected at same location and same dates; 
e 




























1.6 Fungi  
 
1.6.1 The Genus Penicillium  
 
Penicillium belongs to the family Trichocomaceae of the order Eurotiales of the 
kingdom Fungi.
262,263
 The genus is characterized by the production of asexual spores 
(conidia) from verticels of phialides supported on a conidiophore.
262
 The conidiophore 
lacks a distinctive foot-cell, and it branches at the apex into a brush-like structure 
known as the penicillus.
263
 The taxonomy of this genus is complicated as its 
classification is based mainly on the structures of the conidiophore and conidia.
264
 A 





1.6.2 Chemical Constituents of the Genus Penicillium  
 
Penicillium species are known to produce a great variety of compounds including, -
lactam antibiotics, alkaloids (e.g, indole, quinoline, ergot, etc.), diketopiperazines, and 
polyketides.
266
 However, the production of secondary metabolites from a species may 
vary and is highly dependent on some variables, such as the medium ingredients, types 
of Petri dishes, volume of media, method of inoculation, and incubation conditions 
including temperature, air exchange, duration, and sporadic exposure to light.
265 
Several 
compounds of different structural classes isolated from this genus are given in Table 
1.3.   
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Table 1.3: Selected Compounds of Different Structural Classes from Penicillium 
Fungi Chemical Constituents Structural Class References 
P. aurantiogriseum Aurantiomide A (391) Quinazoline alkaloids 267 
(Sponge-derived Aurantiomide B (392)  267 
fungus) Aurantiomide C (393)  267 
    
    
P. chrysogenum Chrysogedone A (382) 2-Pyridone alkaloids 268 
 Chrysogedone B (383)  268 
 Chrysogeside A (416) Cerebroside alkaloids 268 
 Chrysogeside B (417)  268 
 Chrysogeside C (418)  268 
 Chrysogeside D (419)  268 
 Chrysogeside E (420)  268 
 Penicillin G (396) -lactam antibiotic 269 
    
    
P. chrysogenum Sorbicillactone A (397) Sorbicillinoid  270 
(Sponge-derived Sorbicillactone B (398) alkaloids 270 
fungus) Sorbivinetone (421)  270 
    
    
P. citrinum Agroclavine I (395) Ergot alkaloid 271 
 Quinocitrinin A (390) Quinoline alkaloid 272 
    
    
P. citrinum Scalusamide A (413) Pyrrolidine alkaloids 273 
(Marine-derived Scalusamide B (414)  273 
fungus) Scalusamide C (415)  273 
    
    
P. citrinum 22-Acetylisocyclocitrinol A (423) Steroids 274 
(Sponge-derived  Isocyclocitrinol A (424)  274 
fungus)    
    
    
P. cluniae Paraherquamide H (403) Oxindole alkaloids 275 
 Paraherquamide I (404)  275 
    
    
P. crustosum Thom Thomitrem A (405) Indole alkaloids 276 
 Thomitrem E (406)  276 
    
    
P. decaturense Decaturin A (401) Oxalicine alkaloids 277 
 15-Deoxyoxalicine B (400)  277 
    
    
P. fellutanum Fellutanine A (407) Indole-containing  278 
 Fellutanine B (408) diketopiperazine 278 
 Fellutanine C (409) alkaloids 278 
 Fellutanine D (410)  278 
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Table 1.3, continued  
Fungi Chemical Constituents Structural Class References 
P. griseofulvum Variecolorin M (387) Indole-containing  279 
(Ocean sediment Variecolorin N (388) diketopiperazine 279 
derived fungus) Variecolorin O (389) alkaloids 279 
    












    
    
P. paneum Penipanoid A (384) Triazole alkaloid 281 
(Marine-derived     
fungus)    
    
    
P. rivulum Frisvad Communesin G (411) Alkaloids 282 
 Communesin H (412)  282 
    
    
P. roqueforti Roquefortine D (399) Indole alkaloid 283,284 
    
    
P. solitum Solistatin (422) Statin (analogue of  285 
  compactin)  
    
    
P. thiersii Decaturin B (402) Oxalicine alkaloid 277 
    
    

















1.7.1 The Genus Streptomyces  
  
Streptomyces belongs to the family Streptomycetaceae of the order Actinomycetales of 
the kingdom Bacteria. This genus produces a well-developed mycelium and the hyphae 
vary greatly in length. The vegetative mycelium does not form cross walls and it does 
not break up into rod-shaped and coccus-like bodies. The spores or conidia are formed 
in special spore-bearing hyphae or sporophores which arise from the aerial mycelium, 
either monopodially or in the form of tufts or whorls.
287
 To date, a total of 576 species 
are reported and the number of new species increases every year.
288  
 
1.7.2 Chemical Constituents of the Genus Streptomyces  
 
Streptomyces species also produce secondary metabolites of different structural classes. 
Some examples are given in Table 1.4.   
 
Table 1.4: Selected Compounds of Different Structural Classes from Streptomyces 
Bacteria Chemical Constituents Structural Class References 
S. anulatus Telomestatin (461) Macrocyclic alkaloid 289 
    
    
S. fumanus Dioxapyrrolomycin (436) Pyrrole alkaloids 290 
 Pyrrolomycin G (437)  290 
 Pyrrolomycin H (438)  290 
 Pyrrolomycin I (439)  290 




Table 1.4, continued 
Bacteria Chemical Constituents Structural Class References 
S. griseus Cephamycin A (445) -lactam antibiotic 291 
 Cephamycin B (446)  291 
 Farinamycin (447) Quinazoline 292 
 Streptomycin (458) Aminoglycoside 293,294 
    
    
S. hygroscopicus  4,5-Dihydro-19-S-methylgeldanamycin 
(459) 
Benzoquinone  295 
 19-S-Methylgeldanamycin (460) Ansamycin 295 
    
    
S. hygroscopicus Mannopeptimycin  (462) Glycopeptides 296 
 Mannopeptimycin  (463)  296 
 Mannopeptimycin  (464)  296 
 Mannopeptimycin  (465)  296 
 Mannopeptimycin  (466)  296 
    
    
S. longisporus 
ruber 
Metacycloprodigiosin (444) Tripyrrole alkaloid 297 
    
    
S. nitrosporeus Benzastatin E (448) Indoline alkaloids 298 
 Benzastatin F (449)  298 
 Benzastatin G (450)  298 
    
    
S. platensis Platencin A1 (441) Platensimycins 299 
 Platensimycin (442)  299 
 Platensimide A (443) Platencin 299 
    













 -Hydroxy-Nb-acetyltryptamine (429)  300 
    







 1,6-Dimethoxyphenazine (430) Phenazines 301 
 6-Methoxy-1-phenazinol (431)  301 
 1,6-Phenazinediol (432)  301 
 1-Phenazinol (433)  301 
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Table 1.4, continued  
Bacteria Chemical Constituents Structural Class References 
S. uncialis Cladoniamide A (451) Tryptophan-derived 302 
 Cladoniamide B (452) alkaloids 302 
 Cladoniamide C (453)  302 
 Cladoniamide D (454)  302 
 Cladoniamide E (455)  302 
 Cladoniamide F (456)  302 









1.8 Objective of the Present Research 
 
The aim of the present research is to carry out a detailed investigation of the alkaloid 
composition of Leuconotis griffithii (collected from Pahang, Peninsular Malaysia) and 
Kopsia pauciflora (collected from Terengganu, Peninsular Malaysia) involving the 
characterization of the isolated alkaloids, the discovery of new alkaloid structures, and 
the screening and evaluation of biological activity. In addition, several Penicillium and 
Streptomyces strains were selected and screened for their chemical constituents with 




2 Results and Discussion 
 
2.1 Alkaloids from Leuconotis griffithii 
 
Investigation of the alkaloidal content of the Malayan Leuconotis griffithii has provided 
a total of 60 alkaloids, of which 24 are new. Of these, several such as the tetracyclic 
ring-opened oxindole leucolusine (1), the strychnan alkaloids, leuconicines AG (28), 
the ring-C contracted rhazinilam alkaloid, nor-rhazinicine (22), the unprecedented 
eburnanequinoline dimer, leucophyllidine (36), the eburnanesarpagine bisindole, 
leuconoline (37), the aspidospermatanaspidospermatan bisindole, leucofoline (38) and 
the StrychnosStrychnos bisindoles, leucoridines AD (3942), are notable for 
incorporating novel or intriguing molecular skeletons. The remaining new alkaloids 
isolated include the leuconoxineleuconolamrhazinilam alkaloids, leuconodines AE 
(913), 3,14-dehydroleuconolam (18), and 5,21-dihydrorhazinilam N-oxide (23), and 
the eburnane alkaloid, ()-eburnamaline (28). 5,21-Dihydrorhazinilam N-oxide (23), 
leucophyllidine (36), and leucoridine A (39) showed pronounced cytotoxic effects 
against human KB cells, while leuconicines AB (23) showed strong ability to reverse 
multi-drug resistant in vincristine-resistant KB (VJ300) cells. The alkaloid composition 
of the stem-bark of L. griffithii is summarized in Table 2.1. 
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Table 2.1: Alkaloid Composition of L. griffithii 
Plant part Alkaloid Yield (g kg
1
) 
Stem-bark (13.8 kg) Leucolusine (1) [New] 0.0002 
 Leuconicine A (2) [New] 0.0297 
 Leuconicine B (3) [New] 0.0379 
 Leuconicine C (4) [New] 0.0034 
 Leuconicine D (5) [New] 0.0033 
 Leuconicine E (6) [New] 0.0034 
 Leuconicine F (7) [New] 0.0016 
 Leuconicine G (8) [New] 0.0007 
 Leuconodine A (9) [New] 0.0017 
 Leuconodine B (scholarisine G) (10) [New] 0.0012 
 Leuconodine C (11) [New] 0.0004 
 Leuconodine D (12) [New] 0.0005 
 Leuconodine E (13) [New] 0.0003 
 Leuconoxine (14) 0.0104 
 Leuconodine F (6-oxoleuconoxine) (15) 0.0006 
 Mersicarpine (16) 0.0040 
 Arboloscine (17) 0.0037 
 3,14-Dehydroleuconolam (18) [New] 0.0002 
 Leuconolam (19) 0.1124 
 O-Methylleuconolam (20) 0.0355 
 Epi-leuconolam (21) or 6,7-dehydroleuconoxine 
(21a) 
0.0005 
 Nor-rhazinicine (22) [New] 0.0011 
 5,21-Dihydrorhazinilam N-oxide (23) [New] 0.0004 
 5,21-Dihydrorhazinilam (24) 0.0044 
 Rhazinilam (25) 0.0628 
 Rhazinal (26) 0.0019 
 Rhazinicine (27) 0.0009 
 ()-Eburnamaline (28) [New] 0.0003 
 ()-Eburnamonine (29) 0.0016 
 ()-Eburnamenine (30) 0.0024 
 O-Methylisoeburnamine (31) 0.0010 
 O-Methyleburnamine (32) 0.0010 
 ()-Isoeburnamine (33) 0.0101 
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Table 2.1, continued 
Plant part Alkaloid Yield (g kg
1
) 
 ()-Eburnamine (34) 0.0113 
 ()-Vincamine (35) 0.0006 
 Leucophyllidine (36) [New] 0.0008 
 Leuconoline (37) [New] 0.0029 
 Leucofoline (38) [New] 0.0004 
 Leucoridine A (39) [New] 0.0004 
 Leucoridine B (40) [New] 0.0004 
 Leucoridine C (41) [New] 0.0003 
 Leucoridine D (42) [New] 0.0006 
 Tetrahydroalstonine (43) 0.0058 
 17(S)-Ajmalicinial (44) and 17(R)-Ajmalicinial 
(45) 
0.0012 
 Akuammidine (46) 0.0032 
 16(R)-19,20-E-Isositsirikine (47) 0.0029 
 16(S)-19,20-E-Isositsirikine (48) 0.0009 
 Z-Geissoschizol (49) 0.0003 
 Fluorocarpamine (50) 0.0006 
 Pleiocarpamine (51) 0.0290 
 16-Hydroxymethylpleiocarpamine (52) 0.0016 
 ()-Isovallesiachotamine (53) 0.0011 
 ()-Isovallesiachotamine (53) and  
()-Vallesiachotamine (54) 
0.0013 
 Norfluorocurarine (55) 0.0008 
 12-Hydroxynorfluorocurarine (56) 0.0033 
 Tubotaiwine (57) 0.0262 
 Tubotaiwine N-oxide (58) 0.0004 
 N(4)-Chloromethyltubotaiwine chloride (59)  0.0137 
 Venoterpine (60) 0.0005 





2.1.1 Oxindole Alkaloids 
 




 was isolated in a very small amount as a light yellowish oil, [α]D 55 
(CHCl3, c 0.12). The UV spectrum was characteristic of an unsubstituted oxindole 
chromophore showing absorption maxima at 206, 252, and 288 nm, while the IR 
spectrum showed bands at 3406, 3249 and 1716 cm
1
, suggesting the presence of OH, 
NH, and lactam functionalities, respectively. The EIMS of 1 showed a molecular ion 
peak at m/z 330, and HREIMS measurements established the molecular formula as 
C19H26N2O3, requiring 8 degrees of unsaturation. Strong fragment peaks were observed 
at m/z 182 (47%) and 168 (100%), which though initially puzzling, became intelligible 
after eventual unravelling of the overall structure (vide infra). The 
1
H NMR spectrum of 
1 (Figure 2.3) showed the presence of four aromatic hydrogens ( 6.747.37), an indolic 
NH ( 7.63), a broad downfield signal due to OH ( 8.13), a relatively downfield one-H 
singlet due to H(21) ( 4.29), and an ethyl side chain ( 0.84; 1.37, 1.55). The 13C NMR 
data (Table 2.2) showed a total of 19 carbon resonances (one methyl, eight methylene, 
five methine, and five quaternary carbons) in agreement with the molecular formula. 
The six aromatic carbon resonances can be readily assigned from consideration of their 
characteristic shifts as well as from the HMBC and NOE data (Figure 2.2). The 
observed NOE between the indolic NH and the aromatic doublet of doublets at  6.74 
allowed the assignment of this resonance to H(12) and the lower field doublet of 
doublets at  7.37 to H(9). The three-bond correlations from H(9) and NH to the 
downfield quaternary signal at δ 77.3 indicated that this signal was due to C(7), which, 
from its downfield shift, suggested some form of oxygenation. The C(7) substituent was 
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deduced to be an OH from the IR, MS, and 
1
H NMR data. Another downfield 
quaternary signal at δ 180.5 indicated the presence of an oxindole functionality, which 
received further support from the observed three-bond correlation from H(6) to the 
oxindole C(2). The COSY spectrum revealed three partial structures, viz., an -NCH2CH2 
fragment corresponding to NC(5)C(6), an OCH2CH2 fragment corresponding to 
OC(16)C(17), and an -NCH2CH2CH2 fragment corresponding to NC(3)C(14)C(15). 
The latter fragment was deduced with the aid of HMBC (three-bond correlations from 
H(3) and H(21) to C(15)), as the H(15) resonances were partially overlapped with the 
H(14) and H(19) signals. The singlet observed at δ 97.7 was attributed to the isolated 
methine corresponding to C(21), its downfield shift due to it being linked to both a 
nitrogen (N(4)) and an oxygen atom. 
 
 
          Figure 2.2: Selected HMBCs and NOEs of 1 
 
The above data permitted assembly of the complete structure of leucolusine (1). The 
C(7) hydroxy-substituted oxindole chromophore is attached via C(7) to one end of the 
C(5)C(6) fragment, the other end being attached to N(4). This was supported by the 
observed HMBC correlations from H(6) to C(2), and from H(21) to C(5). The N(4) 
atom forms part of an ethyl substituted cis-fused piperidine-tetrahydrofuran ring (a 3a-
ethyloctahydrofuro[2,3-b]pyridine unit) as indicated by the HMBC and NOE data. Thus, 
the three-bond correlations from H(21) to C(3), and from H(3) to C(21), indicated 
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connection of C(21) to N(4), while the observed three-bond correlation from H(14) to 
C(20) indicated attachment of C(15) to the quaternary C(20). The observed H(15)/C(21) 
and H(21)/C(15) correlations indicated that C(21) and C(20) are contiguous forming 
part of the piperidine ring. The observed correlation from H(16) to C(21) and from 
H(17) to C(21) permitted assembly of the tetrahydrofuran ring, cis-fused at C(20) and 
C(21), while the observed correlations from H(18) to C(20), and from H(17), H(21) to 
C(19), indicated attachment of the ethyl side-chain at the quaternary C(20). The cis-
fusion of the piperidino-tetrahydrofuran rings was deduced from the observed NOE 
between H(18) and H(21) (Figure 2.2) which also fixes the relative configurations at 
C(20) and C(21). The structure thus unravelled is completely in agreement with the full 
HMBC and NOE data. 
 
Scheme 2.1: Mass spectral fragmentation of 1 
 
The completed structure also permitted interpretation of the mass spectrum of 
leucolusine as shown in Scheme 2.1, in particular the origin of the strong fragments 
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observed at m/z 168 and 182, due to scission of the C(5)C(6) and C(6)C(7) bonds, 
respectively. 
A possible origin of this unusual ring-opened alkaloid is from an Aspidosperma 
precursor such as vincadifformine (186)
303
 (Scheme 2.2). Oxidative cleavage of 186 
gives the oxindole-ketoester 1a, which on subsequent decarboxylation followed by 
reduction, gives the alcohol 1b. A Grob-like, lone-pair assisted fragmentation of 1b 
leads to cleavage of the C(7)C(21) bond, furnishing the iminium ion 1c, which on 
intramolecular trapping by OH yields the tetracyclic intermediate 1d. Oxidation of 1d 
gives the epoxide 1e, which on subsequent oxidation at C(2) with concomitant epoxide 
ring-opening, leads to leucolusine (1). The proposed pathway leads to the relative 
configuration as shown in 1 although the available data does not allow assignment of 
the configuration at C(7). 
 
 
Scheme 2.2: A possible biogenetic pathway to 1 
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Another possible pathway to leucolusine (1) is from another Aspidosperma precursor, 
such as ()-quebrachamine (182) (Scheme 2.3). Saturation of the C(2) carbon of ()-
quebrachamine (182) by a free radical followed by oxidative coupling gives the oxygen-
radical adduct 1f. Hydrogen abstraction by the oxygen-radical adduct 1f furnishes the 
dioxetane intermediate 1g. Homolytic cleavage of the weak OO and C(2)C(16) bonds 
of the dioxetane intermediate leads to the diradical oxindole intermediate 1h, which is 
then followed by radical quenching to give the 7-hydroxy oxindole alkaloid 1i. 
Oxidation of the oxindole alkaloid furnishes the iminium ion 1j, which on 
intramolecular trapping by OH yields leucolusine (1). 
 











C NMR Spectroscopic Data of Leucolusine (1)
a 





2  180.5    
3 2.69 m 44.6 14 15, 21  
 2.69 m     
5 2.86 dt (13.5, 4) 50.2  21 21 
 3.38 ddd (13.5, 11, 3)     
6 1.65 m 32.2  2  
 2.12 ddd (15, 11, 4)     
7  77.3    
8  132.3    
9 7.37 dd (7.6, 1) 124.1  7, 11, 13  
10 6.98 td (7.6, 1) 122.8  8, 12  
11 7.15 td (7.6, 1) 129.2  9, 13  
12 6.74 dd (7.6, 1) 110.2  8, 10 NH 
13  140.0    
14 1.53 m 21.2  20  
 1.55 m     
15 1.35 m 26.9  3, 21  
 1.56 m     
16 3.83 td (9, 4) 64.1 17 21  
 3.94 dd (16.6, 9)     
17 1.60 m 35.1 16 15, 19, 21  
 1.75 m     
18 0.84 t (7.6) 8.9 19 20 21 
19 1.37 m 27.0 18, 20 15, 17, 21  
 1.55 m     
20  42.4    
21 4.29 s 97.7  3, 5, 15, 16, 17, 19 5, 18 
NH 7.63 s  13 7, 8 12 
OH 8.13 br s     
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13













H NMR spectrum (CDCl3, 400 MHz) of leucolusine (1) 
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2.1.2 Strychnos Alkaloids 
 




 was obtained as a light yellowish oil, with []D 473 (CHCl3, c 
0.24). The UV spectrum showed absorption maxima at 211, 282, and 369 nm, 
characteristic of a methyleneindoline chromophore. The IR spectrum (thin film) showed 
a broadened band at 3361 cm
1
 due to an amide NH2 function and another broad band at 
1672 cm
1
, due probably to overlap of conjugated lactam carbonyl and the amide I 
(carbonyl) band, while the amide II (NH) band was observed at 1614 cm
1
. In CHCl3 
solution, the two primary amide NH stretching (symmetric and asymmetric) bands were 
both detected. The H-bonded NH stretching absorptions were seen at 3479 and 3299 
cm
1
, while the free NH stretching vibrations were observed at 3684 and 3620 cm
1
. 
The lactam carbonyl and amide II signals were unchanged at 1674 and 1613 cm
1
. The 
EIMS of 2 showed a molecular ion at m/z 361, which was also the base peak, the odd 
mass indicating the presence of a third nitrogen atom. This was confirmed by HREIMS, 
which yielded the molecular formula C22H23N3O2 requiring 13 double-bond equivalents. 
Other notable fragment peaks were observed at m/z 332 (MEt) and 288 
(MEtCONH2). The 
13
C NMR data (Table 2.4) accounted for all of the 22 carbon 
resonances, comprising one methyl, five methylene, eight methine, and eight quaternary 
carbons. The presence of conjugated lactam and amide carbonyl functionalities was 
supported by the observed quaternary carbon signals at δ 161.1 and 165.8, respectively. 
The 
1
H NMR spectrum (Figure 2.6) showed the presence of an unsubstituted aromatic 
moiety (δ 7.40, dd, J = 8, 1.3 Hz, H(9); 7.30, td, J = 8, 1.3 Hz, H(10); 7.38, td, J = 8, 1.3 
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Hz, H(11); 8.50, dd, J = 8, 1.3 Hz, H(12)), an olefinic singlet at δ 8.29, and an ethyl side 
chain (δ 1.06, t, J = 7.3 Hz, H(18); 1.28, m, H(19); 1.51, m, J = 7.3 Hz, H(19)). In 
addition, the signals due to the hydrogens of a primary amide group were observed as 
two distinct one-H doublets (J = 4 Hz) at δ 9.48 and 5.92. The two signals are mutually 
coupled, as shown by homonuclear decoupling, and both slowly exchanged on addition 
of D2O (complete exchange required more than 24 h). The nonequivalence of these 
amide hydrogens is likely a consequence of a substantial barrier to rotation of the amide 





The NMR data were suggestive of a strychnan derivative, such as for example, 
akuammicine (89), except for the presence of an ethyl in place of an ethylidene side 
chain, and the incorporation of an additional ring. The COSY and HMQC data disclosed 
partial structures that are consistent with the presence of an akuammicine type skeleton, 
viz., NCH2CH2 and NCH2CH, corresponding to the NC(5)C(6) and NC(21)C(20) 
units, respectively. The COSY spectrum also showed the presence of an NCHCH2 
fragment. This partial structure should in fact be part of the NC(3)C(14)C(15) 
fragment, but extensive overlap allowed only the NC(3)C(14) fragment to be 
discerned. The presence of the C(15) methine as part of the NC(3)C(14)C(15) 
fragment linked from C(15) to C(20) can however be deduced from the three-bond 
correlations observed from H(3) and H(21) to C(15) in the HMBC spectrum. Additional 
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elements to be accounted for include a conjugated lactam carbonyl (C 161.1), a 
trisubstituted alkene (C 120.2, 145.4; olefinic H, H 8.29), and a primary amide 
function. The lactam carbonyl must be attached to the indolic nitrogen N(1) from the 
observed deshielding of the aromatic H(12) (the observed reciprocal NOEs between 
H(9) ( 7.40) and H(3) ( 4.11) allowed the assignment of the aromatic signal at  8.50 
as H(12)). Insertion of the trisubstituted double bond between this lactam carbonyl and 
C(16) results in the formation of the sixth ring (a 2-pyridone) and completes the 
assembly of the molecule.  
 
Figure 2.4: Selected HMBCs of 2 
 
Attachment of the olefinic methine, C(17) is to C(16) from the observed three-bond 
correlations from this hydrogen (H(17)) to C(2), C(15), and C(22), while the 
substitution of the amide function at C(23) is supported by the three-bond correlation 
from H(17) to the amide carbonyl as seen in the HMBC spectrum (Figure 2.4).  
        
Figure 2.5: Selected NOEs of 2 
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The relative configurations at the various stereogenic centers were established from 
NOEs (Figure 2.5) and analysis of the vicinal coupling constants. The reciprocal NOEs 
observed for H(9)/H(3) determined the relative configurations at C(7) and C(3), which 
in turn allowed the orientation of H(15) to be assigned as ,which is also in accord with 
the observed H(15)/H(17) NOE. The preferred chair conformation adopted by the 
piperidine ring D can be deduced from the absence of H(14S)/H(21) NOEs,308 as well 
as from analysis of the J20-21 vicinal coupling constants. Thus, the observed J20-21 and 
J20-21 values of 11 and 4 Hz, respectively, are consistent with the dihedral angles 
resulting from a - or equatorially-oriented C(20) ethyl group (H(21) and H(20) 
trans-diaxial with the piperidine ring D in a chair conformation).
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 In addition, the 
NOEs observed for H(15)/H(20), H(18) and H(20)/H(14S), H(21) are only consistent 
with -ethyl substitution or an equatorially-oriented ethyl at C(20). The structure and 











 was obtained as a light yellowish oil with []D  (CHCl3, c 
1.55). The UV spectrum (203, 279, and 374 nm) was similar to that of 2, while the IR 
spectrum showed bands due to conjugated ester (1737 cm
1
) and lactam (1703 cm
1
) 
carbonyl functionalities. The mass spectrum of 3 showed a molecular ion at m/z 376 
(base peak) which analyzed for C23H24N2O3, requiring 13 degrees of unsaturation. The 
13
C NMR data of 3 showed a total of 23 carbon resonances including two methyl, five 
methylene, eight methine, and eight quaternary carbons. The 
1
H (Table 2.3) and 
13
C 
NMR (Table 2.4) data of 3 were generally similar to those of 2, indicating the presence 
of an unsubstituted aromatic moiety, an olefinic singlet, a conjugated lactam function, 
and an ethyl side chain. Notable differences include the absence of the signals due to the 
amide hydrogens, and the presence instead of signals due to a methyl ester (C 165.9, 
52.4;  3.95), suggesting the replacement of the amide function in 2 by a methyl ester 
at C(23) in 3. The HMBC data also indicated incorporation of the sixth (2-pyridone) 
ring branched from the indolic nitrogen, and in addition confirmed the substitution at 
C(23) by a methyl ester group. Thus, the resonance at δ 158.8 was assigned to C(22) 
(lactam) from the observed three-bond correlation from the olefinic H(17) to C(22), 
while the other carbonyl resonance was assigned to the ester carbonyl attached to C(23), 
from the observed three-bond correlations from H(17) and the ester methyl hydrogens to 
the carbonyl resonance at δ 165.9.  
 
The relative configurations at the various stereogenic centers were established from the 
observed NOEs (which were similar to those seen in 2, Figure 2.5) as well as from 
analysis of the coupling constants (Table 2.3), which showed that the configurations at 
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the stereogenic centers in 3 are similar to those in 2. An alkaloid (alkaloid 376) with 
similar NMR (low-field) data was previously isolated from L. griffithii and L. 
eugenifolia, but with incorrect assignments of some of the 
13
C NMR signals and without 




2.1.2.3    Leuconicine C (4) 
 
Compound 4, leuconicine C,
134
 was isolated as a light yellowish oil, []D 374 (CHCl3, 
c 0.22). The UV and IR spectra were similar to those of 2, suggesting an akuammicine-
type compound with similar functionalities, such as the presence of a primary amide 
group. The EIMS of 4 showed a molecular ion at m/z 359, and HREIMS measurements 




C NMR data 
of 4 (Tables 2.3 and 2.4, respectively) were generally similar to those of 2 except for 
some differences. First, the 
13
C NMR spectrum of 4 indicated the presence of an 
additional double bond from the resonances observed at  122.8 and 129.8, 
corresponding to olefinic quaternary and methine carbons, respectively. Comparison of 
the 
13
C NMR spectrum with that of 2 showed that while the chemical shifts of the other 
carbons were essentially unchanged, those of C(20) and C(21) have undergone 
substantial shifts to the lower field sp
2
 region, indicating that these carbons correspond 
to the site of the unsaturation. This was also supported by the observed two-bond 
correlation from H(21) to C(20), and the three-bond correlations from H(3) and H(15) to 
C(21) in the HMBC spectrum. The signal due to H(20) seen in the spectrum of 2 ( 
1.88) was absent in that of 4. Instead, a new olefinic H signal corresponding to H(21) 
was observed as a singlet at  5.55 in the 1H NMR spectrum of 4, in place of the two 
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H(21) signals previously seen for 2 at  1.95 and 3.03. Corresponding changes have also 
occurred in the signals due to H(19), which in 4 are seen as a quartet (J = 7.3 Hz) at  
2.14. These features are all consistent with the presence of a double bond across C(20) 
and C(21). Catalytic hydrogenation (H2, Pd/C) of 4 yielded 2 as the sole product 
furnishing additional proof for the structure of leuconicine C (4). 
 




 was obtained as a light yellowish oil, with []D 501 (CHCl3, c 
0.42). The UV and IR spectra of 5 were similar to those of 3, indicating the presence of 
similar functionalities. The EIMS of 5 showed a molecular ion peak at m/z 374, and 
HREIMS measurements gave the molecular formula C23H22N2O3 (DBE 14). As in the 




C NMR spectroscopic data of 5 and 3 
(Tables 2.3 and 2.4, respectively) indicated that 5 is the 20,21-dehydro congener of 3. 
The C(20) and C(21) olefinic signals of 5 were seen at  122.6 and 129.9, respectively, 
and the vinylic H(21) signal was seen as a singlet at  5.55. The assignment of the 
vinylic singlet to H(21) was consistent with the observed two-bond correlation from 
H(21) to C(20), and the three-bond correlation from H(3) to C(21) in the HMBC 
spectrum.  
 
As in the case of 4, catalytic hydrogenation of 5 proceeded smoothly to furnish 3 as the 
sole product. These facile hydrogenations (4 to 2 and 5 to 3) provided additional support 
for the configurational assignments of 2 and 3 as hydrogenation was seen to proceed 




H NMR Spectroscopic Data of Leuconicines AD (25)a 
H 2 3 4 5 
3 4.11 m 4.18 m 4.21 m 4.19 m 
5 2.90 m 2.95 m 3.18 dd (12, 6.4) 3.18 dd (12, 6.4) 
5 3.17 m 3.23 m 3.30 td (12, 4.4) 3.29 td (12, 4.5) 
6 2.02 m 2.01 m 1.86 dd (12, 4.4) 1.85 dd (12, 4.5) 
6 2.94 m 2.92 m 2.28 td (12, 6.4) 2.29 m 
9 7.40 dd (8, 1.3) 7.39 dd (8, 1) 7.49 dd (8, 1) 7.44 dd (7.5, 1) 
10 7.30 td (8, 1.3) 7.28 td (8, 1) 7.34 td (8, 1) 7.30 td (7.5, 1) 
11 7.38 td (8, 1.3) 7.36 td (8, 1) 7.42 td (8, 1) 7.41 td (7.5, 1) 
12 8.50 dd (8, 1.3) 8.56 dd (8, 1) 8.57 dd (8, 1) 8.65 dd (7.5, 1) 
14R 1.38 dt (13, 3) 1.43 dt (13, 3) 1.33 dt (13, 3) 1.35 m 
14S 2.21 dt (13, 3) 2.24 dt (13, 3) 2.28 m 2.29 m 
15 2.92 m 2.88 m 3.12 m 3.05 m 
17 8.29 s 7.91 s 8.48 s 8.12 s 
18 1.06 t (7.3) 1.07 t (7.3) 1.07 t (7.3) 1.77 t (7.4) 
19 1.28 m 1.29 m 2.14 q (7.3) 2.14 q (7.4) 
 1.51 m 1.47 m 2.14 q (7.3) 2.14 q (7.4) 
20 1.88 m 1.93 m  
21 1.95 t (11) 2.01 t (11) 5.55 s 5.55 s 
21 3.03 dd (11, 4)  3.09 dd (11, 4)   
OMe  3.95 s  3.95 s 
NH 5.92 d (4)  6.30 d (4.4) 
 9.48 d (4)  9.51 d (4.4)  
a




C NMR Spectroscopic Data of Leuconicines AD (25)a 
C 2 3 4 5 
2 161.6 162.0 161.2 159.3 
3 62.2 62.1 59.9 59.9 
5 54.4 54.3 53.5 53.5 
6 44.8 44.7 46.0 46.0 
7 55.5 55.5 56.5 56.7 
8 139.9 139.3 139.8 139.4 
9 120.2 119.9 120.5 120.3 
10 127.0 126.6 127.0 126.7 
11 128.1 128.2 128.3 128.4 
12 117.5 117.7 117.8 118.1 
13 140.6 140.8 140.5 140.7 
14 31.3 31.2 30.8 30.8 
15 36.3 35.9 33.6 33.6 
16 115.7 113.9 119.3 118.7 
17 145.4 145.9 142.9 143.7 
18 11.5 11.4 12.8 12.8 
19 26.4 26.3 27.4 27.5 
20 38.7 38.5 122.8 122.6 
21 51.4 51.3 129.8 129.9 
22 161.1 158.8 158.2 158.6 
23 120.2 120.0 120.8 120.3 
CO2Me  52.4  52.2 
CO2Me  165.9  166.0 
CONH2 165.8  166.1 
a


















































H NMR spectrum (CDCl3, 400 MHz) of leuconicine D (5)
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 was isolated as a light yellowish oil, with []D 193 (CHCl3, c 
0.04). The EIMS showed in addition to the M

 ion peak at m/z 360, a fragment peak due 
to MCO2 at m/z 316. HREIMS measurements established the molecular formula as 
C22H20N2O3. The UV spectrum of 6 was similar to those of 25, while the IR spectrum 
showed broadened bands at 3457 and 1728 cm
1
, due to OH and acid/lactam carbonyl 




C NMR data (Tables 2.5 and 2.6, 
respectively) of 6 were also generally similar to those of 4 and 5, indicating the presence 
of an unsubstituted aromatic moiety (δ 7.52, dd, J = 8, 1 Hz, H(9); 7.40, td, J = 8, 1 Hz, 
H(10); 7.47, td, J = 8, 1 Hz, H(11); 8.55, dd, J = 8, 1 Hz, H(12)), two isolated olefinic 
hydrogens (singlets at δ 5.58 and 8.44), two trisubstituted double bonds ( 122.4, 143.9; 
122.7, 130.2), and an ethyl side chain (δ 1.08, t, J = 7.3 Hz, H(18); 2.15, q, J = 7.3 Hz, 
H(19)). Two downfield quaternary carbon signals were also observed at  159.7 and 
166.0, of which the former was assigned to the lactam carbonyl C(22) from the 
observed three-bond correlation from H(17) to this carbon. A notable departure in the 
1
H NMR data (Table 2.5) of 6 compared with those of compounds 25 was the absence 
of signals due either to the methyl ester CH3 singlet or the amide NH2 doublets, which 
were observed in the previous four compounds. In their place however, a low field one-
H broad singlet (exchanged with D2O) was observed at δ 14.31, suggesting the presence 
of an acid function. Since the carbonyl resonance observed at  166.0 was not 
associated with ester or amide groups, it must be associated with the carboxylic acid 
group. The observed three-bond correlation from H(17) to the carboxyl carbon 
confirmed the substitution of C(23) by the carboxylic acid group.  
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 was obtained as a light yellowish oil, with []D 353 (CHCl3, c 
0.19). The EIMS showed the highest mass fragment at m/z 361 which corresponds to the 
fragment ion from loss of oxygen, a behavior characteristic of alkaloid N-oxides. The 
molecular ion could be detected by ESIMS which showed an MH

 peak at m/z 378. 
HRESIMS measurements gave the formula C22H24N3O3, 16 mass units higher than that 
of 2. The UV and IR spectra were similar to those of 2 while the NMR data of 7 showed 
a close resemblance to those of 2, except for the downfield shifts of the carbon 
resonances for C(3), C(5), and C(21). Similarly the H(3), H(5), and H(21) signals have 
undergone downfield shifts compared to those in 2. Compound 7 was therefore readily 
identified as the N(4)-oxide of 2. 
 




 was obtained as a light yellowish oil, with []D 265 (CHCl3, c 
0.06), and UV and IR spectra which were similar to those of 3. As in the case of 7, 
compound 8 was readily identified as the N(4)-oxide of 3 based on the ESIMS data 
(MH

 m/z 393, C23H25N2O4) and the characteristic downfield shifts of the C(3), C(5), 










H NMR Spectroscopic Data of Leuconicines EG (68)a 
H 6 7 8 
3 4.25 m 4.50 m 4.45 m 
5 3.22 dd (12, 6.5) 3.65 dd (12, 8) 3.65 dd (12, 8) 
5 3.33 td (12, 4) 3.86 td (12, 9) 3.84 td (12, 9) 
6 1.90 dd (12, 4) 2.29 dd (15, 8) 2.28 dd (15, 8) 
6 2.31 dd (12, 6.5) 2.58 m 2.51 m 
9 7.52 dd (8, 1) 7.52 dd (8, 1) 7.45 dd (8, 1) 
10 7.40 td (8, 1) 7.37 td (8, 1) 7.34 td (8, 1) 
11 7.47 td (8, 1) 7.46 td (8, 1) 7.44 td (8, 1) 
12 8.55 dd (8, 1) 8.50 dd (8, 1) 8.55 dd (8, 1) 
14R 1.36 dt (13, 3) 1.45 ddd (14, 4, 3) 1.46 m 
14S 2.34 m 2.85 dt (14, 3) 2.84 ddd (14, 3, 2) 
15 3.16 m 3.07 m 3.03 m 
17 8.44 s 8.31 s 7.90 s 
18 1.08 t (7.3) 1.11 t (7.3) 1.11 t (7.3) 
19 2.15 q (7.3) 1.28 m 1.29 m 
 2.15 q (7.3) 1.51 m 1.47 m 
20  2.52 m 2.57 m 
21 5.58 s 3.02 t (13) 3.03 t (12) 
21  3.56 dd (13, 4.4) 3.55 dd (12, 5) 
OMe   3.96 s 
NH  6.32 d (4.4) 
  9.33 d (4.4)  
OH 14.31 br s  
a




C NMR Spectroscopic Data of Leuconicines EG (68)a 
C 6 7 8 
2 159.7 161.3 158.5 
3 60.0 74.7 75.0 
5 53.6 67.4 68.1 
6 46.3 39.8 39.9 
7 57.1 51.5 51.7 
8 139.8 137.6 137.3 
9 120.8 120.5 120.0 
10 128.0 127.6 127.3 
11 128.8 129.5 129.6 
12 118.4 117.8 118.0 
13 139.9 139.9 140.2 
14 30.9 27.1 27.2 
15 33.9 34.4 34.5 
16 116.1 114.7 113.1 
17 143.9 144.9 145.2 
18 12.8 11.0 11.1 
19 27.5 24.9 25.0 
20 122.7 34.4 34.4 
21 130.2 64.9 65.2 
22 163.1 156.9 157.8 
23 122.4 122.0 122.0 
CO2Me   52.6 
CO2Me   165.1 
CONH2  165.3 
CO2H 166.0  
a




































H NMR spectrum (CDCl3, 400 MHz) of leuconicine G (8)
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2.1.3 LeuconoxineLeuconolamRhazinilam Alkaloids 
 
2.1.3.1    Leuconodine A (9) 
 
Leuconodine A (9) was isolated as a light yellowish oil, and subsequently crystallized 
from EtOH as colorless needles, mp 135138 oC, with [α]D 20 (CHCl3, c 0.26). The 
UV spectrum showed absorption maxima at 242 and 277 nm, while the IR spectrum 
showed bands at 3346 and 1677 cm
1
, suggesting the presence of OH, and lactam 
functionalities, respectively. The EIMS of 9 showed a molecular ion peak at m/z 326, 
and HREIMS measurements established the molecular formula as C19H22N2O3, 
requiring 10 degrees of unsaturation. The 
13
C NMR data (Table 2.8) showed a total of 
19 carbon resonances (one methyl, six methylene, six methine, and six quaternary 
carbons) in agreement with the molecular formula. The observed quaternary carbon 





Detailed examination of the NMR data of 9 indicated a close similarity to that of 
leuconoxine (14),
128
 except for some differences. The 
1
H NMR spectrum (Figure 2.16) 
of 9 showed the presence of two additional methine singlets at  3.90 and 4.51, a broad 
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singlet at  5.11, and the absence of the characteristic benzylic H(7) doublet at  3.82 
when compared to the spectrum of 14. The methine singlet at  3.90 was assigned to 
C(7), based on the observed three-bond correlations from H(7) to C(5) and C(9) in the 
HMBC spectrum. The remaining methine singlet at  4.51, together with the 
corresponding oxymethine at  75.1, suggested oxygenation at C(6). The presence of the 
OH group was indicated by the broad singlet observed at  5.11 in the 1H NMR 
spectrum, as well as from the absorption band at 3346 cm
1 
in the IR spectrum. The 
placement of the OH substituent at C(6) was further supported by the observed three-
bond correlation from H(6) to the doubly spirocyclic C(21) in the HMBC spectrum.  
 
The relative configuration at C(6) was deduced to be R (H(6)), from the observed 
reciprocal NOEs between H(9) and H(6). Compound 9 is therefore leuconodine A or 
6-hydroxyleuconoxine. The structure of 9 was further confirmed by X-ray diffraction 
analysis (Figure 2.13). 
 








 was isolated as a light yellowish amorphous solid, and 
subsequently crystallized from CH2Cl2MeOH as colorless block crystals, mp 198200 
o
C, with [α]D 48 (CHCl3, c 0.14). The UV and IR spectra of 10 were similar to those of 
9, suggesting a leuconoxine-type
128
 compound with similar functionalities, such as the 
presence of OH, and lactam functionalities. The EIMS of 10 showed a molecular ion 
peak at m/z 326, and HREIMS measurements established the molecular formula as 




C NMR spectroscopic 
data of 10 (Tables 2.7 and 2.8, respectively) were similar in all respects to those of 9 
except for the chemical shifts involving H(6) and H(7). The two methine singlets 
corresponding to H(6) and H(7) seen in the 
1
H NMR spectrum of 9 were absent in that 
of 10. Instead, a pair of AB doublets was observed at  2.89 and 2.97 (J = 17 Hz; C 
42.2) in the 
1
H NMR spectrum of 10, suggesting the presence of an isolated methylene 
in 10.  
 
This observation has led to the placement of the OH substituent at C(7), while the AB 
doublets were assigned to the two H(6). This assignment received additional support 
from the observed downfield shift of the C(7) signal to  81.9 in 10, compared to c 
49.6 observed for C(7) in 9. The HMBC data further confirmed the site of oxygenation 
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at C(7) from the observed three-bond correlation from H(9) to C(7). Compound 10 is 
therefore leuconodine B (or 7-hydroxyleuconoxine).  
 
Since, suitable crystals were obtained, an X-ray diffraction analysis (Figure 2.14) was 
carried out (X-ray analysis by Y. Y. Low) which confirmed the structure deduced based 
on the spectroscopic data. 
 
During the course of this study, an alkaloid (scholarisine G) corresponding to 10 was 











2.1.3.3    Leuconodine C (11) 
 
Leuconodine C (11) was isolated in minute amounts as a light yellowish oil, [α]D 71 
(CHCl3, c 0.24). The UV and IR spectra of 11 were similar to those of 9. The ESIMS of 
11 showed an [M H] peak at m/z 327, and HRESIMS measurements established the 





NMR spectroscopic data of 11 (Tables 2.7 and 2.8, respectively) were generally similar 
to those of leuconoxine (14), except for the aromatic region. Detailed examination of 
the 
13
C NMR data indicated downfield shift of an aromatic signal to  155.0, suggesting 
oxygenation of one of the aromatic carbons of 11. The most deshielded signal at  7.49 
(J = 8.6 Hz) in the 
1
H NMR spectrum (Figure 2.18) of 11 was assigned to H(12), due to 
anisotropy of the proximate lactam carbonyl function at C(2). This feature is common in 
all the other leuconoxine-type compounds. Analysis of the vicinal coupling constants of 
the remaining two aromatic signals, allowed the assignment of the signal at  6.64 (J = 
8.6, 2 Hz) to H(11) and the signal at  6.60 (J = 2 Hz) to H(9). The COSY and HSQC 
data also revealed the presence of a CHCH unit, corresponding to the C(11)C(12) 
fragment, consistent with a 10-hydroxy substituted leuconoxine (14).  
 
Figure 2.15: Selected HMBCs of 11 
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The HMBC data (Figure 2.15) further confirmed the placement of the OH group at 
C(10) from the observed three-bond correlations from H(9) to C(7) and C(11), H(11) to 
C(9), and from H(12) to C(10). The structure deduced is entirely consistent with the rest 





H NMR Spectroscopic Data of Leuconodines AC (911)a 
H 9 10 11 
3 2.89 ddd (13, 11, 4) 2.63 td (13, 3.4) 2.70 m 
 3.99 ddd (13, 4) 3.92 br d (13) 3.86 br d (12) 
6 4.51 s 2.89 d (17)  2.56 d (17)  
  2.97 d (17)  2.77 dd (17, 7)  
7 3.90 s  3.69 d (7) 
9 7.27 dd (7.8, 1) 7.31 d (7.6) 6.60 d (2) 
10 7.13 td (7.8, 1) 7.17 t (7.6) 
11 7.25 td (7.8, 1) 7.34 t (7.6) 6.64 dd (8.6, 2) 
12 7.87 dd (7.8, 1) 7.76 d (7.6) 7.49 d (8.6) 
14 1.70 m 1.50 m 1.53 m 
 1.70 m 1.63 m 1.53 m 
15 1.64 m 1.68 m 1.59 m 
 1.92 m 1.94 td (13, 3.4) 1.89 ddd (14, 12, 5) 
16 2.53 ddd (19, 6, 1.4) 2.45 dd (19, 6) 2.41 dd (19, 5) 
 2.78 ddd (19, 14, 6) 2.73 ddd (19, 13, 6) 2.65 m 
17 1.60 m 1.68 m 1.59 m 
 1.94 m 2.18 m 1.78 dd (14, 5) 
18 0.90 t (7.3) 0.91 t (7.3) 0.86 t (7) 
19 1.49 dq (13, 7.3) 1.77 dq (14, 7.3) 1.29 dq (13, 7) 
 1.96 m 2.15 m 1.68 dq (13, 7) 
OH br s br s 
a




C NMR Spectroscopic Data of Leuconodines AC (911)a 
C 9 10 11 
2 173.1 173.6 173.6 
3 36.8 36.8 37.0 
5 172.0 170.0 171.6 
6 75.1 42.2 37.7 
7 49.6 81.9 42.2 
8 132.1 137.4 134.3 
9 124.5 122.9 111.3 
10 125.4 125.6 155.0 
11 128.3 129.4 114.4 
12 119.6 120.7 121.0 
13 141.9 141.3 136.5 
14 19.4 20.0 20.2 
15 27.3 27.2 26.6 
16 30.2 29.5 29.3 
17 27.5 25.5 27.0 
18 7.7 6.9 7.4 
19 28.5 22.4 26.3 
20 36.7 39.1 38.3 
21 93.5 90.4 93.1 
a








































H NMR spectrum (CDCl3, 400 MHz) of leuconodine C (11) 
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2.1.3.4    Leuconodine D (12) 
 
Leuconodine D (12) was obtained in small amounts as a light yellowish oil and 
subsequently as light yellowish crystals from CH2Cl2MeOH, mp 100105 
o
C, [α]D 37 
(CHCl3, c 0.10). The UV spectrum showed absorption maxima at 210, 253, 283, and 
376 nm, while the IR spectrum showed a band at 1670 cm
1
 due to a lactam carbonyl 
function. The EIMS of 12 showed a molecular ion peak at m/z 296, and HREIMS 
measurements established the molecular formula as C19H24N2O. The 
1
H NMR data of 
12 (Table 2.9) were essentially similar to those of leuconoxine (14),
128
 except for the 
upfield shifts of the proton resonances due to H(3), H(6), H(18), and H(19). The 
13
C 
NMR data (Table 2.9) of 12 were essentially similar to those of 14, except for the 
absence of the signal due to one lactam carbonyl and the presence instead of a 





Analysis of the COSY and HMQC data of 12 revealed the presence of some fragments 
which were also present in leuconoxine (14), such as NCH2CH2CH2, CH2CH2, and 
CH2CH3, corresponding to the NC(3)C(14)C(15), C(16)C(17), and C(19)C(18) 
units, respectively. However, an additional fragment was observed, viz., NCH2CH2CH 
in the COSY spectrum of 12, which was assigned to NC(5)C(6)C(7), indicating that 
the lactam carbonyl function at C(5) had been replaced by an aminomethylene carbon. 
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This is consistent with the observed upfield shifts of some of the proton resonances in 
the 
1
H NMR spectrum (Figure 2.21) of 12 (vide supra).  
 
Figure 2.19: Selected HMBCs of 12 
 
The HMBC data (Figure 2.19) provided further confirmation for the methylene 
corresponding to C(5) from the observed three-bond correlations from H(3) to C(5), 
H(5) to C(3), C(7) and C(21), and from H(7) to C(5). The structure deduced is entirely 





2.1.3.5    Leuconodine E (13) 
 
Leuconodine E (13) was obtained in minute amounts as a light yellowish amorphous 
solid and subsequently as colorless crystals from CH2Cl2MeOH, mp >230 
o
C, [α]D 13 
(CHCl3, c 0.03). The UV spectrum of 13 was similar to that of 12, while the IR 
spectrum showed bands due to OH (3416 cm
1
) and lactam (1636 cm
1
) functions. The 
EIMS of 13 showed a molecular ion peak at m/z 312, 16 mass units higher than that of 





H NMR data of 13 (Table 2.9) showed a close resemblance to those of 12, except 
for the absence of the characteristic benzylic H(7) seen at  3.77 in 12. Comparison of 
the 
13
C NMR data of 13 with that of 12 showed that while the chemical shifts of the 
other carbons were essentially unchanged, the signal due to C(7) has undergone 
substantial shift to the lower field region at  91.8, indicating that the site of oxygen 
substitution is at C(7).  
 
This was also supported by the observed three-bond correlations from H(5) and H(9) to 
C(7) in the HMBC spectrum. Since suitable crystals of 13 were obtained, an X-ray 
diffraction analysis was also carried out which provided further confirmation of the 
structure deduced from analysis of the spectroscopic data (Figure 2.20). 
 







C NMR Spectroscopic Data of Leuconodines DE (1213)a 
Position 12  13  
 H C H C 
2  172.6  173.2 
3 2.52 td (12, 3.5) 50.9 2.96 m 49.5 
 3.03 br d (13)  2.96 m  
5 2.72 dd (13, 6.5) 52.2 2.70 m 49.6 
 2.93 td (13, 6.5)  2.87 m  
6 1.50 dd (13, 6.5) 33.3 2.08 dd (11, 6) 44.4 
6 2.60 m  2.74 m  
7 d (9.5) 47.0  91.8 
8  133.7  135.6 
9 7.13 br d (7.3) 127.5 7.27 br d (8) 120.6 
10 7.00 td (7.3, 1) 123.5 7.08 td (8, 1.5) 123.8 
11 7.16 td (7.3, 1) 123.5 7.23 td (8, 1.5) 128.9 
12 8.11 br d (7.3) 114.5 8.11 br d (8) 115.2 
13  143.0  141.2 
14 1.61 m 19.9 1.70 m 20.5 
 1.82 m  1.80 m  
15 1.21 td (13, 3.5) 32.0 1.74 m 29.6 
 1.79 m  1.74 m  
16 2.34 ddd (14, 5, 2.5) 32.8 2.31 dt (14, 3) 31.9 
 3.59 td (14, 8)  3.53 ddd (14, 12, 10)  
17 1.70 m 28.9 1.77 m 32.3 
 1.73 m  1.77 m  
18 0.73 t (7.3) 7.4 0.74 t (7.6) 7.4 
19 1.07 dq (13, 7.3) 31.4 1.14 dq (14, 7.6) 28.9 
 1.30 dq (13, 7.3)  1.74 m  
20  40.3  41.5 
21  97.6  95.3 
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13



































H NMR spectrum (CDCl3, 400 MHz) of leuconodine E (13) 
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2.1.3.6    3,14-Dehydroleuconolam (18) 
 
3,14-Dehydroleuconolam (18) was obtained in small amounts as a light yellowish oil, 
with [α]D 385 (CHCl3, c 0.17). The UV spectrum showed absorption maxima at 266 
and 323 nm, while the IR spectrum showed bands at 3270, 1694, and 1663 cm
1
, 
corresponding to a hydroxyl group and two lactam carbonyl functions. The EIMS of 18 
showed a molecular ion peak at m/z 324, and HREIMS measurements established the 




The NMR data (Table 2.10) of 18 were generally similar to those of leuconolam 
(19),
124,126
 except for the absence of the methylene signals at C(3) and the presence 
instead of two low field methine signals at  5.04 (br t, J = 6 Hz) and 6.52 (d, J = 6 Hz) 
in the 
1
H NMR spectrum (Figure 2.24). The 
13
C NMR data (Table 2.10) of 18 indicated 
the presence of an additional double bond from the resonances observed at  107.6 (H 
5.04) and 118.2 (H 6.52), corresponding to two methine carbons. The usual 
NCH2CH2CH2 fragment corresponding to NC(3)C(14)C(15) was replaced by a 
CH=CHCH2 fragment in the COSY spectrum, suggesting the site of unsaturation to be 
at C(3)C(14), or alternatively, at C(14)C(15). However, the presence of unsaturation 
at C(14)C(15) can be ruled out based on the following observations. The methylene 
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signals at  1.84 and 2.27 were assigned to H(15) based on the observed three-bond 
correlations from this H(15) to C(17) and C(21), and from H(19) to C(15) in the HMBC 
spectrum (Figure 2.23). The double bond at C(3)C(14) is supported by the NMR data 
(C(3) 118.2, H(3) 6.52; C(14) 107.6, H(14) 5.04) and was further confirmed by the 
observed three-bond correlations from H(3) to C(15) and C(21). Compound 18 is 
therefore assigned as 3,14-dehydroleuconolam. 
 
 

















C NMR Spectroscopic Data of 3,14-Dehydroleuconolam (18)
a
 
Position H C 
2  179.1 
3 6.52 d (6) 118.2 
5  166.6 
6 6.01 s 128.7 
7  156.4 
8  133.7 
9 7.68 d (7) 129.3 
10 7.25 t (7) 127.2 
11 7.32 t (7) 130.2 
12 7.19 d (7) 127.2 
13  135.5 
14 5.04 br t (6) 107.6 
15 1.84 dd (18, 6) 34.5 
 2.27 d (18)  
16 1.99 m 28.9 
 1.99 m  
17 1.41 m 26.6 
 1.41 m  
18 0.50 t (7) 7.4 
19 1.11 dq (14, 7) 24.7 
 1.46 dq (14, 7)  
20  43.6 
21  92.6 
NH 8.48 s  
OH 4.98 s 
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13




























































H NMR spectrum (CDCl3, 400 MHz) of 3,14-dehydroleuconolam (18) 
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2.1.3.7    Nor-rhazinicine (22) 
 
Nor-rhazinicine (22) was obtained as a light yellowish oil and subsequently crystallized 
from CH2Cl2MeOH as light yellowish needles, mp 190192 
o
C, with [α]D 285 
(CHCl3, c 0.13). The IR spectrum showed bands due to NH (3252 cm
1
) and lactam 
carbonyl functions (1752 and 1666 cm
1
), while the UV spectrum showed absorption 
maxima at 232 and 273 nm, which is somewhat similar to those of the rhazinilam-type 
alkaloids.
124,126
 The EIMS showed a molecular ion peak at m/z 294, and HREIMS 
measurements established the molecular formula as C18H18N2O2. The 
13
C NMR data 
(Table 2.11) showed a total of eighteen carbon resonances, comprising one methyl, four 
methylene, six methine, and seven quaternary carbon atoms.  
 
The NMR data of 22 (Table 2.11) indicated a general similarity to those of rhazinicine 
(27)
188
 except for several notable differences. The most prominent difference is the 
presence of a pair of AB doublets at  2.70 and 2.95 (J = 18.5 Hz; C 47.8) in the 
1
H 
NMR spectrum (Figure 2.28) of 22, indicating the presence of an isolated methylene 
signal. Since the 
13
C NMR spectrum of 22 indicated the loss of one methylene carbon 
signal, ring contraction must have occurred either in ring-B (22a) or ring-C (22b). The 
two alternative structures 22a and 22b are shown in Figure 2.25.       
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Figure 2.25: Comparison of 
13
C NMR chemical shifts of C(2) and C(3) (or C(14)) 
lactam carbonyls in various leuconolam-rhazinilam alkaloids 
 
It transpired that both of the structures proposed (22a and 22b) are in complete accord 
with the HMBC data (Figure 2.26). Fortunately, the two alternative structures can be 
distinguished based on consideration of their 
13
C NMR chemical shifts. In the 
leuconolamrhazinilam series of alkaloids (Figure 2.25)124,126,128 the carbon chemical 
shift of the C(2) lactam carbonyl with an intact 9-membered ring-B is usually found 
from  176179 (e.g., C(2) leuconolam 178.2, C(2) rhazinilam 177.4). In the case of 
rhazinicine, which possesses two lactam carbonyl functions, the resonance of the C(2) 
lactam carbonyl is observed at C(2)176.4, while that of the C(3) lactam carbonyl is 
found at C(3)167.9. In the two possible structures for 22 (22a, 22b), which are 
consistent with the HMBC data, it can be seen that 22a incorporates an 8/6 B/C ring, 
while 22b incorporates a 9/5 B/C ring. The lactam carbonyl resonances observed for 22 
are at 176.7 and 170.5. The former resonance must be due to a C(2) lactam carbonyl 
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in an intact 9-membered ring B (while the latter resonance is due to the C(14) lactam 
carbonyl), which in turn favor structure 22b.  
 
Figure 2.26: Selected HMBCs of 22a and 22b 
 
 
Finally, an X-ray diffraction analysis was carried out (Figure 2.27) which confirmed the 
structure proposed for 22 (or 22b) based on analysis of the spectroscopic data. 
 
Figure 2.27: X-ray crystal structure of 22 
 
A possible biogenetic pathway to 22 is as shown in Scheme 2.4. Oxidation of 
rhazinilam (25) leads to the conjugated iminium ion 22c, which on deprotonation and 
isomerization, gives the enamine 22d. Oxidative cleavage of the enamine 22d yields the 
dicarboxylic acid derivative 22e, which on decarboxylation to give the carboxylic acid 
derivative, 22f. Esterification of 22f, followed by ring-closure (lactam formation) gives 
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nor-rhazinicine (22). Alkaloid 22b is the first example of a nor-rhazinilam alkaloid in 
the rhazinilam-leuconolam group of alkaloids, in which a carbon atom (C(3), following 
Scheme 2.4) has been lost from the rhazinilam carbon skeleton.  
 
 











2.1.3.8    5,21-Dihydrorhazinilam N-oxide (23) 
 
5,21-dihydrorhazinilam N-oxide (23) was isolated as a light yellowish oil, [α]D 370 
(CHCl3, c 0.07). The EIMS of 23 showed the highest mass fragment at m/z 294 while 
the molecular ion was detected by ESIMS, which showed an [M  H] peak at m/z 313 
which analyzed for C19H24N2O2. The UV spectrum showed absorption maxima at 228 
and 256 nm, while the IR spectrum showed bands due to NH (3392 cm
1
) and lactam 
carbonyl (1655 cm
1
) functions. The NMR spectroscopic data (Table 2.11) of 23 
showed a close resemblance to those of 5,21-dihydrorhazinilam (24),
124,126
 except for 
the downfield shifts of the C(3), C(5), and C(21) resonances in the 
13
C NMR spectrum, 
and the corresponding H(3), H(5), and H(21) resonances in the 
1
H NMR spectrum, a 
behaviour characteristic of alkaloid-N-oxides Compound 23 is therefore readily 
















Position 22 23 
 H C H C 
2  176.7  178.5 
3   3.56 td (13, 4)  66.6 
   3.87 br d (13)   
5 7.00 d (3) 110.7 4.15 dd (15, 3) 73.1 
   4.63 d (15)  
6 6.19 d (3) 120.6 5.87 br s 125.8 
7  117.4  137.9 
8  135.2  133.2 
9 7.37 dd (7.3, 2) 131.1 7.56 dd (7.5, 2) 128.8 
10 7.42 td (7.3, 2) 129.0 7.31 td (7.5, 2) 127.0 
11 7.34 td (7.3, 2) 127.6 7.33 td (7.5, 2) 129.4 
12 7.27 dd (7.3, 2) 127.4 7.20 dd (7.5, 2) 126.3 
13  137.0  136.4 
14  170.5 1.81 m 19.1 
   1.81 m  
15 2.70 d (18.5) 47.8 1.49 ddd (13, 10, 3) 34.6 
 2.95 d (18.5)  1.71 td (13, 3)  
16 2.08 m 28.0 1.46 m 27.8 
 2.37 ddd (13, 10, 5)  2.02 br t (13)  
17 2.08 m 37.0 1.82 dd (15, 7) 27.5 
 2.26 ddd (13, 10, 5)  2.21 dd (15, 7)  
18 0.72 t (7.3) 8.6 0.67 t (7.5) 7.4 
19 1.36 dq (14, 7.3) 28.6 1.22 dq (14, 7.5) 32.4 
 1.50 dq (14, 7.3)  1.35 dq (14, 7.5)  
20  42.7  44.9 
21  141.4 4.43 s 92.0 
NH 7.12 br s  8.18 s  
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13





























H NMR spectrum (CDCl3, 400 MHz) of 5,21-dihydrorhazinilam N-oxide (23)
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2.1.3.9    Leuconoxine (14), Leuconodine F (15), Mersicarpine (16), Arboloscine 
(17), Leuconolam (19), O-Methylleuconolam (20), Epi-leuconolam (21), 
5,21-Dihydrorhazinilam (24), Rhazinilam (25), Rhazinal (26), and 
Rhazinicine (27) 
 























 and rhazinicine 
(27)
188
 were also isolated. The 
1
H NMR spectra of these compounds are shown in 
Figures 2.302.40, while the NMR spectroscopic data are summarized in Tables 




H NMR Spectroscopic Data of Leuconoxine (14), Leuconodine F (15), and 
Mersicarpine (16)
a 
H 14 15 16 
3 2.73 dd (13, 6.5) 3.10 ddd (13, 11, 4) 3.87 m 
 3.96 br d (13) 4.11 ddd (13, 5, 2.3) 3.87 m 
6 2.69 d (17)  
 2.87 dd (17, 7.5)   
7 3.82 d (7.5) 4.23 s  
9 7.17 dd (7, 1) 7.22 dd (7.6, 1) 7.66 br d (8) 
10 7.14 td (7, 1) 7.16 td (7.6, 1) 7.09 td (8, 1) 
11 7.26 td (7, 1) 7.37 td (7.6, 1) 7.39 td (8, 1) 
12 7.77 br d (7) 7.82 dd (7.6, 1) 8.13 br d (8) 
14 1.65 m 1.70 m 1.65 m 
 1.65 m 1.70 m 1.65 m 
15 1.68 m 1.70 m 2.07 m () 
 1.97 td (13, 4) 2.05 m 1.75 dt (14.3, 3.5) () 
16 2.49 ddd (19, 6, 1) 2.59 ddd (19, 6, 1.4) 2.48 ddd (18.5, 9.5, 3.5) () 
 2.80 m 2.86 ddd (19, 14, 6.5) 2.35 ddd (18.5, 8.8, 7.8) () 
17 1.68 m 1.66 td (14, 6) 1.89 dddd (14, 9.5, 7.8, 1.5) () 
 1.86 ddd (14, 5, 1) 1.98 ddd (14, 6.5, 1.4) 1.65 m () 
18 0.93 t (7.4) 0.92 t (7.4) 0.74 t (7.5) 
19 1.37 dq (13, 7.4) 1.23 dq (13, 7.4) 1.10 dq (14.5, 7.5) 
 1.78 dq (13, 7.4) 1.49 dq (13, 7.4) 1.32 dqd (14.5, 7.5, 1.5) 
a




C NMR Spectroscopic Data of Leuconoxine (14), Leuconodine F (15), 
and Mersicarpine (16)
a 
C 14 15 16 
2 172.9 172.2 169.6 
3 36.8 37.8 50.5 
5 170.8 157.5  
6 37.6 192.5  
7 41.9 53.4 168.9 
8 135.4 126.2 124.4 
9 123.8 125.1 122.2 
10 125.5 125.9 124.2 
11 128.0 129.9 133.2 
12 120.1 121.0 116.7 
13 142.1 142.6 146.5 
14 20.1 20.1 22.9 
15 26.2 26.3 34.3 
16 29.4 29.5 29.1 
17 26.6 26.6 25.4 
18 7.3 7.3 6.8 
19 26.9 27.7 21.1 
20 38.1 37.6 39.3 
21 92.5 88.0 93.8 
a






C NMR Spectroscopic Data of Arboloscine (17) and Leuconolam 
(19)
a 
Position 17  19  
 H C H C 
2  169.6  178.2 
3 2.80 m 40.3 2.94 td (12.5, 4.6) 35.6 
 3.21 td (12.6, 3.3)  3.98 dd (12.5, 3.5)  
5  168.9  166.8 
6 6.51 s 110.4 5.79 s 128.3 
7  140.8  156.1 
8  127.1  133.5 
9 7.43 dd (7.6, 1) 120.4 7.18 dd (7.5, 1) 126.5 
10 7.09 td (7.6, 1) 124.0 7.36 td (7.5, 1) 126.9 
11 7.33 ddd (8.2, 7.6, 1) 130.9 7.32 td (7.5, 1) 129.7 
12 8.35 d (8.2) 118.3 7.90 dd (7.5, 1) 129.6 
13  142.5  135.3 
14 1.61 m 26.4 1.48 m 20.0 
 1.85 m  1.48 m  
15 2.49 dd (16.9, 9.9) 29.9 1.60 m 24.4 
 2.75 m  1.79 td (13.5, 5)  
16 1.43 m 30.3 1.99 td (14, 1.7) 32.4 
 1.64 m  2.12 td (14, 7)  
17 1.56 ddd (13, 7, 3) 25.4 1.40 br t (14) 25.7 
 2.68 ddd (13, 7, 1)  1.60 m  
18 0.82 t (7.5) 6.95 0.55 t (7.6) 7.3 
19 1.48 m 20.1 1.24 dq (13.6, 7.6) 27.9 
 1.70 m  1.60 m  
20  36.8  45.2 
21  88.1  93.8 
OH   5.63 br s  
NH   7.84 br s  
CO2Me 3.83 s 52.3   
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13






C NMR Spectroscopic Data of O-Methylleuconolam (20) and Epi-
leuconolam (21) (or 6,7-dehydroleuconoxine (21a))
a 
Position 20  21  
 H C H C 
2  178.1  175.9 
3 2.61 td (13, 5) 35.9 3.22 ddd (15, 9.6, 6) 36.8 
 4.18 br d (13)  4.46 ddd (15, 12, 4)  
5  166.8  173.4 
6 6.32 s 131.9 6.22 s 118.0 
7  150.9  164.1 
8  134.5  123.4 
9 7.27 m 126.8 7.46 ddd (7.5, 1, 0.6) 124.2 
10 7.34 m 127.1 7.12 td (7.5, 1) 121.5 
11 7.42 m 129.9 7.33 td (7.5, 1) 131.4 
12 7.40 m 128.7 8.16 ddd (7.5, 1, 0.6) 115.7 
13  135.6  148.5 
14 1.56 m 19.6 1.79 m 16.6 
 1.56 m  2.04 m  
15 1.58 m 32.6 1.10 td (14, 7) 25.9 
 1.60 m  1.66 ddd (14, 6, 1.5)  
16 2.05 td (14, 1) 27.9 2.62 ddd (15, 5, 2) 34.0 
 2.16 dd (14, 6)  3.09 td (15, 6)  
17 1.50 m 26.2 1.71 td (15, 5) 30.3 
 1.74 m  2.09 ddd (15, 6, 2)  
18 0.57 t (7.6) 7.3 0.76 t (7.4) 8.2 
19 1.28 m 24.2 1.35 dq (13.6, 7.4) 33.0 
 1.55 m  dq (13.6, 7.4) 
20  45.5  44.4 
21  97.4  93.5 
OMe 3.14 s 49.9  
NH 8.16 br s   
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13






C NMR Spectroscopic Data of 5,21-Dihydrorhazinilam (24) and 
Rhazinilam (25)
a 
Position 24  25  
 H C H C 
2  179.1  177.4 
3 2.42 td (13, 3) 50.4 3.78 t (13, 5) 46.0 
 3.01 br dd (13, 4.5)  4.00 br dd (13, 5.5)  
5 3.23 m 58.1 6.50 d (2.7) 119.5 
 3.81 m    
6 5.62 m 130.3 5.75 d (2.7) 109.5 
7  141.0  117.3 
8  136.0  138.0 
9 7.22 dd (7.5, 2) 126.8 7.42 dd (7.5, 2) 131.4 
10 7.27 m 127.3 7.34 td (7.5, 2) 128.0 
11 7.30 td (7.5, 2) 128.1 7.30 td (7.5, 2) 127.2 
12 7.22 m 129.4 7.20 dd (7.5, 2) 126.7 
13  138.7  140.3 
14 1.36 m 21.2 1.85 m 19.4 
 1.77 qt (13, 4.5)  2.22 qdd (13, 5.5, 3)  
15 1.09 td (13, 4.5) 37.2 1.54 dt (13, 3) 33.0 
 1.59 br d (13)  1.72 td (13, 3)  
16 1.98 ddd (14, 11.5, 1) 27.8 1.95 dd (12.5, 8) 28.1 
 2.15 dd (14, 9.5)  2.37 t (12.5)  
17 1.32 dd (15, 11.5) 26.2 1.47 dd (12.5, 8) 36.6 
 2.64 dd (15, 9.5)  2.45 t (12.5)  
18 0.60 t (7.5) 6.9 0.71 t (7.3) 8.1 
19 0.86 dq (14.2, 7.5) 29.3 1.24 dq (14.2, 7.3) 30.1 
 1.21 dq (14.2, 7.5)  1.46 dq (14.2, 7.3)  
20  41.2  38.8 
21 3.26 s 76.1  130.5 
NH 7.42 br s  6.64 br s 
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13






C NMR Spectroscopic Data of Rhazinal (26) and Rhazinicine (27)
a 
Position 26  27  
 H C H C 
2  176.5  176.4 
3 3.98 ddd (14, 13, 5) 46.3  167.9 
 4.77 dd (14, 5.5)    
5  130.2 7.42 d (3) 116.6 
6 6.54 s 125.4 5.93 d (3) 114.6 
7  120.4  121.9 
8  138.2  137.1 
9 7.40 dd (7.5, 2) 131.3 7.41 m 130.0 
10 7.42 td (7.5, 2) 129.0 7.41 m 128.9 
11 7.35 br t (7.5) 127.7 7.37 m 127.8 
12 7.26 br d (7.5) 127.3 7.28 d (8) 127.5 
13  137.6  137.1 
14 1.95 m 18.5 2.70 ddd (18, 4.5, 3.5) 29.0 
 2.19 qdd (13, 5.5, 3)  2.93 ddd (18, 13.5, 5)  
15 1.54 m 31.9 1.73 ddd (13.5, 5, 3.5) 31.7 
 1.77 td (13, 3)  2.12 td (13.5, 4.5)  
16 2.04 dd (12.5, 8) 28.0 2.12 m 28.2 
 2.43 t (12.5)  2.40 m  
17 1.54 m 36.5 1.58 m 33.6 
 2.50 t (12.5)  2.44 m  
18 0.72 t (7.3) 8.1 0.74 t (7.5) 7.9 
19 1.26 dq (14.2, 7.3) 29.8 1.31 dq (14.5, 7.5) 29.7 
 1.52 dq (14.2, 7.3)  1.47 dq (14.5, 7.5)  
20  39.6  38.2 
21  141.3  133.2 
CHO 9.39 s 178.7  
NH 6.80 s  6.75 s  
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13














































































































2.1.3.9a     Note on epi-leuconolam (21) 
During the preparation of this thesis, concurrent work in this Laboratory by Yun-Yee 
Low on the chemistry of leuconolam (19) indicated that the originally assigned structure 
for epi-leuconolam (21) was incorrect.
313
 This conclusion was eventually confirmed by 
X-ray diffraction analysis, which yielded structure 21a (or 6,7-dehydroleuconoxine) for 
the previously assigned epi-leuconolam (21). It was also shown that the ‘epi-
leuconolam’ (or 6,7-dehydroleuconoxine) was a product formed by transannular 
cyclization of leuconolam in the presence of acid. It has also been previously shown by 
Goh et al. that ‘epi-leuconolam’ is likely an artifact due to the presence of acid, as 
extraction carried out under neutral or basic conditions did not result in the isolation of 
this compound, whereas extraction under acidic conditions resulted in its isolation. 
During the course of this study, an alkaloid corresponding to 6,7-dehydroleuconoxine 
(21a) (NMR data identical to ‘epi-leuconolam’ or 6,7-dehydroleuconoxine) was 
recently reported as a minor alkaloid from the stem-bark extract of Melodinus henryi.
314
 
In view of the above, the possibility that this alkaloid is an artifact due to the action of 
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H NMR spectrum (CDCl3, 400 MHz) of rhazinicine (27) 
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2.1.4 Eburnane Alkaloids 
 
2.1.4.1    ()-Eburnamaline (28) 
()-Eburnamaline (28)134 was obtained as a light yellowish oil, with []D 49 (CHCl3, c 
0.21). The UV spectrum (230 and 280 nm) was typical of an indole chromophore, while 
the IR spectrum indicated the presence of hydroxyl groups at 3370 cm
1
. The EIMS of 
28 showed a molecular ion peak at m/z 312, which analyzed for C19H24N2O2 (DBE 9, 16 
mass units higher than ()-eburnamine (34)), with a prominent fragment peak due to 
loss of H2O at m/z 294. The NMR data (Table 2.18) of 28 showed a close resemblance 
to those of ()-eburnamine (34), except for some notable differences associated with 
changes involving ring E. 
 
 
First, compared with 34, a doublet was observed at  3.90 (C 71.7) which indicated the 
presence of an oxymethine. This doublet was coupled to the other oxymethine 
hydrogen, H(16), which required it to be vicinal to C(16). Eburnamaline (28) is 
therefore the 17-hydroxy congener of ()-eburnamine (34). This conclusion is 
consistent with the loss of the H(17) signals seen in 34 and the presence of a CHCH 
fragment in 28, in place of the CHCH2 fragment seen in the COSY spectrum of 34. 
Since this eburnane alkaloid co-occurs with ()-eburnamonine (29), ()-eburnamenine 
 139 
(30), O-methylisoeburnamine (31), O-methyleburnamine (32), ()-isoeburnamine (33), 
and ()-eburnamine (34) found in this plant, and all these alkaloids belong to the 20, 
21 (20R, 21R) enantiomeric group, it is reasonable to suppose that 28 also belongs to 
the same series with 20R, 21R configuration.
150,188,215,315
 The configuration at C(16) in 
the 16-hydroxysubstituted eburnane alkaloids can be deduced from the presence or 
absence of paramagnetic deshielding exerted by the oxygen of the C(16)-OH 
substituent.
155,316-318
 Thus, in ()-eburnamine (34) (C(16)-OH), the H(15) resonances 
are found upfield at ca.  0.69 and 1.16 (absence of paramagnetic deshielding by OH), 
whereas in ()-isoeburnamine (33), the -oriented C(16)-OH causes a downfield shift 
of the H(15) resonances to  1.55 and 1.64, as a result of paramagnetic deshielding by 
the hydroxyl oxygen.
177,215
 The observed upfield resonances for H(15) in eburnamaline 
(28) at  0.66 and 1.37, coupled with the observed H(16)/H(15) NOE (Figure 2.41) 
provided strong support for the presence of a -oriented C(16)-OH.  
 
 
Figure 2.41: Selected NOEs of 28 
 
The relative configuration at the hydroxy-substituted C(17) was deduced to be R (-OH) 
based on the following grounds. First, the reciprocal NOEs (Figure 2.41) observed 
between H(16)/H(17), H(17)/H(15), and H(17)/H(18) are only consistent with a -
 140 
oriented C(17)-OH. Second, the observed J16-17 of 3 Hz is in agreement of an 
equatorially-disposed H(17) (an axial or -oriented H(17) would result in H(17) and 
H(16) being trans-diaxial). Third, the resonances for H(21) and H(19) were shifted 
downfield ( 4.02; 1.79, 2.30) when compared to those of ()-eburnamine (34) ( 3.48; 
1.27, 1.89), as a result of paramagnetic deshielding exerted by the proximate oxygen of 













C NMR Spectroscopic Data of ()-Eburnamaline (28)a 
Position H C 
2  131.5 
3 2.35 m 44.8 
 2.53 br d (13)  
5 3.14 ddd (14, 12, 6) 50.9 
 3.22 dd (14, 6)  
6 2.42 ddd (16, 6, 2) 16.7 
 2.88 dddd (16, 12, 6, 2)  
7  105.6 
8  128.7 
9 7.45 dd (7, 1) 118.0 
10 7.13 td (7, 1) 120.2 
11 7.17 td (7, 1) 121.3 
12 7.79 dd (7, 1) 112.3 
13  137.2 
14 1.29 m 20.0 
 1.70 dt (13, 3.6)  
15 0.66 td (13, 3.6) 21.9 
15 1.37 br d (13)  
16 5.54 d (3) 77.0 
17 3.90 d (3) 71.7 
18 0.89 t (7.7) 6.9 
19 1.79 dq (14.5, 7.7) 22.9 
 2.30 dq (14.5, 7.7)  
20  40.8 
21 4.02 br s 55.8 
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13

















H NMR spectrum (CDCl3, 400 MHz) of ()-eburnamaline (28) 
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2.1.4.2    ()-Eburnamonine (29), ()-Eburnamenine (30), O-Methylisoeburnamine 
(31), O-Methyleburnamine (32), ()-Isoeburnamine (33), ()-Eburnamine 
(34), and ()-Vincamine (35) 
 








 ()-isoeburnamine (33),214,215 ()-eburnamine (34),214 and ()-vincamine 
(35)
320,321
 were also isolated. The 
1
H NMR spectra of these compounds are shown in 
Figures 2.432.49, while the NMR spectroscopic data are summarized in Tables 2.19–




H NMR Spectroscopic Data of ()-Eburnamonine (29) and ()-
Eburnamenine (30)
a 
H 29 30 
3 2.42 ddd (12.5, 11, 4) 2.89 td (13, 3) 
 2.59 m 2.96 br s 
5 3.24 ddd (14, 11, 6) 3.42 ddd(13, 12, 5.5) 
 3.33 br dd (14, 7) 3.54 dd (13, 5.5) 
6 2.48 dddd (17, 6, 3, 0.8) 2.77 dd (17.5, 5.5) 
 2.90 dddd (17, 11, 7, 3) 3.08 dddd (17.5, 12, 5.5, 3) 
9 7.43 dd (7, 1.5) 7.48 br d (8) 
10 7.30 td (7, 1.5) 7.14 td (8, 1) 
11 7.32 td (7, 1.5) 7.24 td (8,1) 
12 8.37 dd (7, 1.5) 7.36 br d (8) 
14 1.39 m 1.55 m 
 1.76 m 1.97 m 
15 1.03 td (13.5, 4) 1.21 td (13, 3) 
 1.49 dt (13.5, 4) 1.55 m 
16  6.96 d (7.8) 
17 2.58 d (16.7) 5.12 d (7.8) 
 2.67 d (16.7)  
18 0.93 t (7.5) 1.04 t (7.4) 
19 1.66 dq (14, 7.5) 1.85 dq (14, 7.4) 
 2.05 dq (14, 7.5) 2.12 dq (14, 7.4) 
21 3.98 br s 4.50 s 
a




C NMR Spectroscopic Data of ()-Eburnamonine (29) and ()-
Eburnamenine (30)
a 
C  29 30 
2 132.0 127.7 
3 44.2 45.4 
5 50.5 52.4 
6 16.4 16.5 
7 112.4 106.8 
8 130.0 127.4 
9 117.9 118.8 
10 123.7 120.7 
11 124.2 122.7 
12 116.1 109.0 
13 134.0 134.2 
14 20.5 19.8 
15 26.8 30.3 
16 167.5 120.3 
17 44.1 116.2 
18 7.6 9.0 
19 28.2 27.7 
20 38.2 37.8 
21 57.4 56.6 
a






C NMR Spectroscopic Data of O-Methylisoeburnamine (31) and 
O-Methyleburnamine (32)
a 
Position 31  32  
 H C H C 
2  131.2  136.7 
3 2.59 m 44.9 2.34 td (13, 3) 44.4 
 2.59 m  2.51 m  
5 3.25 td (13.6, 5.4) 51.4 2.27 m 50.9 
 3.33 dd (13.6, 6.8)  2.27 m  
6 2.55 m  16.9 2.54 m 16.9 
 2.97 dddd (16, 11, 6.8, 2.3)  2.95 dddd (16, 11, 6.8, 2.3)  
7  105.5  105.9 
8  128.8  128.7 
9 7.46 br d (7.7) 118.3 7.47 dd (7, 1) 118.1 
10 7.11 td (7.7, 1) 120.1 7.14 td (7, 1) 120.2 
11 7.16 td (7.7, 1) 121.2 7.18 td (7, 1) 121.5 
12 7.26 br d (7.7) 110.6 7.58 dd (7, 1) 112.0 
13  134.7  133.2 
14 1.35 m 20.9 1.28 m 20.6 
 1.74 m  1.72 dt (13, 4)  
15 1.39 m 25.6 0.88 td (13, 4) 25.4 
 1.80 m  1.38 m  
16 5.46 dd (4, 1.3) 83.1 5.53 dd (9.5, 5) 82.4 
17 1.79 dd (15, 4) 35.0 1.84 dd (14, 9.5) 36.7 
 2.25 br d (15)  2.15 dd (14, 5.5)  
18 0.93 t (7.5) 7.8 0.93 t (7.5) 7.7 
19 1.49 dq (14, 7.5) 29.1 1.58 dq (14, 7.5) 29.0 
 2.13 dq (14, 7.5)  2.10 dq (14, 7.5)  
20  34.7  36.7 
21 3.87 s 59.3 3.91 s 58.9 
OMe 3.50 s 55.8 3.33 s 50.7 
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13





H NMR Spectroscopic Data of ()-Isoeburnamine (33), ()-Eburnamine 
(34), and ()-Vincamine (35)a 
H 33 34 35 
3 2.59 td (13, 3) 2.29 td (13, 2.9) 2.51 td (11, 2.9) 
 2.66 br d (13) 2.51 m  2.60 dd (11, 2.9) 
5 3.25 ddd (13.6, 11.5, 5.5) 3.17 ddd (13.5, 11.5, 5.8) 3.27 ddd (14, 11, 6) 
 3.33 dd (13.6, 6.5) 3.24 dd (13.5, 6.5) 3.33 dd (14, 7) 
6 2.54 ddd (16, 5.5, 1.5) 2.51 m 2.54 m 
 2.91 dddd  
(16, 11.5, 6.5, 2.5) 
2.92 dddd  
(16, 11.5, 6.5, 2) 
2.99 dddd  
(16.6, 11, 7, 2) 
9 7.50 br d (7.5) 7.47 ddd (7, 1.5, 0.8) 7.49 m 
10 7.15 td (7.5, 1.5) 7.16 td (7, 1.5) 7.11 m 
11 7.20 td (7.5, 1.5) 7.19 td (7, 1.5) 7.12 m 
12 7.41 br d (7.5) 7.73 ddd (7, 1.5, 0.8) 7.09 m 
14 1.39 dt (13, 3) 1.26 m 1.37 m 
 1.76 qt (13, 3) 1.68 qt (13, 3.5) 1.68 m 
15 1.55 dt (13, 3) 0.82 td (13, 3.5) 1.42 m 
 1.64 td (13, 3) 1.34 m 1.73 m 
16 6.06 dd (4.8, 1) 5.55 dd (9.5, 5) 
17 2.00 dd (15, 4.8) 1.48 dd (13.8, 9.5) 2.12 d (14) 
 2.19 br d (15) 2.29 dd (13.8, 9.5) 2.22 d (14) 
18 0.93 t (7.6) 0.88 t (7.6) 0.91 t (7.6) 
19 1.46 dq (14.5, 7.6) 1.42 dq (14.4, 7.6) 1.47 dq (14, 7.6) 
 2.19 dq (14.5, 7.6) 2.04 dq (14.4, 7.6) 2.24 dq (14, 7.6) 
21 3.85 br s 3.71 br s 3.92 s 
OH   4.60 br s 
OMe   3.82 s 
a




C NMR Spectroscopic Data of ()-Isoeburnamine (33), ()-Eburnamine 
(34), and ()-Vincamine (35)a 
C 33 34 35 
2 131.2 132.4 131.2 
3 44.9 44.2 44.4 
5 51.3 50.5 51.0 
6 16.7 16.7 16.8 
7 105.6 105.1 105.9 
8 129.0 128.6 128.9 
9 118.5 117.9 118.5 
10 120.1 120.0 121.7 
11 121.2 121.1 120.3 
12 109.7 112.3 110.3 
13 134.7 136.7 134.1 
14 21.0 20.2 20.7 
15 26.6 24.6 25.1 
16 74.7 76.6 81.9 
17 39.9 43.0 44.6 
18 7.6 7.5 7.6 
19 29.0 28.4 28.9 
20 34.6 36.7 35.1 
21 59.2 58.4 59.1 
CO2Me   54.3 
CO2Me   174.4 
a




































































































H NMR spectrum (CDCl3, 400 MHz) of ()-vincamine (35)
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2.1.5 Bisindole Alkaloids 
 




 was isolated in minute amounts as a light yellowish oil and 
subsequent crystallization from Et2OEtOAc, as pale yellowish crystals, mp 215217 

C, []D 138 (CHCl3, c 0.18). The UV spectrum (230, 288, and 354 nm) indicated a 
composite chromophore from the superposition of indole and quinoline moieties,
322
 
while the IR spectrum showed the presence of only one functionality, viz., an absorption 
due to OH at 3376 cm
1
. The EI mass spectrum of 36 showed an M

 at m/z 572 (base 
peak), which analyzed for C38H44N4O (corresponding to a DBE value of 19), with other 





H NMR spectrum (Figure 2.53) showed signals due to six aromatic hydrogens, 
four of which correspond to the four contiguous hydrogens of an indole unit as indicated 
from the COSY spectrum. The remaining two aromatic hydrogens appeared as two 
singlets at  7.77 and 7.54. The 1H NMR spectrum also revealed the presence of two 
ethyl and one vinyl side chain, two isolated methylenes and one isolated methine. The 
13
C NMR data (Table 2.24) accounted for all 38 carbon resonances comprising 2 
methyl, 14 methylene, 9 methine, and 13 quaternary carbons. Examination of the NMR 
chemical shifts, as well as the COSY and HETCOR data, revealed partial structures 
(unsubstituted indole, NCH2CH2, NCH2CH2CH2, NCHCH2, NCH, and CH3CH2) which 
indicated that one unit of the bisindole corresponds to an eburnane moiety. This 
attribution was readily confirmed by examination of the 
13
C NMR spectrum as well as 
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the HMBC spectrum, where the signals corresponding to an eburnane half (eburnamine 
(34)) were clearly evident.
124,214
 The signal due to H(16') was observed as a one-H 
multiplet at  5.77, suggesting branching of the bisindole from this carbon, a conclusion 
which was supported by the observed H(9) to C(16') three-bond correlation seen in the 
HMBC spectrum of 36 (Figure 2.50). Since the eburnane alkaloids present in this plant 
such as ()-eburnamaline (28), ()-eburnamonine (29), ()-eburnamenine (30), O-
methylisoeburnamine (31), O-methyleburnamine (32), ()-isoeburnamine (33), and ()-
eburnamine (34), all belong to the 20,21-enantiomeric group, the eburnane half in 
leucophyllidine (36) is in all probability derived from ()-eburnamine (34). The 
attachment of the other unit at C(16') is likely to be , in analogy to the other 
Aspidosperma-eburnea bisindoles
188,223
 with branching from the eburnane C(16'). 
 
 
Figure 2.50: Selected HMBCs of 36 
 
The other unit constituting the bisindole, after discounting the eburnane half, 
incorporates an aromatic ring substituted at C(10) and C(11), from the observation of 
two aromatic singlets at  7.54 and 7.77. Other fragments associated with this 
monomeric unit includes an ethyl ( 7.1, 35.0), and a vinyl ( 123.1, 131.1) side chain. 
The OH group indicated in the IR spectrum constitutes one of the aromatic substituents, 
which is consistent with the observed shift of this carbon at  155.8, while the adjacent 
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aromatic carbon ( 118.7) represents the site of eburnane substitution. The carbon shifts 
of the aromatic unit can be assigned based on the HMBC spectrum. The three-bond 
correlation from the aromatic signal at  7.54 to the eburnane C(16') ( 49.7) and to 
another aromatic carbon at  143.9 (C(7)) allowed the assignment of this signal to H(9) 
and that at  7.77 to H(12). The correlation from H(9) to the signal at  155.8 
establishes hydroxy-substitution to be at C(11) and hence eburnane substitution at C(10) 
( 118.7). The remaining correlations from H(9) and H(12) allowed the assignment of 
the other aromatic carbons (Figure 2.50). The low field resonance observed at  160.7 
indicated the presence of an imine function
 
and this, with the two remaining quaternary 
aromatic signals at  120.9 and 143.9, can be attributed to C(2), C(16), and C(7), 
respectively, of a quinoline chromophore. Attachment of the vinyl side chain is to C(7) 
due to the observed three-bond correlation from the vinylic H(5) to C(7). The NMR data 
also showed the presence of an isolated methylene and an isolated aminomethylene, in 
addition to an ethyl side chain attached to a quaternary carbon. The three-bond 
correlations observed from H(17) to C(21), H(21) to C(2), and the two bond correlation 
from H(17) to C(20) allowed the methylene, ethyl-substituted quaternary carbon, and 
the aminomethylene fragments to be linked to form a third ring fused to the 
vinylquinoline unit, constituting a tetrahydrobenzo[b][1,8]naphthyridine ring system. 
 
This leaves a three-carbon fragment to complete assembly of the molecule. The COSY 
spectrum showed the presence of an NCH2CH2 fragment. This partial structure should 
in fact be part of the NC(3)C(14)C(15) fragment, but extensive overlap allowed only 
the NC(3)C(14) fragment to be discerned. The presence of the C(15) methylenes as 
part of the NC(3)C(14)C(15) fragment linked from C(15) to C(20) can however be 
deduced indirectly from the correlations observed from H(21) and H(17) to C(15). The 
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observed correlation from H(3) to C(2) allowed the linking of this fragment from C(3) 
to N(4) to complete assembly of the fourth ring. The resulting tetracylic quinolinic 
structure unraveled corresponds to a new alkaloid skeleton. A search of the literature 
however, revealed that a vinyl-substituted quinoline alkaloid different to the quinolinic 








J HMBCs of 467 
 
Although the structure proposed for strictigine was different from that of the 
vinylquinoline moiety of leucophyllidine (36), the NMR data of the non-aromatic part 
of the molecule were virtually similar to those of the quinolinic coupling partner in 36. 
A closer examination of the NMR data of strictigine revealed, in addition to a major 
incorrect assignment of the  37.0 carbon shift and the absence of the C(7) signal, an 




J HMBCs (Figure 2.51), which in combination led to the 
wrong structural assignment. 
 
 
Figure 2.52: X-ray crystal structure of 36 
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In order to secure unambiguous confirmation of the proposed structure of 
leucophyllidine (36), an X-ray diffraction analysis was carried out (Figure 2.52) which 
provided vindication of the structure proposed for 36 based on analysis of the 
spectroscopic data. The structure of leucophyllidine (36) is unprecedented on two 
counts. First, it represents the first member of a new structural subclass of the bisindole 
alkaloids based on the constituent monomeric halves. Secondly, the vinylquinoline half 
is distinguished by a novel skeleton incorporating an unprecedented 
tetrahydrobenzo[b][1,8]naphthyridine chromophore.  
 
Scheme 2.5: A possible biogenetic pathway to 36 
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A possible pathway to 36
135
 is presented in Scheme 2.5 from an Aspidosperma 
precursor (e.g., 11-hydroxyvincadifformine 36a).
324
 Transformation of 36a to the 
Melodinus-type alkaloid 36b is well established.
325,326
 Decarboxylation, followed by 
oxidation gives the iminium ion 36c. Cleavage of the C(5)N(4) bond (which has 
precedents in the thermally-induced transformations of kopsinic acid and secodine 
derivatives
327
) furnishes the ring-E seco-alkaloid 36d. Reduction, followed in 
succession by a lone pair-assisted Grob-like fragmentation, leads to the vinyl-
substituted dihydroquinoline derivative 36e, which on aromatization following 
reduction of the imine, yields the vinylquinoline derivative 36f. Ring closure via attack 
of the piperidine NH onto the imine carbon yields the tetracyclic dihydroquinoline 36g, 
which on aromatization furnishes the vinylquinoline alkaloid incorporating a 
tetrahydrobenzo[b][1,8]naphthyridine core. Coupling of this novel vinylquinoline 



















C NMR Data of Leucophyllidine (36)
a 
Position H C Position H C 
2  160.7 2'  133.6 
3 3.12 t (11) 55.6 3' 2.41 m 44.3 
 3.80 m   2.62 m  
5 4.84 d (18) 123.1 5' 3.34 m 50.6 
 5.32 d (12)   3.34 m  
6 6.50 dd (18, 12) 131.1 6' 2.62 m 17.1 
    2.99 m  
7  143.9 7'  104.5 
8  130.9 8'  128.3 
9 7.54 s 123.5 9' 7.48 d (7.3) 117.7 
10  118.7 10' 7.02 t (7.3) 118.9 
11  155.8 11' 6.85 t (7.3) 120.2 
12 7.77 s 110.1 12' 6.71 d (7.3) 112.4 
13  147.2 13'  136.1 
14 1.24 m 19.4 14' 1.36 m 20.4 
 1.36 m   1.80 m  
15 1.45 m 36.0 15' 1.20 m 24.4 
 1.69 m   1.36 m  
16  120.9 16' 5.77 m 49.7 
17 2.39 m 36.4 17' 1.58 m 42.0 
 2.58 m   2.56 m  
18 0.89 t (7) 7.1 18' 0.77 t (7) 7.5 
19 1.27 m 35.0 19' 1.45 m 28.6 
 1.27 m   2.06 m  
20  30.5 20'  34.7 
21 2.88 d (12) 57.3 21' 4.05 s 59.3 
 2.99 d (12)     
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13


















H NMR spectrum (CDCl3, 400 MHz) of leucophyllidine (36)
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 was isolated as a light yellowish oil and subsequently light 
yellowish crystals from EtOH, mp 223224 oC, []D +142 (CHCl3, c 0.49). The IR 
spectrum indicated the presence of OH (3401 cm
1
) and ester carbonyl (1713 cm
1
) 
functions. The UV spectrum showed absorption maxima at 230 and 285 nm, 
characteristic of an indole chromophore. The EIMS showed a molecular ion at m/z 646, 
and HREIMS measurements established the molecular formula as C40H46N4O4. The 
13
C 
NMR data (Table 2.25) of 37 gave a total of 40 carbon resonances (three methyl, eleven 
methylene, twelve methine, and fourteen quaternary carbons) in agreement with the 
molecular formula from HREIMS. The 
1
H NMR data (Table 2.25) of 37 showed the 
presence of six aromatic hydrogens, four of which correspond to the four contiguous 
hydrogens of an indole unit as indicated from the COSY spectrum. The remaining two 




H NMR spectrum (Figure 2.56) also showed the presence of a broad one-H singlet 
at  7.98 (exchanged with D2O), a methoxy signal at  2.97 which is associated with a 
methyl ester moiety, signals due to an ethyl side chain at  0.97; 1.54, 2.27; another pair 
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of signals due to an ethylidene side chain at  1.64 and 5.38; an oxymethylene 
associated with a hydroxymethyl group at  3.59 and 3.80; a singlet at  4.05 due to an 
isolated methine, H(21'); and an isolated methylene signal at  3.52 and 3.61, due to 
H(21). The observation of ester carbonyl and oxymethylene resonances at  175.2 and  
69.4, respectively, are consistent with the presence of the methyl ester and 
hydroxymethyl groups. The broad singlet at  7.98 is attributed to the indolic NH 
associated with the disubstituted indole moiety. This is based on the observed NOE 
between NH and H(12) ( 7.05) of the disubstituted indole unit which also allowed 
assignment of the aromatic AB doublets to H(11) and H(12). Since the molecular 
formula showed the presence of four oxygen atoms and three have already been 
accounted for, the remaining oxygen must be due to a phenolic OH associated with the 
disubstituted indole moiety. This was further supported by acetylation (Ac2O/DMAP), 
which yielded a diacetate derivative 37a ( 1.72 and 1.98; C 20.2, 169.0; 20.9, 170.8; 
see Experimental Section).  
 
Examination of the NMR chemical shifts as well as the 2-D COSY and HETCOR data 
revealed that one unit of the bisindole corresponds to an eburnane moiety. This is 
supported by examination of the 
13
C NMR data which showed a close correspondence 
to those of eburnamine (34) or to bisindole alkaloids incorporating an eburnane half, 
such as leucophyllidine (36). The H(16') signal was observed as a doublet of doublets (J 
= 12, 4.4 Hz) indicating branching of the bisindole from C(16') of the eburnane unit. 
This conclusion receives additional support from the observation of long-range 
correlation from the eburnane H(16') to the aromatic C(10) of the other indole unit (vide 
infra). The configurations at C(20) and C(21) of the eburnane unit were deduced to be 
20R and 21R (20, 21) on the basis of a presumed common biogenetic origin, since 
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Figure 2.54: Selected HMBCs of 37 
 
The other unit constituting the bisindole, after discounting the eburnane half, 
incorporates a disubstituted indole moiety, an indolic NH, a methyl ester, a 
hydroxymethyl, an aminomethylene, an ethylidene side chain, as well as NCHCH2 and 
NCHCH2CH partial structures. Examination of the NMR data as well as assembly of 
these fragments with the help of the HMBC data (Figure 2.54) revealed an alkaloid of 
the sarpagine subclass (e.g. 11-hydroxyakuammidine (468)). The unusual shielding of 
the ester methyl at  2.97 is in agreement with the configuration at C(16), which places 
the ester function in the shielding zone of the aromatic ring of the sarpagine unit. The 
location of hydroxy-substitution was deduced to be at C(10) from the observed three-
bond H(16') (eburnane half) to C(10) (sarpagine half,  148.8) correlation observed in 
the HMBC spectrum. The bisindole is therefore branched from C(16') of the eburnane 
half to C(10) of the sarpagine half. The attachment of the sarpagine unit at the eburnane 
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C(16') is likely to be  in analogy to the other Aspidosperma-eburnea bisindoles with 
branching from the eburnane C(16'). This is also supported by the observed coupling 
constants for H(16') of 12 and 4.4 Hz which are consistent with an axial or -oriented 
H(16') and diagnostic of eburnane alkaloids belonging to the eburnamine series, as 
opposed to those belonging to the diastereomeric ()-isoeburnamine (33) (or epi-





Figure 2.55: X-ray crystal structure of 37 
 
 
Since suitable crystals of leuconoline (37) were obtained, an X-ray diffraction was also 
carried out which provided further confirmation of the structure deduced from analysis 








C NMR Spectroscopic Data of Leuconoline (37)
a
 
Position H C Position H C 
2  138.8 2'  133.7 
3 4.21 d (10) 50.5 3' 2.52 m 44.6 
    2.64 m  
5 3.01 m 57.9 5' 3.29 m 50.9 
    3.33 m  
6 3.01 m 27.6 6' 2.57 m 17.0 
 3.31 m   3.02 m  
7  104.5 7'  107.0 
8  124.7 8'  128.9 
9  117.3 9' 7.43 d (7.6) 117.8 
10  148.8 10' 7.01 td (7.6, 1) 120.0 
11 6.62 d (8.5) 113.3 11' 6.74 td (7.6, 1) 121.2 
12 7.05 d (8.5) 110.9 12' 6.57 d (8.3) 111.7 
13  132.0 13'  137.7 
14 1.87 m 29.9 14' 1.46 m 20.7 
 2.63 m   1.79 m  
15 3.05 m 28.9 15' 1.21 td (13, 3) 24.0 
16  50.8  1.56 m  
17 3.59 d (10.5) 69.4 16' 5.65 dd (12, 4.4) 51.4 
 3.80 d (10.5)  17' 2.21 dd (14, 12) 39.5 
18 1.64 d (7) 12.9  2.61 m  
19 5.38 q (7) 116.4 18' 0.97 t (7.6) 7.5 
20  137.3 19' 1.54 m 29.1 
21 3.52 d (17) 55.0  2.27 dq (14, 7)  
 3.61 d (17)  20'  35.3 
NH 7.98 s  21' 4.05 s 59.7 
CO2Me 2.97 s 51.4    
CO2Me      
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13














H NMR spectrum (CDCl3, 400 MHz) of leuconoline (37) 
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 was isolated as a light yellowish oil, []D +113 (CHCl3, c 0.28). The 
UV spectrum showed absorption maxima at 214 and 273 nm indicating the presence of 
an indolenine chromophore. The ESIMS of 38 showed a quasi molecular ion at m/z 557, 
and HRESIMS measurements established the molecular formula as C38H44N4 (DBE 19). 
The 
13
C NMR data (Table 2.26) accounted for all of 38 carbon resonances, comprising 
two methyl, twelve methylene, fourteen methine, and ten quaternary carbons. The 
1
H 
NMR spectrum (Figure 2.58) showed the presence of eight aromatic hydrogens 
corresponding to two unsubstituted aromatic moieties, and two isolated methylenes (H 
1.86, 3.30; C 42.6; H 3.75, 4.11; C 48.4). In addition to the two aromatic 
CHCHCHCH units, the main partial structures revealed by the COSY and HSQC data 
were two NCHCHCH2CH3 fragments, which are characteristic of the 









C NMR data showed that one unit of the bisindole 
corresponds to the known alkaloid, epi-condyfoline (469),
328
 except for C(16) which is a 
quaternary carbon in 38 instead of a methylene in 469. This provided the first indication 
that branching of the bisindole from this indolenine unit is from C(16), since there was 
no evidence of substitution at the other carbons of the condyfoline-like unit. 
Examination of the remaining fragments which correspond to those constituting the 
other condylocarpine unit, revealed a similar ring system as 469, except for the presence 
of an enamine double bond instead of an indolenine. This left two isolated methylene 
groups, one each attached to the indolic N(1') and to C(16') of the second indole unit. 
This is consistent with the observed shifts of these methylenes ( 3.75, 4.11, NCH2;  
1.86, 3.30, CCH2) as well as the HMBC data (Figure 2.57). Both of these methylenes 
are linked to C(16) of the first or condyfoline-like unit to forge a tetrahydropyridine ring 




J correlations from H(22') to C(16), and from H(22') to C(2), respectively, as seen in 
the HMBC spectrum. This mode of branching in leucofoline (38) is somewhat similar to 
that in the Aspidosperma–Aspidosperma bisindole, anhydrohazuntiphyllidine (470),329 
and is also in agreement with the HMBC data.  
     
            Figure 2.57: Selected HMBCs and NOEs of 38  
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The NOE data showed that the relative configurations of the monomeric units are 
similar to those of condylocarpine (92). The configuration at the spirocyclic center, 
C(16), was determined to be R, from the observed H(20)/H(22a) reciprocal NOEs, 
which are possible only if C(16) is R (Figure 2.57). In the converse case (C(16S)), these 
two hydrogens will be directed away from each other and would therefore not be 
expected to show any NOE (Figure 2.57).  
 
 
Scheme 2.6: A possible biogenetic pathway to 38 
 
Leucofoline (38) represents the first example of a bisindole of the 
aspidospermatanaspidospermatan type. A possible pathway to 38 is shown in Scheme 
2.6 involving conjugate addition via the indolic nitrogen of the condylocarpine-type 
precursor 38a (or 16-methylenecondyfoline) onto the imine 38b, to effect the N(1′) to 
C(16) link, followed by a subsequent conjugate addition of an enamine to forge the 









C NMR Spectroscopic Data of Leucofoline (38)
a
 
Position H C Position H C 
2  191.3 2'  147.9 
3 3.26 m 58.7 3' 2.78 m 45.2 
 3.26 m   2.92 m  
5 2.86 m 46.3 5' 2.73 m 54.2 
 3.21 m   2.89 m  
6 1.95 td (13, 5) 36.4 6' 1.57 m 41.2 
 2.96 m   2.71 m  
7  66.7 7'  52.7 
8  146.9 8'  136.7 
9 7.29 d (7) 120.3 9' 7.08 d (7) 120.0 
10 7.17 t (7) 125.9 10' 6.77 t (7) 119.5 
11 7.28 t (7) 127.7 11' 7.09 t (7) 126.9 
12 7.46 d (7) 120.2 12' 6.63 d (7) 107.7 
13  153.4 13'  149.2 
14 1.72 m 21.6 14' 1.52 m 19.9 
 1.72 m   1.90 m  
15 2.02 m 36.0 15' 2.02 m 36.0 
16  44.3 16'  110.5 
18 0.74 t (7) 12.0 18' 0.90 t (7) 12.3 
19 1.54 m 24.9 19' 1.76 m 24.4 
 1.54 m   1.76 m  
20 1.07 m 38.4 20' 1.31 m 41.8 
21 3.64 s 71.3 21' 3.56 s 65.0 
22a 3.75 m 48.4 22'a 1.86 d (15) 42.6 
22b 4.11 d (12)  22'b 3.30 m  
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13














H NMR spectrum (CDCl3, 400 MHz) of leucofoline (38) 
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 was obtained as a light yellowish oil, with []D 29 (CHCl3, c 
0.26). The UV spectrum showed absorption maxima at 213 and 267 nm, characteristic 
of an indolenine chromophore. The ESIMS of 39 showed an [M  H] peak at m/z 557, 




C NMR data (Table 2.28) accounted for 38 carbon resonances, comprising two 
methyl, 12 methylene, 14 methine, and 10 quaternary carbons. The presence of the 
imine function was supported by the observed carbon resonance at δ 188.0, while the 
presence of a tetrasubstituted double bond associated with an enamine function was 
seen at δ 110.2 and 147.8. The 1H NMR data (Table 2.27) showed the presence of eight 
aromatic hydrogens corresponding to two disubstituted aromatic moieties (δ 7.30, dd, J 
= 7.3, 1 Hz, H(9); 7.17, td, J = 7.3, 1 Hz, H(10); 7.26, td, J = 7.3, 1 Hz, H(11); 7.36, dd, 
J = 7.3, 1 Hz, H(12); 7.08, dd, J = 7.3, 1 Hz, H(9′); 6.83, td, J = 7.3, 1 Hz, H(10′); 7.11, 
td, J = 7.3, 1 Hz, H(11′); 6.68, dd, J = 7.3, 1 Hz, H(12′)), two ethyl side chains (δ 1.00, 
t, J = 7.3 Hz, H(18); 1.57, m, H(19); 0.99, t, J = 7.3 Hz, H(18′); 1.75, m, H(19′)), and 
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two isolated methylenes (δ 3.01, d, J = 10 Hz, H(22); 4.59, d, J = 10 Hz, H(22); 2.03, m, 
H(22′); 2.91, d, J = 13 Hz, H(22′)).  
The COSY and HSQC data disclosed the presence of the following partial structures: 
two NCH2CH2, two NCHCH2CH, and one NCH2CHCH2CH3. Another 
NCH2CHCH2CH3 fragment could not be discerned from the COSY spectrum alone but 
was deduced with the aid of HMBC data (three-bond correlations from H(18) to C(20) 




C NMR shifts indicated that the two sets of 
partial structures correspond to the presence of two strychnan units constituting the 
bisindole. The chemical shifts of one of these units (the indolenine-containing half) 
showed a close correspondence to those of the known Strychnos alkaloid tubifoline 
(471),
309
 except for the distinct change involving C(16), which is a quaternary center in 
39 instead of a methylene in tubifoline (471). This provided an early indication that 
branching of the bisindole from this indolenine unit is from C(16), since there was no 
evidence of substitution at the other carbons of the tubifoline-like unit. Examination of 
the remaining fragments that correspond to those constituting the other strychnan unit 
revealed a similar ring system to tubifoline (471), except for the presence of an enamine 
double bond instead of an indolenine.  
         
       Figure 2.59: Selected HMBCs and NOEs of 39  
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This left two isolated methylene groups, one each attached to the indolic nitrogen N(1′) 
and to C(16′) of the second strychnan unit. This is consistent with the observed shifts of 
these methylenes (δ 3.01, 4.59, NCH2; δ 2.03, 2.91, CCH2) as well as the HMBC data 
(Figure 2.59). Both of these methylenes are linked to C(16) of the first or tubifoline-like 
unit to forge a tetrahydropyridine ring incorporating C(16) as a spirocyclic center. This 




J correlations from H(22) to C(16) and from 
H(22′) to C(2), respectively, as seen in the HMBC spectrum. The proposed structure is 
entirely consistent with the full HMBC data (Figure 2.59). The relative configurations at 
the various stereogenic centers in the strychnan moieties were established from NOEs 
(Figure 2.59) and analysis of the vicinal coupling constants, in the same manner as that 
carried out previously for leuconicine A (2).
134
 This leaves the configuration at the 
spirocyclic C(16) to be determined.  
 
Figure 2.60: The 16S and 16R stereoisomers of 39 
 
The two alternative 16S and 16R stereoisomers are shown in Figure 2.60. The 
H(6)/H(22) NOE, previously used to establish the relative configuration (16S) in the 
related Aspidosperma-Aspidosperma bisindole anhydrohazuntiphyllidine (470),
329
 could 
not be applied in the present instance due to the overlap of the H(6) and H(22) signals, 
although the presence of the alternative H(15)/H(22′a) and H(15′)/H(22′a), respectively 
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NOESY cross-peaks was suggestive of the 16S epimer. Additional support for the 16S 
configuration was deduced from the following evidence. In the case of the 16S epimer, 
examination of models revealed that the two indole units are situated in approximately 
the same plane, with the aromatic rings located at opposite ends and pointing in 
opposite directions (H(12) and H(12′) pointing in opposite directions), whereas in the 
16R epimer, folding of the second indole unit results in H(12) of the tubifoline-like unit 
pointing into the aromatic ring of the second unit (Figure 2.60). This would result in 
clear anisotropy experienced by H(12), which would cause the H(12) resonance to be 
shifted significantly upfield compared with H(12′) in the 1H NMR spectrum (Figure 
2.62), an effect previously observed in the bisindole conophylline (472)
330
 (H(9) in 
conophylline (472) seen at δ 5.55). In the present case, the chemical shifts of H(12) and 
H(12′) were seen at δ 7.36 and 6.68, respectively, (the H(12) resonance was in fact 
slightly downfield compared to H(12′)), with no evidence of any upfield shift as a result 
of anisotropy caused by the other aromatic ring. On the basis of the above lines of 
evidence, the relative configuration of the spirocyclic C(16) was assigned as S. 
 
Scheme 2.7: A possible biogenetic pathway to 39 
 
A possible origin of the basic ring system of 39, which are characterized by branching 
of one unit from a common spirocyclic carbon, C(16), is shown in Scheme 2.7, 
involving conjugate addition via the indolic nitrogen of anhydropereirine (110) (vide 
infra) onto the dihydrovalparicine derivative 39a, to effect the N(1′) to C(16) link, 
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followed by a subsequent conjugate addition of an enamine to forge the spirocyclic ring 
system. 
 




 was isolated as a light yellowish oil, []D 56 (CHCl3, c 0.29). 
The UV spectrum showed absorption maxima at 215, 268, and 329 nm, consistent with 
the presence of indolenine and methyleneindoline chromophores, while the IR spectrum 
was similar to that of 39. The ESIMS of 40 showed a quasi molecular ion at m/z 555, 
and HRESIMS measurements established the molecular formula as C38H42N4 (DBE 20), 




C NMR data of 40 (Tables 2.27 
and 2.28, respectively) were generally similar to those of 39. However, the 
13
C NMR 
spectrum of 40 indicated the presence of an additional double bond from the resonances 
at δ 124.1 and 131.9, corresponding to olefinic quaternary and methine carbons, 
respectively. 
 
Comparison of the 
13
C NMR spectrum with that of 39 showed that while the chemical 
shifts of the other carbons were essentially unchanged, those of C(20) and C(21) (of the 




indicating that these carbons correspond to the site of unsaturation. This was also 
supported by the observed three-bond correlations from H(3) and H(15) to C(21) in the 
HMBC spectrum. The signal due to H(20), seen in the 
1
H NMR spectrum of 39 (δ 2.00), 
was absent in that of 40. Instead, a new olefinic H signal corresponding to H(21), was 
observed as a singlet at δ 5.85 in the 1H NMR spectrum (Figure 2.63) of 40, in place of 
the two C(21) methylene signals previously seen for 39 at δ 2.78 and 3.41. 
Corresponding changes also occurred in the signals due to H(19), which in 40 were seen 
at δ 1.95 as a multiplet and at δ 2.08 as a doublet of quartets (J = 14, 7.3 Hz). These 
features are all consistent with the presence of a double bond across C(20) and C(21).   
 




 was isolated as a light yellowish oil, []D 61 (CHCl3, c 0.26). 
The UV spectrum was different from those of 39 and 40, showing absorption maxima at 
206, 250, and 275 nm, while the IR spectrum indicated the presence of primary amine 
(3414, 3358 cm
1
) and ketone (1686 cm
1
) functionalities. The ESIMS of 41 showed a 
quasi molecular ion at m/z 575, and HRESIMS measurements established the molecular 
formula as C38H46N4O (DBE 18).  
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Comparison of the 
13
C NMR data of 41 (Table 2.28) with those of 39 showed that the 
imine function in 39 (δ 188.0, C(2)) has been replaced by a ketone function (δ 215.7, 
C(2)). Similarly, comparison of the 
1
H NMR spectrum of 41 with that of 39 indicated 
that the major difference was the appearance of two exchangeable hydrogens as a broad 
peak at δ 4.85, which was attributed to the presence of a primary amine (NH2) group, 
which was also detected in the IR spectrum. Other changes in the 
13
C NMR spectrum 
involved the shifts of C(7) (δ 60.6), and C(16) (δ 52.4), which are  to C(2), and C(13) 
(δ 147.5), to which the amino group is attached in compound 41. These changes are 
consistent with hydrolytic cleavage of the N(1)C(2) imine linkage of 39 to yield a 
primary amine and a ketone function. The ready detection of the NH2 signal in the 
1
H 
NMR spectrum is probably due to intramolecular H-bonding of the amine hydrogens 
with the proximate ketone function at C(2). Another significant change involved the 
ethyl hydrogens of the other strychnan moiety. These hydrogens have been significantly 
shifted upfield, in particular the methylene hydrogens, H(19′) (δ 0.11, 0.13). This is 
likely the result of anisotropy due to the carbonyl function at C(2), as a consequence of 
the new conformation adopted in the seco compound 41. 
 
The configurations at the spirocyclic C(16) in compounds 40 and 41 were deduced to be 
similar, i.e., 16S, to that in compound 39 for the same reasons that were discussed in the 
case of 39 (vide supra). In the case of compound 41, however, the observed anisotropic 
shielding of the ethyl hydrogens provide further support for the 16S configuration of the 
spirocyclic C(16), since if the C(16) configuration is R, the ethyl side chain of the 
second strychnan moiety would be directed away, and therefore too far removed from 
the tubifoline unit (Figure 2.60) to experience anisotropic effects. 
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 was isolated as a light yellowish oil, []D 6 (CHCl3, c 0.40). The 
UV spectrum showed absorption maxima at 213, 253, and 299 nm, indicating the 
presence of indolenine and dihydroindole chromophores, while the IR spectrum 
indicated the presence of an indolic NH (3246 cm
1
). The ESIMS of 42 showed a quasi 
molecular ion at m/z 559, and HRESIMS measurements established the molecular 
formula as C38H46N4 (DBE 18). The 
13
C NMR data (Table 2.28) accounted for 38 
carbon resonances, comprising two methyl, 12 methylene, 15 methine, and nine 
quaternary carbons.  
 
The presence of the imine function was supported by the observed carbon resonance at 
δ 192.7, while the presence of a gem-disubstituted double bond was indicated by the 
signals seen at δ 115.7 and 146.9. Aside from these, the 12 remaining low-field sp2 
carbon resonances can be attributed to the presence of two aromatic rings associated 
with two indole moieties. The 
1
H NMR data (Table 2.27) showed the presence of seven 
aromatic hydrogens (δ 7.30, dd, J = 7.6, 1 Hz, H(9); 7.19, td, J = 7.6, 1 Hz, H(10); 7.32, 
td, J = 7.6, 1 Hz, H(11); 7.54, dd, J = 7.6, 1 Hz, H(12); 6.90, d, J = 7.6 Hz, H(9′); 6.70, 
t, J = 7.6 Hz, H(10′); 6.92, d, J = 7.6 Hz, H(11′)), one indolic NH as a doublet at δ 6.85 
(J = 5 Hz), two ethyl side chains (δ 1.03, t, J = 7.3 Hz, H(18); 1.43, m, H(19); 1.56, m, 
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H(19); 1.00, t, J = 7.3 Hz, H(18′); 1.26, m, H(19′); 1.43, m, H(19′)), and two singlets at 
δ 5.06 and 5.40 due to the geminal hydrogens of an exocyclic double bond. Since only 
seven aromatic hydrogens are present, branching of the bisindole must be from one of 
the aromatic carbons. The NMR shifts showed that one unit of the bisindole corresponds 
to the same tubifoline-like unit as in the previous three alkaloids (3941), except that in 
compound 42, C(16) was a methine and not a quaternary center as in the previous three 
alkaloids (3941).  
 
        Figure 2.61: Selected HMBCs and NOEs of 42 
 
In addition, examination of the NMR data of the other monomeric unit yielded a 
structure that corresponded to the strychnan compound anhydropereirine (or 
anhydrogeissoschizoline) (110),
331
 previously obtained as a dehydration product of 
pereirine (or geissoschizoline).
331,332
 All four aromatic shifts of the tubifoline-like unit 
were seen, while only three contiguous aromatic hydrogens of the anhydropereirine-like 
unit were present. These were assigned to the C(9′)C(10′)C(11′) fragment from the 
observed NOE between H(9′) and H(3′) of the anhydropereirine unit. Branching of the 
bisindole is therefore from C(16) of the tubifoline-like unit to C(12′) of the 
anhydrogeissoschizoline unit. The 2-D NMR data (COSY, HSQC, and HMBC) 
revealed all the partial structures associated with the two strychnan halves constituting 
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the bisindole, except for the presence of an additional methylene (δC 35.0, δH 2.50, 
3.40), which is attributed to the methylene bridge linking the two halves from C(12′) of 
the anhydropereirine unit to C(16) of the tubifoline-like unit. This assignment is 




J correlations from H(22) to C(11′) and C(13′) and 
from H(22) to C(16), respectively, in the HMBC spectrum (Figure 2.61). The relative 
configuration of the stereogenic centers in the two strychnan halves were shown by 
NOE to correspond to those in the constituent monomers, tubifoline (471) and 
anhydropereirine/geissoschizoline (110) (Figure 2.61). The relative configuration at the 
branching point, C(16), was demonstrated by NOE (Figure 2.61) as follows. First, the 
observed reciprocal NOEs between H(16) and H(21) are only possible if H(16) is  
(16S), since, if H(16) is R, the two hydrogens will be located on opposite faces of the 
molecule and too far removed for NOEs to be observed. Similarly, the observed 
reciprocal NOEs between H(22a) and N(1′)-H, and between H(12) and H(22′a), are only 
possible if H(16) is .  
 
Scheme 2.8: A possible biogenetic pathway to 42 
 
A possible biogenetic origin of 42 is shown in Scheme 2.8, involving the same coupling 
partners as in the proposed biogenetic route to the bisindoles 3941 (vide supra). In the 
case of 42, the sequence is initiated by conjugate addition of the nucleophilic ortho 




H NMR Spectroscopic Data of Leucoridines AD (3942)a 
H 39 40 41 42 
3 3.74 br s 3.79 br s 3.75 br s 3.69 br s 
5 2.98 m 3.43 td (12, 5) 2.84 td (13, 3) 3.15 m 
5 3.32 m 3.54 dd (12, 6.5) 2.84 td (13, 3) 3.15 m 
6 2.13 dd (13, 4) 1.57 m 2.13 m 1.86 m 
6 3.05 m 2.65 td (13, 5.6) 3.44 dt (14, 9) 2.64 td (12, 7) 
9 7.30 dd (7.3, 1) 7.30 d (7.6) 7.19 d (8) 7.30 dd (7.6, 1) 
10 7.17 td (7.3, 1) 7.19 t (7.6) 6.65 t (7.7) 7.19 td (7.6, 1) 
11 7.26 td (7.3, 1) 7.31 t (7.6) 6.96 t (7.7) 7.32 td (7.6, 1) 
12 7.36 dd (7.3, 1) 7.39 d (7.6) 6.56 d (7) 7.54 dd (7.6, 1) 
14R 1.32 br d (14) 1.60 m 2.33 dt (14, 3) 1.56 m 
14S 1.70 br d (14) 1.95 m 2.98 m 1.56 m 
15 2.00 m 2.16 m 2.00 m 2.04 m 
16    2.97 m 
18 1.00 t (7.3) 1.03 t (7.3) 1.00 t (7) 1.03 t (7.3) 
19 1.57 m 1.95 m 1.48 m 1.43 m 
 1.57 m 2.08 dq (14, 7.3) 1.64 m 1.56 m 
20 2.00 m  1.93 m 1.77 m 
21 2.78 t (12) 5.85 s 2.18 t (13) 2.54 m 
21 3.41 dd (12, 5.6)  2.92 dd (13, 3) 3.21 m 
22b 3.01 d (10) 3.00 m 2.48 d (11) 2.50 m 
22a 4.59 d (10) 4.21 d (11) 4.11 d (9) 3.40 dd (13, 11) 
NH   4.85 br s  
2'    4.12 d (5) 
3' 3.80 br s 3.76 br s 3.72 br s 3.02 br s 
5' 2.78 dd (12, 7.6) 2.80 m 2.76 dd (12, 8) 2.92 m 
5' 2.98 m 3.05 m 3.01 m 3.09 m 
6' 1.50 m 1.49 m 1.82 m 2.26 m 
6' 2.57 td (12, 5) 2.01 m 2.62 dd (13, 4) 2.26 m 
9' 7.08 dd (7.3, 1) 7.08 d (7.6) 7.02 d (7) 6.90 d (7.6) 
10' 6.83 td (7.3, 1) 6.80 t (7.6) 6.77 t (7.7) 6.70 t (7.6) 
11' 7.11 td (7.3, 1) 7.09 t (7.6) 7.10 t (7.7) 6.92 d (7.6) 
12' 6.68 dd (7.3, 1) 6.64 d (7.6) 6.54 d (7.2) 
14'R 1.50 m 2.04 m 1.28 dt (12, 3) 1.86 m 
14'S 2.03 m 2.67 m 1.85 m 2.35 dt (13, 3) 
15' 2.33 br s 2.32 br s 1.93 m 2.82 m 
18' 0.99 t (7.3) 1.00 t (7.3) 0.53 t (7) 1.00 t (7.3) 
19' 1.75 m 1.63 m 0.13 m 1.26 m 
 1.75 m 1.68 m 0.11 m 1.43 m 
20' 1.77 m 1.78 m 1.41 m 1.72 m 
21' 2.62 t (12) 2.57 t (12) 1.72 t (12) 2.13 t (12) 
21' 3.01 m 3.00 m 2.69 dd (12, 4) 2.70 dd (12, 4) 
22'b 2.03 m 1.97 m 1.98 d (14) 5.06 s 
22'a 2.91 d (13) 2.93 d (12) 2.52 d (16) 5.40 s 
NH'    6.85 d (5) 
 a




C NMR Spectroscopic Data of Leucoridines AD (3942)a  
C  39 40 41 42 
2 188.0 187.9 215.7 192.7 
3 69.5 66.6 64.7 70.9 
5 58.0 55.0 52.7 57.6 
6 35.0 40.5 36.5 33.0 
7 65.6 65.7 60.6 66.4 
8 146.5 147.0 124.8 145.2 
9 120.4 120.2 125.1 121.0 
10 125.6 125.8 118.1 125.4 
11 127.4 127.6 128.5 127.6 
12 119.8 120.3 117.6 119.5 
13 153.7 154.7 147.5 153.7 
14 30.1 27.1 28.0 28.5 
15 42.4 42.3 47.7 41.8 
16 47.7 47.5 52.4 40.5 
18 12.9 13.0 14.2 11.4 
19 27.4 29.4 27.5 24.8 
20 44.6 124.1 46.1 42.4 
21 53.6 131.9 51.8 51.5 
22 49.4 50.3 50.5 35.0 
2' 147.8 148.2 149.4 71.1 
3' 61.5 61.7 61.8 67.1 
5' 53.6 53.9 53.7 55.2 
6' 40.0 31.8 40.7 41.2 
7' 50.6 51.1 51.3 53.9 
8' 136.9 137.1 135.3 137.7 
9' 119.9 119.7 119.7 120.1 
10' 120.4 120.4 119.9 118.9 
11' 126.8 126.9 127.5 128.6 
12' 108.9 108.8 108.1 122.4 
13' 150.0 150.2 148.8 149.4 
14' 31.5 37.5 32.0 26.9 
15' 34.1 34.8 34.7 33.7 
16' 110.2 108.8 101.7 146.9 
18' 11.8 12.0 12.8 11.7 
19' 25.3 25.6 24.6 24.1 
20' 39.7 40.0 39.0 43.3 
21' 51.5 51.9 52.0 50.7 
22' 46.3 45.4 40.0 115.7 
a





























































H NMR spectrum (CDCl3, 400 MHz) of leucoridine D (42)
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2.1.6 Corynanthe Alkaloids 
 
2.1.6.1   Tetrahydroalstonine (43), 17(S)-Ajmalicinial (44), 17(R)-Ajmalicinial (45), 
Akuammidine (46), 16(R)-19,20-E-Isositsirikine (47), 16(S)-19,20-E-
Isositsirikine (48), Z-Geissoschizol (49), Pleiocarpamine (50), 16-
Hydroxymethylpleiocarpamine (51), Fluorocarpamine (52), ()-
Isovallesiachotamine (53), and ()-Vallesiachotamine (54) 
 
























 ()-isovallesiachotamine (53),343,344 and ()-
vallesiachotamine (54)
340,343,344
 were isolated. 17(S)-ajmalicinial (44) and 17(R)-
ajmalicinial (45) were obtained as an inseparable mixture of isomers at C(17), while 
()-isovallesiachotamine (53) and ()-vallesiachotamine (54) were obtained as a pair of 
inseparable Z/E isomers with respect to the C(19)C(20) double bond. However, the 
thermodynamically more stable isomer, ()-isovallesiachotamine (53) was also 
obtained. The 
1
H NMR spectra of these compounds are shown in Figures 2.662.76, 
while the NMR spectroscopic data are summarized in Tables 2.29–2.35. Other data are 







H NMR Spectroscopic Data of Tetrahydroalstonine (43), 17(S)-
Ajmalicinial (44), and 17(R)-Ajmalicinial (45)
a 
H 43 44 H 45 
3 3.35 dd (12, 2) 3.24 d (10) 3′ 3.32 d (10) 
5 2.55 m 2.64 td (11.3, 5) 5′ 2.64 td (11.3, 5) 
 2.93 m 3.08 m  3.08 m 
6 2.69 m 2.73 br d (16) 6′ 2.73 br d (16) 
 2.93 m 3.08 m  3.08 m 
9 7.27 d (7.5) 7.46 br d (7.2) 9′ 7.46 br d (7.2) 
10 7.07 td (7.5, 1.5) 7.07 td (7.2, 1) 10′ 7.07 td (7.2, 1) 
11 7.12 td (7.5, 1.5) 7.11 td (7.2, 1) 11′ 7.11 td (7.2, 1) 
12 7.45 d (7.5) 7.29 br d (7.2) 12′ 7.29 br d (7.2) 
14 1.53 q (12) 1.31 m 14′ 1.31 m 
 2.50 m 1.99 m  1.99 m 
15 2.76 m 1.36 m 15′ 1.92 m 
16  1.20 m 16′ 1.50 m 
  1.83 d (12)  1.74 dd (14, 3) 
17 7.56 s 4.73 dd (9.5, 1.8) 17′ 5.29 d (2.3) 
18 1.40 d (6.2) 1.23 d (6) 18′ 1.16 d (6) 
19 4.50 dq (10.3, 6.2) 3.32 m 19′ 3.88 dq (15.8, 6) 
20 1.69 m 1.36 m 20′ 1.50 m 
21 2.73 dd (12.3, 2) 1.99 m 21′ 2.10 t (11.3) 
 3.10 dd (12.3, 3.5) 2.95 br d (12)  2.95 br d (12) 
NH 7.87 s 8.66 br s NH′ 8.66 br s 
CO2Me 3.75 s    
a




C NMR Spectroscopic Data of Tetrahydroalstonine (43), 17(S)-
Ajmalicinial (44), and 17(R)-Ajmalicinial (45)
a 
C 43 44 C 45 
2 134.5 134.4 2′ 134.4 
3 59.8 60.0 3′ 60.0 
5 53.5 53.5 5′ 53.4 
6 21.7 21.6 6′ 21.6 
7 108.0 107.7 7′ 107.7 
8 127.2 127.3 8′ 127.2 
9 118.0 118.2 9′ 118.2 
10 114.4 119.3 10′ 119.3 
11 121.4 121.4 11′ 121.3 
12 110.8 111.1 12′ 111.1 
13 136.0 136.3 13′ 136.2 
14 34.2 35.5 14′ 35.3 
15 31.3 38.1 15′ 32.6 
16 109.5 39.2 16′ 36.6 
17 155.7 95.6 17′ 91.6 
18 18.5 19.0 18′ 19.0 
19 72.5 73.9 19′ 67.3 
20 38.4 45.7 20′ 46.4 
21 36.3 56.6 21′ 56.6 
CO2Me 51.1    
CO2Me 168.0    
a




H NMR Spectroscopic Data of Akuammidine (46), 16(R)-19,20-E-
Isositsirikine (47), and 16(S)-19,20-E-Isositsirikine (48)
a
 
H  46 47 48 
3 4.28 br d (10) 4.33 br s 3.90 br s 
5 2.97 d (5) 3.15 m 2.82 td (12, 4) 
  3.27 ddd (13, 6, 2) 3.16 dd (5.5, 1) 
6 3.08 br d (15.5) 2.67 dd (16, 6) 2.68 br d (15) 
 3.31 dd (15.5, 1.7) 2.99 m 3.00 m 
9 7.28 br d (7.7) 7.47 br d (8) 7.48 d (7.6) 
10 7.05 td (7.7, 1) 7.10 td (8, 1) 7.09 t (7.6) 
11 7.11 td (7.7, 1) 7.16 td (8, 1) 7.14 t (7.6) 
12 7.42 br d (7.7) 7.39 br d (8) 7.30(7.6)
14 1.88 ddd (13, 10, 1.5) 2.24 m 2.25 m 
 2.68 ddd (13, 4.6, 1.5) 2.24 m 2.27 m 
15 3.06 dd (4.6, 1.5) 3.15 m 3.41 m 
16  2.52 ddd (11, 8, 5) 2.66 m 
17 3.66 d (10.5) 3.54 m 3.87 m 
 3.82 d (10.5) 3.54 m 3.92 m 
18 1.65 dt (7, 1.8) 1.66 dd (7, 2) 1.62 dd (6.8, 1.7) 
19 5.40 q (7) 5.65 br q (7) 5.52 q (6.8) 
21 3.60 m 2.98 d (13) 3.08 br d (13) 
 3.60 m 3.54 m 3.80 br d (13) 
NH 7.67 br s 8.81 s 8.23 br s 
CO2Me 2.94 s s 3.59 s
a




C NMR Spectroscopic Data of Akuammidine (46), 16(R)-19,20-E-
Isositsirikine (47), and 16(S)-19,20-E-Isositsirikine (48)
a
 
C 46 47 48 
2 136.5 133.8 134.2 
3 50.5 52.8 53.3 
5 57.7 51.3 51.3 
6 24.2 17.7 19.2 
7 105.2 107.7 107.8 
8 126.4 127.6 127.3 
9 117.7 118.0 118.0 
10 118.9 119.5 119.3 
11 121.2 121.6 121.4 
12 110.9 111.3 110.9 
13 136.6 136.2 136.2 
14 28.8 30.2 30.1 
15 28.9 32.6 32.8 
16 51.2 49.6 49.7 
17 68.1 62.1 61.6 
18 12.7 13.3 12.9 
19 117.4 123.7 121.8 
20 136.8 133.7 134.8 
21 54.9 52.5 55.9 
CO2Me 51.2 52.2 51.5 
CO2Me 173.6 175.4 174.7 
a










Position 49  50  
 H C H C 
2  134.5  76.0 
3 3.45 d (11.4) 60.0 3.51 br s 61.8 
5 2.62 td (11, 4.5) 52.3 2.99 m 55.0 
 3.09 ddd (11.3, 5.9, 2)  2.99 m  
6 2.74 m 21.4 2.21 dd (12, 6) 39.0 
 2.95 m  2.99 m  
7  107.0  205.2 
8  127.0  120.4 
9 7.27 br d (7.7) 118.0 7.62 br d (8) 124.1 
10 7.01 td (7.7, 1) 119.1 6.90 br t (8) 119.5 
11 7.06 td (7.7, 1) 121.2 7.51 br t (8) 137.2 
12 7.39 br d (7.7) 111.1 6.70 br d (8) 111.1 
13  136.3  163.6 
14 1.20 m 35.8 1.37 dt (13, 3) 24.9 
 2.32 dt (12.7, 3.4)  1.91 dt (13, 3)  
15 2.26 m 37.9 3.64 br d (9) 30.5 
16 1.44 ddt (14, 8, 5.9) 33.8 4.56 d (9) 63.0 
 1.93 ddd (14, 11.8, 7)    
17 3.69 t (5.9) 60.0   
 3.69 t (5.9)    
18 1.65 d (7) 13.0 1.63 d (6) 12.3 
19 5.27 q (7) 116.9 5.50 br q (6) 121.0 
20  136.5  133.9 
21 2.69 d (12) 55.5 3.31d (14) 53.4 
 3.81 d (12)  3.38 br d (14)  
NH 9.24 br s    
CO2Me   3.72 s 51.8 
CO2Me    172.5 
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13










Position 51  52  
 H C H C 
2  136.2  137.1 
3 3.87 t (3) 50.6 3.77 m 50.4 
5 2.30 ddd (13.3, 8.5, 6.5) 50.0 2.25 ddd (13.3, 8.5, 6.5) 49.5 
 3.38 ddd (13.3, 10, 2.8)  3.35 ddd (13.3, 10, 2.8)  
6 2.69 ddd (15.5, 10, 6.5) 20.5 2.63 ddd (15.5, 10, 6.5) 20.5 
 3.17 ddd (15.5, 8.5, 2.8)  3.15 ddd (15.5, 8.5, 2.8)  
7  108.2  108.7 
8  128.4  128.7 
9 7.12 m 118.4 7.54 m 118.3 
10 6.97 m 120.1 7.10 m 120.2 
11 7.08 m 120.9 7.10 m 121.0 
12 7.55 m 112.3 7.10 m 112.0 
13  137.7  139.0 
14 2.22 ddd (13.5, 4.2, 2.5) 28.0 2.03 ddd (13.5, 4, 2.2) 25.4 
 2.51 ddd (13.5, 4, 2.5)  2.62 m  
15 3.53 m 33.5 3.74 t (3.5) 33.3 
16 5.23 d (4) 61.1  68.5 
17   4.24 d (12) 66.0 
   4.52 d (12)  
18 1.49 dd (7, 2) 12.5 1.52 dd (7, 2) 12.5 
19 5.33 qd (7, 2) 123.6 5.29 qd (7, 2) 122.2 
20  132.4  134.5 
21 1.76 dt (13, 2) 56.4 1.85 dt (13, 2) 56.5 
 2.62 d (13)  2.61 d (13)  
CO2Me 3.58 s 51.9 3.32 s 51.5 
CO2Me  168.9  173.1 
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13






C NMR Spectroscopic Data of ()-Isovallesiachotamine (53) and 
()-Vallesiachotamine (54)a 
Position 53  Position 54  
 H C  H C 
2  132.2 2′  132.6 
3 4.25 br d (12) 47.7 3′ 4.47 br d (12) 49.4 
5 3.59 td (12, 5) 50.9 5′ 3.59 td (12, 5) 51.0 
 3.69 td (12, 5)   3.69 td (12, 5)  
6 2.79 m 21.9 6′ 2.79 m 22.1 
 2.92 m   2.92 m  
7  108.1 7′  108.3 
8  136.3 8′  136.4 
9 7.46 br d (7) 117.8 9′ 7.48 br d (7) 118.1 
10 7.10 td (7, 1) 119.4 10′ 7.10 td (7, 1) 119.7 
11 7.16 td (7, 1) 121.8 11′ 7.16 td (7, 1) 122.0 
12 7.30 br d (7.8) 111.1 12′ 7.30 br d (7.8) 111.2 
13  126.6 13′  126.8 
14 1.79 ddd (13, 12, 5.6) 32.6 14′ 1.91 ddd (13, 12, 6) 34.1 
 2.24 m   2.20 m  
15 4.03 m 30.8 15′ 4.02 m 28.6 
16  93.3 16′  94.1 
17 7.76s 147.9 17′ 7.68 s 147.7 
18 2.19 d (7.6) 13.0 18′ 2.10 d (7.3) 15.2 
19 6.55 q (7.6) 147.3 19′ 6.68 q (7.3) 153.3 
20  143.1 20′  146.5 
21-CHO 10.27 s 190.8 21′-CHO 9.36 s 196.2 
NH 8.29 br s  NH′ 8.22 br s  
CO2Me 3.66 s 50.7 CO2Me′ 3.64 s 51.2 
CO2Me  168.2 CO2Me′  168.6 
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13





























































































































































H NMR spectrum (CDCl3, 400 MHz) of ()-isovallesiachotamine (53) and ()-vallesiachotamine (54)
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2.1.7 Norfluorocurarine Alkaloids 
 
2.1.7.1    Norfluorocurarine (55) and 12-Hydroxynorfluorocurarine (56) 
 





 were also isolated. The 
1
H NMR spectra of these 
compounds are shown in Figures 2.77 and 2.78, while the NMR spectroscopic data are 










Position 55  56  
 H C H C 
2  168.8  172.2 
3 4.10 td (4, 2) 61.7 4.15 m 62.2 
5 3.07 ddd (12.4, 6.5, 1) 56.6 3.11 br dd (12.6, 6.6) 57.0 
 3.31 td (12.4, 5.4)  3.38 td (12.6, 5)  
6 1.83 ddd (12.4, 5.4, 1) 46.4 1.84 br dd (12.6, 5) 46.7 
 2.39 td (12.4, 6.5)  2.47 td (12.6, 6.6)  
7  58.2  60.1 
8  136.9  139.2 
9 7.29 dd (7.5, 1) 120.8 6.86 dd (7.7, 1) 112.1 
10 6.98 td (7.5, 1) 121.9 6.98 t (7.7) 124.7 
11 7.20 td (7.5, 1) 127.7 6.88 dd (7.7, 1) 116.7 
12 6.92 dd (7.5, 1) 110.3  143.1 
13  142.8  141.0 
14 1.29 ddd (13.5, 4, 2.2) 30.8 1.33 dt (13.5, 3) 31.0 
 2.58 ddd (13.5, 4, 2.2)  2.61 ddd (13.5, 4 , 2)  
15 3.71 m 31.2 3.72 m 32.1 
16  111.0  110.1 
17 9.36 s 188.4 9.07 s 186.7 
18 1.60 ddd (6.9, 2.3, 1.6) 12.8 1.62 dt (6.9, 2) 13.2 
19 5.40 qt (6.9, 2.3) 120.4 5.43 qt (6.9, 2) 121.4 
20  139.5  129.2 
21 2.94 br d (15.7) 56.7 2.95 br d (15.9) 57.0 
 4.00 dq (15.7, 2.3)  4.02 dq (15.9, 2)  
NH 10.33 br s  11.50 br s  
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13





























H NMR spectrum (CDCl3, 400 MHz) of 12-hydroxynorfluorocurarine (56) 
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2.1.8 Aspidospermatan Alkaloids 
 
2.1.8.1    Tubotaiwine (57), Tubotaiwine N-oxide (58), and N(4)-Chloromethyl-
tubotaiwine chloride (59) 
 





 and N(4)-chloromethyltubotaiwine chloride (59)
349
 were isolated. The 
1
H NMR spectra of these compounds are shown in Figures 2.792.81, while the NMR 




H NMR Spectroscopic Data of Tubotaiwine (57), Tubotaiwine N-oxide 
(58), and N(4)-Chloromethyltubotaiwine chloride (59)
a
 
H 57 58 59 
3 2.45 dt (12, 9) 3.49 m 3.39 td (14, 4) 
 2.95 dt (12, 4) 3.49 m 4.09 dd (14, 4) 
5 2.83 dd (10.5, 7) 3.62 dd (11, 8) 3.80 m 
 2.89 m 3.73 td (12, 8) 4.44 td (12, 8) 
6 1.80 m 2.10 dd (15, 8) 2.26 dd (14, 8) 
 2.92 m 2.60 td (14, 8) 2.89 ddd (14, 12, 8) 
9 7.13 dd (7.6, 0.5) 7.26 d (7.6) 8.00 br d (7.6) 
10 6.87 td (7.6, 0.5) 6.94 t (7.6) 6.99 td (7.6, 1) 
11 7.10 td (7.6, 0.5) 7.17 t (7.6) 7.18 td (7.6, 1) 
12 6.80 dd (7.6, 0.5) 6.85 d (7.6) 6.87 br d (7.6) 
14 1.80 m 1.78 br d (13) 1.98 br d (14) 
 1.80 m 2.38 m 2.30 m 
15 3.04 m 3.20 m 3.33 m 
18 0.70 t (7) 0.73 t (7) 0.77 t (7) 
19 0.81 m 0.87 m 0.88 dqu (14, 7) 
 0.81 m 0.87 m 1.01 dqu (14, 7) 
20 1.96 tt (7, 2.5) 2.51 m 2.30 m 
21 3.79 m 4.25 m 5.51 m 
22   5.97 d (10) 
   6.60 d (10) 
CO2Me 3.76 s 3.79 s 3.81 s 
NH 8.86 s 8.77 s 8.81 s 
a




C NMR Spectroscopic Data of Tubotaiwine (57), Tubotaiwine N-oxide 
(58), and N(4)-Chloromethyltubotaiwine chloride (59)
a
 
C 57 58 59 
2 170.8 166.7 166.7 
3 45.3 59.9 50.2 
5 54.1 67.6 59.5 
6 44.1 39.3 38.9 
7 55.2 51.3 53.6 
8 137.3 134.5 133.2 
9 119.6 119.6 121.8 
10 121.1 121.9 122.6 
11 127.2 128.5 128.7 
12 109.7 110.5 110.2 
13 143.7 143.1 142.3 
14 28.6 24.8 24.4 
15 31.0 29.6 29.0 
16 95.7 95.8 95.0 
18 11.7 11.2 10.9 
19 24.0 22.5 22.5 
20 41.3 36.8 37.3 
21 65.6 78.7 73.6 
22   65.2 
CO2Me 51.2 51.5 50.2 
CO2Me 168.9 168.0 167.5 
a










































H NMR spectrum (CDCl3, 400 MHz) of N(4)-chloromethyltubotaiwine chloride (59)
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2.1.9 Monoterpene Alkaloids and Lignans 
 
2.1.9.1    Venoterpine (60) and Syringaresinol (61) 
 
One known monoterpene indole alkaloid, venoterpine (60)
350,351
 and one known lignan, 
syringaresinol (61),
352-354
 were isolated in this study. The 
1
H NMR spectra of these 
compounds are shown in Figures 2.82 and 2.83, while the NMR spectroscopic data are 










Position 60  Position 61  
 H C  H C 
1 8.37 s 147.6 1, 5 3.10 m 54.2 
3 8.35 d (5) 145.1 4, 8 3.91 m 71.6 
4 7.18 d (5) 120.4  4.29 m  
5  150.4 2, 6 4.73 d (5) 85.9 
6 2.93 dd (17, 2) 40.9 1', 1''  131.9 
 3.12 dd (17, 5)  2', 2'' 6.59 br s 102.6 
7 4.58 td (5, 2) 75.2 3', 3''  147.1 
8 3.24 qd (7, 5) 42.7 4', 4''  134.2 
9  141.9 5', 5''  147.1 
7-OH 2.32 br s  6', 6'' 6.59 br s 102.6 
8-Me 1.39 d (7) 11.9 5'-OMe, 5''-OMe 3.90 s 56.2 
   4'-OH, 4''-OH 5.60 br s  
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13




























H NMR spectrum (CDCl3, 400 MHz) of syringaresinol (61) 
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2.2 Alkaloids from Kopsia pauciflora  
 
Investigation of the alkaloidal content of the Malayan Kopsia pauciflora Hook. f. has 
provided a total of 50 alkaloids, of which 10 are new. These new alkaloids are the seco-
leuconoxine alkaloid, compound 62, the eburnane derivatives, compounds 63 and 64, 
the corynanthean oxindole alkaloids, compounds 6971, the corynanthean 
pseudoindoxyl alkaloid, tetrahydroalstonine pseudoindoxyl (73), the aspidofractinine 
derivative, 11,12-dimethoxykopsinaline (77), and the unusual pentacyclic indole 
alkaloids, andransinine (90) and compound 91. Compounds 62, 64, 71, 90, and 91 
showed strong ability to reverse multi-drug resistant in vincristine-resistant KB (VJ300) 










Table 2.40: Alkaloid Composition of K. pauciflora 
Plant part Alkaloid Yield (g kg
1
) 
Stem-bark (19 kg) Leuconoxine (14) 0.0027 
 Rhazinilam (25) 0.0015 
 Compound 63 [New] 0.0047 
 Compound 64 [New] 0.0040 
 (+)-Eburnamonine (29) 0.0030 
 (+)-Eburnamenine (30) 0.0121 
 (+)-Isoeburnamine (33) 0.0043 
 ()-Eburnamine (34) 0.0531 
 ()-19-Oxoeburnamine (66) 0.0006 
 ()-19(R)-Hydroxyisoeburnamine (67) 0.0064 
 ()-19(R)-Hydroxyeburnamine (68) 0.0018 
 Tetrahydroalstonine (43) 0.0136 
 11,12-Dimethoxykopsinaline (77) [New] 0.0017 
 Pseudokopsinine (78)  0.0258 
 Kopsinine (79) 0.1662 
 Kopsamine (80) 0.0880 
 N(1)-Decarbomethoxykopsamine (81) 0.1926 
 Kopsilongine (82) 0.0028 
 Paucifinine (83) 0.0133 
 Kopsanone (84) 0.0024 
 11,12-Methylenedioxykopsine (85) 0.0029 
 Kopsifine (87) 0.0514 




 Methyl 11,12-methylenedioxychanofruticosinate 
(96) 
0.0036 
 ()-Norpleiomutine (100) 0.0036 
   
Leaves (8.8 kg) Compound 62 [New] 0.0088 
 Leuconoxine (14) 0.0055 
 Leuconodine F (6-oxoleuconoxine) (15) 0.0007 
 Mersicarpine (16) 0.0046 
 Leuconolam (19) 0.0010 
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Table 2.40, continued 
Plant part Alkaloid Yield (g kg
1
) 
 Rhazinilam (25) 0.0060 
 Compound 63 [New] 0.0157 
 Larutenine (65) 0.0028 
 Compound 69 [New] 0.0006 
 Compound 70 [New] 0.0473 
 Compound 71 [New] 0.0211 
 ()-Catharinensine (72) 0.0048 
 Tetrahydroalstonine pseudoindoxyl (73) [New] 0.0277 
 Tetrahydroalstonine (43) 1.2463 
 16(R)-19,20-E-Isositsirikine (47) 0.0003 
 ()-Aspidospermidine (74) 0.0105 
 ()-1,2-Dehydroaspidospermidine (75) 0.0592 
 ()-Quebrachamine (76) 0.0148 
 Pseudokopsinine (78)  0.0016 
 Kopsinine (79) 0.0014 
 N(1)-Decarbomethoxykopsamine (81) 0.0224 
 Paucifinine (83) 0.0018 
 11,12-Methylenedioxykopsine (85) 0.0005 
 12-Methoxykopsine (86) 0.0030 
 Akuammicine (89) 0.0005 
 Andransinine (90) [New] 0.0022 
 Compound 91 [New] 0.0009 
 Condylocarpine (92) 0.0031 
 Precondylocarpine (93) 0.0047 




 Methyl 11,12-methylenedioxychanofruticosinate 
(96) 
0.0915 
 Methyl chanofruticosinate (97) 0.0791 
 Methyl N(1)-decarbomethoxychanofruticosinate 
(98) 
0.1594 
 Methyl 12-methoxychanofruticosinate (99) 0.0648 
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2.2.1 LeuconoxineLeuconolamRhazinilam Alkaloids 
 
2.2.1.1    Compound 62 
 
Compound 62 was obtained from the leaf extract of K. pauciflora as a yellowish oil 
with []D 72 (CHCl3, c 0.87). The UV spectrum of 62 showed absorption maxima at 
246, 271, and 326 nm, indicating the presence of an N-acyl dihydroindole (e.g., 
leuconoxine (14)),
128
 and an ,-unsaturated ester function (vide infra). The IR 
spectrum showed bands at 3304, 1722, and 1665 cm
1
 due to NH, ester, and lactam 
functionalities, respectively. The carbon resonances observed at  168.7 and 169.7 in 
the 
13
C NMR data (Table 2.41) confirmed the presence of the ester and lactam 
functionalities, respectively. The ESIMS of 62 showed an [M  H] peak at m/z 355 and 
the HRESIMS measurements gave the formula C21H26N2O3. The 
13
C NMR data (Table 
2.41) gave a total of 21 carbon resonances (two methyl, seven methylene, five methine, 






C NMR data (Table 2.41) of 62 showed a close resemblance to those of 
arboloscine (17),
157
 except for the absence of the methoxy singlet at  3.83 in 17 which 
in 62, has been replaced by a 2H multiplet at  4.28 and a methyl triplet at  1.35. The 
COSY and HSQC data disclosed the presence of two CH2CH3 fragments, one was 
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assigned to the usual C(19)C(18) ethyl side chain, and the other was attributed to the 
C(22)C(23) ethoxy group. The ethoxy substituent was deduced to be at C(5) from the 
observed three bond correlation from H(22) to C(5) in the HMBC spectrum (Figure 
2.84), which revealed that the carbomethoxy function in 17 was replaced by a 
carboethoxy function in 62. The geometry of the exocyclic double bond at C(6)C(7) 
was deduced to be similar to that in 17, i.e., Z, from the observed NOE (Figure 2.84) 
between the aromatic H(9) and the vinylic H(6). In view of the presence of the ethoxy 
group and the use of ethanol during extraction of alkaloids, it is likely that this 
compound is an artifact of the isolation process.   
 
         Figure 2.84: Selected HMBCs and NOEs of 62 
 
Compound 62 can be envisaged to have arisen from 6,7-dehydroleuconoxine (21a), 
following hydrolytic cleavage and esterification (Scheme 2.9). 
 








C NMR Spectroscopic Data of Compound 62
a
 
Position H C HMBC DNOE/NOESY 
   2J 3J  
2  169.7    
3 2.79 m 40.4 14 15, 21  
 3.22 td (12, 3)     
5  168.7    
6 6.51 s 110.1 7 8, 21 9 
7  140.1    
8  127.3    
9 7.43 d (8) 120.5  11, 13 6, 10 
10 7.09 t (8) 124.1  8, 12 9, 11 
11 7.32 t (8) 130.9  9, 13 10, 12 
12 8.35 d (8) 118.5  10 11 
13  142.5    
14 1.48 m 20.2    
 1.84 m     
15 1.64 m 30.4  21  
 1.70 m     
16 2.50 dd (17, 10) 29.9 2   
 2.74 m     
17 1.56 m 25.2 16 2, 15, 21  
 2.70 m     
18 0.82 t (7.3) 7.1 19 20 19 
19 1.48 m 26.3  15, 17, 21 18 
 1.74 m     
20  36.9    
21  88.1    
22 4.28 m 61.7 23 5 23 
 4.28 m    
23 1.35 t (7.3) 14.2 22  22 
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13















H NMR spectrum (CDCl3, 400 MHz) of compound 62
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2.2.1.2    Leuconoxine (14), Leuconodine F (15), Mersicarpine (16), Leuconolam 
(19), and Rhazinilam (25) 
 
Other known leuconoxineleuconolamrhazinilam alkaloids obtained from K. 
pauciflora include leuconoxine (14),
128












compounds were also obtained from L. griffithii. Their NMR spectroscopic data are 
presented in the previous section (section 2.1.3.9). Other data are given in the 
Experimental Section. 
 
2.2.2 Eburnane Alkaloids 
 
2.2.2.1    Compound 63 
 
Compound 63 was obtained as a light yellowish oil, with []D  (CHCl3, c 0.10). The 
UV spectrum of 63 (228 and 276 nm) was typical of an indole chromophore. The IR 
spectrum showed the presence of Wenkert-Bohlmann bands at 2852, 2796, and 2739 
cm
1
, indicating a trans-quinolizidine skeleton.
355,356
 The ESIMS of 63 showed an [M  
H]

 peak at m/z 295, while the HRESIMS measurements established the molecular 
formula as C19H22N2O (DBE 10).  
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The NMR data of 63 (Table 2.42) were generally similar to those of larutenine 
(65),
214,215
 with the presence of signals due to an unsubstituted indole moiety (δ 7.42, br 
d, J = 8 Hz, H(9); 7.05, td, J = 8, 1 Hz, H(10); 7.15, td, J = 8, 1 Hz, H(11); 7.38, br d, J 
= 8 Hz, H(12)), an isolated aminomethine due to H(21) at  3.23 (axial bridgehead 
hydrogen within a trans-quinolizidine skeleton), and the characteristic H(16) signal at  
5.92 (d, J = 4 Hz). However, the main differences were the changes involving ring F. 
Compared with 65, a methyl doublet and an oxymethine were seen at  1.33 (J = 6.3 
Hz) and 3.95 (q, J = 6.3 Hz), respectively, in the 
1
H NMR spectrum of 63 (Figure 2.88). 
Analysis of the COSY and HSQC data revealed an -OCHCH3 fragment corresponding 
to OC(19)C(18) unit, in place of the -OCH2CH2 fragment seen in 65. This observation 
suggests that the 6-membered (tetrahydropyran) ring F in 65 has been reduced to a 5-
membered (tetrahydrofuran) ring with a methyl substituent at C(19) in 63.   
 
Figure 2.86: Selected HMBCs of 63 
 
This was supported by the observed three-bond correlations from H(18) to C(20), and 
from H(19) to C(16) and C(21) in the HMBC spectrum. The structure proposed is in 
agreement with the HMBC data (Figure 2.86). The configurations of C(20) and C(21) 
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are assumed to be similar to those in ()-eburnamonine (29), ()-eburnamenine (30), 
()-isoeburnamine (33), and ()-eburnamine (34)214 found in this plant, i.e., 20R, 21R 
(or 20, 21assuming that they are biogenetically related). It therefore follows the 
stereochemistry of the C(16) ether oxygen has to be  to permit the formation of the 
sixth ring (ring F) in 63.    
 
2.2.2.2    Compound 64 
 
Compound 64 was isolated as a light yellowish oil and subsequently light yellowish 
crystals from CH2Cl2MeOH, mp 190192 
o
C, []D  (CHCl3, c 0.16). The UV 
spectrum showed absorption maxima at 210, 234, 257, 308, and 376 nm typical of an 
indole and pseudoindoxyl chromophores.
357
 The IR spectrum also showed similar 
Wenkert-Bohlmann bands at 2855, 2799, and 2742 cm
1
, indicating the presence of a 
trans-quinolizidine skeleton,
355,356
 in addition to a ketone function at 1610 cm
1
. The 
ESIMS of 64 showed an [M  H] peak at m/z 311, while the HRESIMS measurements 
established the molecular formula as C19H22N2O2 (DBE 10, 16 mass units higher than 
compound 63). The 
13
C NMR data (Table 2.42) showed a total of 19 carbon resonances, 
comprising one methyl, six methylene, seven methine, and five quaternary carbon 
atoms, in agreement with the molecular formula.  
 
Figure 2.87: Selected HMBCs of 64 
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The NMR data of 64 were in all other respect similar to those of compound 63, except 
for the carbon resonances associated with C(2) and C(7). In 64, the carbon chemical 
shifts for C(2) and C(7) were seen at  73.1 and 207.2, respectively, consistent with the 
presence of a ketone function (pseudoindoxyl function)
114,116,358
 at C(7). This 
observation was further supported by the HMBC data (Figure 2.87), which showed 
three-bond correlations from H(6), H(9), and H(21) to C(7). The rigid architecture of the 
molecule restricts the configuration at C(2) to R. This is consistent with the observed 
upfield shifts of the H(18) and H(21) signals in 64 when compared to those in 63, due 


















C NMR Spectroscopic Data of Compounds 63 and 64
a 
Position 63  64  
 H C H C 
2  135.1  73.1 
3 2.18 td (11, 3) 53.5 2.60 ddd (11.3, 8.6, 5.9) 52.9 
 2.95 br d (11)  3.05 m  
5 2.74 td (11, 6.3) 54.6 2.27 td (10.6, 4.2) 51.0 
 3.24 dd (12, 8)  3.08 m  
6 2.86 ddd (16, 6.3, 1.4) 22.0 1.96 m 40.8 
 3.03 dddd (16, 11, 8, 2)  1.98 m  
7  109.4  207.2 
8  128.7  126.4 
9 7.42 br d (8) 118.7 7.67 br d (7.7) 124.6 
10 7.05 td (8, 1) 119.9 7.05 td (7.7, 1.4) 122.4 
11 7.15 td (8, 1) 121.6 7.56 td (7.7, 1.4) 136.6 
12 7.38 br d (8) 109.7 7.20 br d (7.7) 116.9 
13  136.5  162.3 
14 1.75 m 23.9 1.70 m 23.7 
 1.75 m  1.70 m  
15 1.58 m 30.3 1.40 m 29.7 
 1.67 m  1.49 br d (11)  
16 5.92 d (4) 83.4 5.56 d (5.5) 89.2 
17 1.80 m 41.6 1.70 m 37.5 
17 1.87 d (11)  2.94 d (11)  
18 1.33 d (6.3) 16.0 0.86 d (6.8) 14.5 
19 3.95 q (6.3) 83.2 3.56 q (6.8) 81.7 
20  41.8  43.8 
21 3.23 s 60.9 2.65 s 66.3 
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13






























H NMR spectrum (CDCl3, 400 MHz) of compound 64
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2.2.2.3    Larutenine (65), ()-19-Oxoeburnamine (66), ()-19(R)-
Hydroxyisoeburnamine (67), ()-19(R)-Hydroxyeburnamine (68), ()-
Eburnamonine (29), ()-Eburnamenine (30), ()-Isoeburnamine (33), and 
()-Eburnamine (34) 
 





 ()-19(R)-hydroxyisoeburnamine (67),188,189 ()-19(R)-
hydroxyeburnamine (68),
188,189
 ()-eburnamonine (29),214 ()-eburnamenine (30),211 
()-isoeburnamine (33),214,215 and ()-eburnamine (34)214 were also isolated. The 1H 
NMR spectra of 6568 are shown in Figures 2.902.93, while the NMR spectroscopic 
data are summarized in Tables 2.43–2.45. Compounds 29, 30, 33, 34 were also obtained 
from L. griffithii. Their NMR spectroscopic data are presented in the previous section 






C NMR Spectroscopic Data of Larutenine (65)
a 
Position H C Position H C 
2  136.5 14 1.70 m 20.0 
3 2.25 m 51.8  1.70 m  
 3.00 m  15 1.42 m 35.5 
5 2.70 td (11, 7) 54.2  1.70 m  
 3.24 dd (11, 7)  16 5.83 t (2) 77.5 
6 2.84 br ddd (15, 7, 1.5) 21.1 17 1.70 m 38.0 
 3.00 m   1.70 m  
7  107.7 18 3.80 dd (13, 6) 58.5 
8  128.5  3.95 td (13, 3)  
9 7.46 d (7) 118.3 19 1.54 br d (13) 40.6 
10 7.11 t (7) 120.1  1.82 td (13, 6)  
11 7.18 t (7) 121.5 20  28.8 
12 7.41 d (7) 109.5 21 3.17 s 63.3 
13  137.7    
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13





H NMR Spectroscopic Data of ()-19-Oxoeburnamine (66), ()-19(R)-
Hydroxyisoeburnamine (67), and ()-19(R)-Hydroxyeburnamine (68)a 
H 66 67 68 
3 2.36 m 2.66 m 2.42 td (13, 4)  
 2.49 m 2.66 m 2.57 m 
5 3.22 m 3.28 ddd (14, 6.5, 1.5) 3.28 ddd (13, 6.5, 1.5) 
 3.22 m 3.33 ddd (13, 11.5, 5) 3.33 ddd (13, 11.5, 5) 
6 2.49 m 2.59 ddt (16, 5, 1.5) 2.57 m 
 2.95 m 3.00 dddd (16, 11.5, 6.5, 2.5) 2.97 dddd (16, 11.5, 6.5, 2.5) 
9 7.49 dd (6, 2) 7.50 br d (7) 7.49 dd (7, 1.5) 
10 7.16 m 7.15 td (7, 1.5) 7.17 td (7, 1.5) 
11 7.19 m 7.20 td (7, 1.5) 7.21 td (7, 1.5) 
12 7.71 dd (6, 2) 7.40 br d (7) 7.72 dd (7, 1.5) 
14 1.43 m 1.38 br d (14) 1.32 br d (13) 
 1.43 m 2.24 m 2.19 qt (13, 4) 
15 0.93 br td (13, 5) 1.75 td (14, 4) 0.89 tdd (13, 4, 1) 
 2.04 br d (13) 1.82 td (14, 4.5) 1.74 br d (13) 
16 5.62 dd (9, 5) 6.02 dd (5, 1) 5.59 dd (10, 5) 
17 1.70 dd (14, 9) 1.85 dd (15, 5) 1.58 br d (15) 
 2.30 m 2.02 dd (15, 1) 2.25 dd (14, 5) 
18 2.36 s 1.25 d (6.5) 1.24 d (6.5) 
19  3.91 qd (6.5, 1) 3.98 qd (6.5, 1) 
21 4.67 s 4.18 br s 4.22 br s 
a




C NMR Spectroscopic Data of ()-19-Oxoeburnamine (66), ()-19(R)-
Hydroxyisoeburnamine (67), and ()-19(R)-Hydroxyeburnamine (68)a 
C 66 67 68 
2 131.5 129.6 130.9 
3 44.0 44.4 43.7 
5 50.6 51.2 50.5 
6 16.8 17.0 16.7 
7 106.6 105.5 105.6 
8 128.7 129.1 128.6 
9 118.2 118.9 118.2 
10 120.4 120.6 120.4 
11 121.6 121.7 121.6 
12 112.0 110.2 112.1 
13 136.7 135.1 136.6 
14 22.6 21.9 21.2 
15 24.9 23.9 22.4 
16 76.3 74.5 76.5 
17 42.0 39.6 43.0 
18 25.6 17.8 17.6 
19 210.3 79.5 78.3 
20 51.7 37.4 39.5 
21 54.8 60.1 59.5 
a



























































H NMR spectrum (CDCl3, 400 MHz) of ()-19(R)-hydroxyeburnamine (68) 
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2.2.3 Corynanthe Alkaloids 
 
2.2.3.1    Compound 69 
 
Compound 69 was isolated as a light yellowish oil from the leaf extract of K. 
pauciflora, []D 3 (CHCl3, c 0.02). The UV spectrum showed absorption maxima at 
208, 253, and 284 nm, indicative of an oxindole chromophore.
359-361
 The IR spectrum 
indicated the presence of NH (3434 cm
1
), Wenkert-Bohlmann bands (2874 and 2796 
cm
1
), ester (1723 cm
1
), and lactam carbonyl (1716 cm
1
) functions. The ESIMS of 69 
showed a quasi molecular ion at m/z 353, and HRESIMS measurements established the 






C NMR data of 69 (Tables 2.46 and 2.47, respectively) were generally 
similar to those of catharinensine (72),
359
 indicating the presence of an unsubstituted 
indole moiety, an indolic NH, two olefinic singlets, and a methoxy singlet. Notable 
differences were the absence of the signals due to the ethyl side chain in the 
1
H NMR 
spectrum (Figure 2.97) of 69, and the presence instead of a quartet and a methyl doublet 
at  5.45 and 1.43, respectively, suggesting that the ethyl group in 72 has been replaced 








C NMR data of 69 are consistent with the presence of an ethylidene side chain at 
C(20), from the carbon resonances observed at  135.2 and 121.6, corresponding to the 
olefinic quaternary and methine carbons, respectively. The COSY and HSQC data of 69 
also revealed the presence of the CHCH3 partial structure, which was readily attributed 
to C(19)C(18) ethylidene side chain.  
 
The C/D ring junction stereochemistry in 69 was determined to be trans from the 
observation of the diagnostic Wenkert-Bohlmann bands (vide supra) in the IR 
spectrum,
355,356
 which was also in agreement with the reciprocal NOEs observed for 
H(3), H(5)/H(21) (Figure 2.94). The orientation of H(3) was assigned as  (C(3) is 
S) from the NOEs observed, as well as from the observed J3-14 value of 12 Hz, which 
require H(3) and H(14) to be in a trans-diaxial arrangement. The configuration at the 
spirocyclic carbon C(7) was determined by comparison with the chemical shifts of the 
related corynanthean-type oxindole alkaloids.
360,362-366
 The marked differences in the 
13
C NMR data of the 3(S), 7(R)- and 3(S), 7(S)-stereoisomers, which involve the carbon 
shifts of C(3) and C(9), provide a diagnostic tool for the determination of the C(7)-
spirocarbon configuration.
362-366
 The carbon resonances of C(3) in the 3(S), 7(R)-
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oxindoles are consistently ca. 2 to 3 ppm lower field than those in the 3(S), 7(S) 
counterparts, while the C(9) resonances in the 3(S), 7(R)-oxindoles are consistently ca. 
2 to 3 ppm higher field than those in the 3(S), 7(S) counterparts. The chemical shifts of 
C(3) and C(9) in 69 ( 70.4 and 125.1, respectively) were found to be consistent with a 
7(S) configuration. This was also supported by the observed reciprocal NOEs between 
H(9)/H(5), H(6), and H(14) as shown in Figure 2.94.  
 
2.2.3.2    Compound 70 
 
Compound 70 was obtained as a light yellowish oil, []D  (CHCl3, c 0.08). The UV 
and IR spectra were similar to those of 69. The ESIMS of 70 showed a quasi molecular 
ion at m/z 353, and HRESIMS measurements established the molecular formula as 
C21H24N2O3 (DBE 11), indicating that compound 70 is isomeric with 69.  
 
The NMR spectroscopic data of 70 (Tables 2.46 and 2.47) were similar in all respects to 
those of 69, except for the chemical shifts of H(15) and C(15), suggesting that 
compound 70 is the C(15) epimer of 69. The 15(R) configuration of 70 can be readily 
verified by NOE experiments (Figure 2.95). In compound 70, NOEs were observed for 
H(17a)/H(21), while NOEs for H(3)/H(15) and H(15)/H(21) were not seen. These 
observations are consistent only with an -methyl methacrylate substitution (or an 
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axially oriented methyl methacrylate) at C(15). In the converse case (15(S)), H(17a) and 
H(21) will be too far apart for NOEs to be observed. Moreover, in the 1H NMR 
spectrum (Figure 2.98) of 70, the chemical shift of H(15) was relatively deshielded ( 
3.78) compared to the chemical shift of H(15) in 69 ( 3.30). This is attributed to 
paramagnetic deshielding caused by the proximity of the C(20)C(19) double bond 
(ethylidene side chain at C(20)).  
 
Figure 2.95: Selected NOEs of 70 
 
 
2.2.3.3    Compound 71 
 
Compound 71 was obtained as a light yellowish oil with []D +42 (CHCl3, c 0.41). The 
UV and IR spectra were similar to those of 70, suggesting a corynanthean oxindole with 
similar functionalities. The ESIMS of 71 showed an [M  H] peak at m/z 353, and 
HRESIMS measurements established the molecular formula as C21H24N2O3, indicating 
that compound 71 is isomeric with 69 and 70.  
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The NMR spectroscopic data of 71 (Tables 2.46 and 2.47) were very similar to those of 
70, except for the chemical shifts of C(3) and C(9), and some key NOEs. This suggested 
that compound 71 is the C(7) epimer of 70. The 7(R) configuration of 71 can be 
determined by comparison of the H(9) chemical shift with those of oxindoles belonging 
to the 7(S) series (6970 and 72). In the 7(S) oxindoles, 6970 and 72, the chemical 
shifts of H(9) were observed at  7.41, 7.34, and 7.35, respectively, due to the close 
proximity of H(9) with the N(4) lone pair. However, the chemical shift of H(9) was 
found to be relatively more shielded ( 7.14) in the case of 71, indicating the opposite 
configuration, i.e., R, at C(7).
366
 This was supported by NOE experiments (Figure 2.96), 
which showed reciprocal NOEs for H(9)/H(3), H(6), whereas these NOEs were not 
observed in 69, 70, and 72. The relative configurations at other stereogenic centers in 71 
were similar to those in 70 from examination of the NOE data (Figure 2.96). 
 






H NMR Spectroscopic Data of Compounds 6971a 
H 69 70 71 
3 2.93 dd (12, 3.2) 2.59 dd (11, 3.2) 2.40 m 
5 2.74 dd (15.4, 8.3) 2.47 dd (17, 8.6) 2.43 m 
5 3.21 m 3.30 td (8.6, 2) 3.35 m 
6 2.03 m 2.03 dt (13, 8.6) 1.99 m ( 
6 2.44 ddd (13, 8.3, 4.5) 2.36 ddd (13, 8.6, 2) 2.46 m ( 
9 7.34 d (7.5) 7.35 br d (7.7) 7.14 dd (7.5, 1) 
10 7.01 t (7.5) 6.98 td (7.7, 1) 6.99 td (7.5, 1) 
11 7.18 t (7.5) 7.15 td (7.7, 1) 7.15 td (7.5, 1) 
12 6.88 d (7.5) 6.83 br d (7.7) 6.88 dd (7.5, 1) 
14 1.29 m 1.31 m 1.50 m 
14 1.36 m 1.36 m 1.86 td (13, 6) 
15 3.30 br d (9) 3.78 br d (5.4) 3.87 br d (6) 
17a 5.42 s 5.47 s 5.35 s 
17b 6.13 s 6.16 s 6.03 s 
18 1.43 d (7) 1.49 dd (7, 2) 1.53 dd (6.8, 1.5) 
19 5.45 q (7) 5.59 q (7) 5.60 q (6.8) 
21 2.98 d (12) 2.98 d (12) 2.85 d (12) 
21 3.51 d (12) 3.55 d (12) 3.59 d (12) 
NH 8.79 br s 8.28 br s 8.83 br s 
CO2Me 3.69 s 3.67 s 3.54 s 
a




C NMR Spectroscopic Data of Compounds 6971a 
C 69 70 71 
2 181.8 181.8 181.9 
3 70.4 67.6 70.3 
5 54.0 54.4 55.0 
6 36.2 35.4 35.0 
7 57.1 56.6 55.8 
8 133.2 133.4 133.1 
9 125.1 125.3 124.1 
10 122.5 122.5 122.6 
11 127.8 127.7 128.0 
12 109.8 109.6 109.9 
13 140.4 140.2 141.2 
14 32.1 29.4 28.2 
15 40.6 34.7 35.0 
16 143.2 140.9 141.4 
17 125.3 126.3 125.3 
18 13.9 13.0 13.0 
19 121.6 123.3 122.9 
20 135.2 134.0 133.4 
21 61.7 60.0 59.4 
CO2Me 52.0 51.9 51.9 
CO2Me 167.4 167.6 168.0 
a










































H NMR spectrum (CDCl3, 400 MHz) of compound 71 
 253 
2.2.3.4    ()-Catharinensine (72) 
 





H NMR spectrum of this compound is shown in Figure 
2.100, while the complete assignments of the NMR spectroscopic data of this compound 






C NMR Spectroscopic Data of Catharinensine (72)
a 
Position H C 
2  181.9 
3 2.54 dd (11.3, 2.7) 72.0 
5 2.52 m 53.5 
5 3.24 m  
6 2.03 m 35.0 
6 2.38 ddd (13, 9.5, 2.7)  
7  57.3 
8  134.2 
9 7.41 br d (7.7) 124.8 
10 7.04 td (7.7, 1.3) 122.6 
11 7.20 td (7.7, 1.3) 127.6 
12 6.91 br d (7.7) 109.7 
13  140.2 
14 0.98 m 25.1 
14 1.02 m  
15 2.73 br d (13) 40.6 
16  142.6 
17a 5.03 s 124.5 
17b 6.07 s  
18 0.84 t (7) 12.8 
19 0.97 m 18.4 
 1.45 m  
20 1.70 m 37.9 
21 2.22 dd (11, 2.3) 54.7 
21 3.23 m  
NH 8.69 br s  
CO2Me 3.71 s 51.9 
CO2Me  167.6 
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13















H NMR spectrum (CDCl3, 400 MHz) of catharinensine (72)
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2.2.3.5    Tetrahydroalstonine pseudoindoxyl (73) 
 
Tetrahydroalstonine pseudoindoxyl (73) was obtained as a light yellowish oil with []D 





), and ester (1621 cm
1
) functions, while the UV spectrum showed 
absorption maxima at 208 and 235 nm, characteristic of a pseudoindoxyl 
chromophore.
357,367
 The ESIMS showed an [M  H] peak at m/z 369, and HRESIMS 
measurements established the molecular formula as C21H24N2O4. The 
13
C NMR data 
(Table 2.49) showed a total of 21 carbon resonances, comprising two methyl, four 









C NMR data (Table 2.49) of 73 showed a general similarity to those of 
ajmalicine pseudoindoxyl (473),
368
 except for some differences. In the 
1
H NMR 
spectrum of ajmalicine pseudoindoxyl (473),
368
 H(19) was observed at  4.36 as a 
quartet of doublets (J = 6.6, 3.5 Hz), while H(19) of 73 was seen at  4.41 as a doublet 
of quartets (J = 10.4, 5.9 Hz), suggesting that H(19) and H(20) in 73 are in a trans-
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diaxial arrangement. This observation requires H(20) in 73 to be -oriented (cis D/E 
ring junction), instead of a -oriented H(20) in 473 (trans D/E ring junction).  
 
Figure 2.101: Selected NOEs of 73 
 
In order to confirm this deduction, NOE experiments were carried out. Reciprocal 
NOEs were observed between H(14) and H(19). These NOEs are only possible if the 
D/E ring junction is cis, with H(20) -oriented (Figure 2.101). In addition, irradiation of 
H(15) resulted in enhancement of the H(3), H(14), H(20), and H(21) signals, 
providing further confirmation for the assignment of the configuration at C(20) as S (-
oriented H(20)). The configuration at C(2) was assigned as R, from the observed 
reciprocal NOEs between the indolic NH and H(6). This assignment also received 
additional support from examination of the chemical shift of the indolic NH in other 
corynanthean-type pseudoindoxyl alkaloids. The indolic NH resonances in all 
corynanthean-type pseudoindoxyl alkaloids with 2(R) configuration (or A 
configuration) are consistently observed above 5 ppm in the 
1
H NMR spectrum, while 
the indolic NH in the 2(S) counterparts are observed below 5 ppm.
368
 Compound 73 is 
therefore tetrahydroalstonine pseudoindoxyl (73), with an allo A configuration (allo: 
H(3), H(15), and H(20) on -face; A configuration: carbonyl below C/D plane).367,368 
Although 73 is encountered as a natural product for the first time, an alkaloid 
corresponding to 73 was previously obtained during oxidative transformation of 
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Position H C DNOE/NOESY 
2  74.5  
3 2.39 m 71.4 15 
5 2.35 m 53.5  
5 3.14 m  5 
6 1.88 m 35.2 NH 
6 2.32 m   
7  202.2  
8  120.4  
9 7.56 br d (7.3) 124.7 10 
10 6.77 td (7.3, 1) 118.5 9 
11 7.42 td (7.3, 1) 137.5 12 
12 6.80 br d (7.3) 111.7 11, NH 
13  160.4  
14 1.31 m 28.8 19 
14 1.70 dt (13, 4.5)  15 
15 2.51 dt (12, 4.5) 30.2 3, 14, 20, 21 
16  110.0  
17 7.47 s 155.1  
18 1.38 d (5.9) 18.7 20, 21 
19 4.41 dq (10.4, 5.9) 72.0 14, 18 
20 1.59 m 37.8 15, 18, 21, 21 
21 2.33 m 53.6 20, 21 
21 3.22 d (11.8)  18, 21 
NH 5.04 br s  6, 12
CO2Me 3.60 s 51.2  
CO2Me  167.7  
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13















H NMR spectrum (CDCl3, 400 MHz) of tetrahydroalstonine pseudoindoxyl (73)
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2.2.3.6    Tetrahydroalstonine (43) and 16(R)-19,20-E-Isositsirikine (47) 
 





 were also isolated. These compounds were also 
obtained from L. griffithii. Their NMR spectroscopic data are presented in the previous 
section (section 2.1.6.1). Other data are given in the Experimental Section. 
 
2.2.4 Aspidosperma Alkaloids 
 
2.2.4.1    ()-Aspidospermidine (74), ()-1,2-Dehydroaspidospermidine (75), and 
()-Quebrachamine (76)  
 
Three known alkaloids belonging to this group, viz., ()-aspidospermidine (74),370-372 
()-1,2-dehydroaspidospermidine (75),370,372 and ()-quebrachamine (76)147,373 were 
also isolated. The 
1
H NMR spectra of these compounds are shown in Figures 
2.1032.105, while the NMR spectroscopic data are summarized in Tables 









H NMR Spectroscopic Data of ()-Aspidospermidine (74), ()-1,2-
Dehydroaspidospermidine (75), and ()-Quebrachamine (76)a 
H 74 75 76 
2 3.53 br s   
3 1.98 m 2.20 m 2.26 td (11.3, 3.2) 
 3.09 m 3.17 m 2.45 m 
5 2.28 m 2.60 ddd (11.3, 8.3, 5.5) 2.34 td (11, 4.5) 
 3.14 m 3.19 m 2.42 m 
6 1.47 m 1.65 dd (12, 5.5) 2.85 ddd (14.5, 4.5, 3.2) 
 2.33 m 2.16 m 2.95 ddd (14.5, 11, 4.5) 
9 7.08 br d (7.7) 7.33 d (7.7) 7.49 dd (7, 2) 
10 6.73 td (7.7, 1) 7.16 t (7.7) 7.07 td (7, 2) 
11 7.01 td (7.7, 1) 7.28 t (7.7) 7.27 td (7, 2) 
12 6.63 br d (7.7) 7.51 d (7.7) 7.09 dd (7, 2) 
14 1.53 m 1.56 m 1.31 m 
 1.77 m 1.86 qt (13, 5) 1.59 m 
15 1.11 td (14, 4.5) 1.00 td (13.6, 5) 1.14 m 
 1.62 m 1.47 br dd (13, 3) 1.23 m 
16 1.40 m 2.76 ddd (14, 10.6, 3) 2.69 m 
 1.65 m 3.11 ddd (14, 12, 5) 2.69 m 
17 1.06 m 1.60 m 1.62 m 
 1.95 m 2.46 td (13, 3.2) 1.92 ddd (11.8, 7, 2.3) 
18 0.63 t (7.2) 0.49 t (7.2) 0.86 t (7.4) 
19 0.87 dq (14, 7.2) 0.62 m 1.14 m 
 1.47 m 0.64 m 1.23 m 
21 2.25 m 2.41 s 1.50 d (11.8) 
   3.26 d (11.8) 
NH   7.72 br s  
a




C NMR Spectroscopic Data of ()-Aspidospermidine (74), ()-1,2-
Dehydroaspidospermidine (75), and ()-Quebrachamine (76)a 
C 74 75 76 
2 65.7 192.5 140.0 
3 54.0 52.1 55.2 
5 53.1 54.6 53.3 
6 38.9 35.2 22.5 
7 53.4 61.3 108.7 
8 135.8 147.1 129.0 
9 122.9 121.1 117.5 
10 119.1 125.2 118.8 
11 127.2 127.6 110.1 
12 110.5 120.2 120.3 
13 149.5 154.5 134.9 
14 21.8 22.1 22.8 
15 34.5 33.3 34.9 
16 28.2 23.8 22.0 
17 23.1 27.3 33.5 
18 6.9 7.4 7.9 
19 30.1 29.8 32.1 
20 35.8 36.6 37.2 
21 71.4 79.1 56.8 
a












































H NMR spectrum (CDCl3, 400 MHz) of ()-quebrachamine (76)
 265 
2.2.5 Aspidofractinine Alkaloids 
 
2.2.5.1    11,12-Dimethoxykopsinaline (77) 
 
11,12-Dimethoxykopsinaline (77) was obtained as a light yellowish oil, []D 18 
(CHCl3, c 0.11). The IR spectrum showed bands at 3490, 3349, and 1733 cm
1 
due to 
OH, NH, and ester functions, respectively. The UV spectrum showed absorption 
maxima at 210, 250, and 293 nm, suggesting the presence of a dihydroindole 
chromophore. The ESIMS of 77 showed an [M  H] peak at m/z 415, and HRESIMS 





spectroscopic data of 77 (Table 2.52) were generally similar to those of the 
aspidofractinine alkaloid, 12-methoxykopsinaline (222),
147
 except for the presence of an 
additional methoxy singlet (H 3.79; C 56.1) and the absence of one aromatic signal. 
The two aromatic doublets (H 6.88 and 6.28) were readily assigned to H(9) and H(10), 
respectively, from the COSY spectrum. The placement of the OMe group at C(11) is 
consistent with the carbon resonance of C(11) at  which was further supported 
by the observed three-bond correlation from H(9) to C(11) in the HMBC spectrum. 








C NMR Spectroscopic Data of 11,12-Dimethoxykopsinaline (77)
a 
Position H C 
2  71.6 
3 2.95 m 47.7 
 3.10 br d (11.8)  
5 2.88 td (9, 2) 50.7 
 3.25 m  
6 1.59 m 35.4 
 2.39 m  
7  58.5 
8  134.0 
9 6.88 d (8.2) 116.7 
10 6.28 d (8.2) 102.9 
11  151.8 
12  135.1 
13  142.8 
14 1.25 m 17.0 
 1.86 m  
15 1.28 m 36.4 
 1.71 m  
16  77.1 
17 1.15 d (15) 40.9 
 3.21 dd (15, 3)  
18 1.61 m 26.3 
 1.75 m  
19 1.07 m 33.7 
 1.49 m  
20  32.7 
21 2.97 s 67.7 
NH 4.45 br s  
11-OMe 3.79 s 56.1 
12-OMe 3.85 s 60.2 
CO2Me 3.80 s 52.3 
CO2Me  174.9 
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13














H NMR spectrum (CDCl3, 400 MHz) of 11,12-dimethoxykopsinaline (77)
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2.2.5.2    Pseudokopsinine (78), Kopsinine (79), Kopsamine (80), N(1)-   
 Decarbomethoxykopsamine (81), Kopsilongine (82), and Paucifinine (83) 
 















H NMR spectra of these 
compounds are shown in Figures 2.1072.112. The NMR spectroscopic data of these 





H NMR Spectroscopic Data of Pseudokopsinine (78) and Kopsinine (79)
a 
H 78 79 
3 3.08 m 3.00 m 
 3.08 m 3.12 ddt (14, 4, 2) 
5 3.16 m 2.96 m 
 3.33 td (8.6, 6.6) 3.35 q (8.3) 
6 1.78 m 1.56 ddd (14, 8.3, 7.6) 
 2.12 ddd (14.5, 6.8, 2.7) 2.64 ddd (14, 8.3, 3.4) 
9 7.26 br d (7.5) 7.18 dd (7.5, 1) 
10 6.85 td (7.5, 1) 6.75 td (7.5, 1) 
11 7.06 td (7.5, 1) 6.99 td (7.5, 1) 
12 6.77 br d (7.5) 6.66 br d (7.5) 
14 1.56 m 1.23 m 
 1.72 m 1.91 m 
15 1.51 m 1.30 m 
 1.51 m 1.61 m 
16 3.03 m 2.89 td (9.3, 1) 
17 1.75 m 1.37 m 
 2.87 ddd (14, 6.4, 1.8) 2.78 ddd (13.7, 9.3, 3) 
18 0.84 d (6.8) 1.42 m 
  1.91 m 
19 1.83 m 1.23 m 
  1.41 m 
21 3.18 d (1.3) 3.01 d (1.5) 
NH 4.36 br s 3.75 br s 
CO2Me 3.69 s 3.76 s 
a




C NMR Spectroscopic Data of Pseudokopsinine (78) and Kopsinine (79)
a 
C 78 79 
2 80.6 66.4 
3 48.1 47.4 
5 55.0 50.5 
6 37.2 34.5 
7 60.3 57.7 
8 140.1 140.4 
9 123.7 121.4 
10 121.3 119.5 
11 127.3 126.4 
12 112.8 110.6 
13 149.5 148.9 
14 20.6 16.9 
15 28.9 36.3 
16 40.2 43.6 
17 31.2 31.9 
18 7.5 33.6 
19 51.0 33.7 
20 44.6 31.5 
21 78.7 68.1 
CO2Me 52.0 51.7 
CO2Me 175.1 174.6 
a






C NMR Spectroscopic Data of Kopsamine (80) and N(1)-
Decarbomethoxykopsamine (81)
a 
Position 80  81  
 H C H C 
2  74.3  71.9 
3 2.87 td (13, 3) 47.5 2.93 td (13, 3) 47.9 
 3.05 m  3.11 dt (13, 2)  
5 2.94 td (8.5, 4) 50.2 2.88 td (8.5, 3.5) 50.7 
 3.09 td (8.5, 7)  3.19 m  
6 1.63 m 36.7 1.54 m 35.6 
 2.06 ddd (14.5, 8.5, 4)  2.26 ddd (14, 8.5, 3.5)  
7  57.5  58.5 
8  134.1  130.9 
9 6.76 d (7.8) 115.0 6.69 d (7.8) 114.4 
10 6.52 d (7.8) 104.1 6.35 d (7.8) 101.1 
11  148.2  147.4 
12  136.2  137.9 
13  123.1  133.2 
14 1.25 m 17.0 1.29 m 17.4 
 1.81 m  1.85 m  
15 1.27 td (14, 4) 35.0 1.30 m 36.1 
 1.65 m  1.65 m  
16  74.5  76.9 
17 1.40 dd (15, 1) 41.6 1.19 dd (15, 1.5) 40.9 
 2.93 br d (15)  3.22 dd (15, 3)  
18 1.50 ddd (13, 11, 8) 23.7 1.72 ddd (13, 11, 8) 26.7 
 2.34 ddd (13, 11, 1.5)  1.95 ddd (13, 11, 1.5)  
19 1.11 br t (11) 32.1 1.14 br t (11) 33.5 
 1.69 m  1.54 m  
20  32.2  33.0 
21 2.86 d (2) 67.9 2.95 d (1.5) 67.9 
NH   4.12 s  
CO2Me 3.76 s 52.5 3.84 s 53.2 
CO2Me  173.0  174.8 
NCO2Me 3.88 s 53.2  
NCO2Me  156.1  
OCH2O 5.88 d (1.5) 100.2 5.85 d (1.5) 100.9 
 5.90 d (1.5)  5.91 d (1.5)  
16-OH 6.98 s   
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13






C NMR Spectroscopic Data of Kopsilongine (82) and Paucifinine 
(83)
a 
Position 82  83  
 H C H C 
2  74.6  74.6 
3 2.86 td (13, 3) 47.6 2.81 m 43.0 
 3.05 m  3.15 m  
5 2.95 m 50.3 3.01 m 47.7 
 3.08 m  3.15 m  
6 1.76 m 37.0 1.65 m 36.6 
 2.21 ddd (14.5, 8.5, 4)  2.05 m  
7  58.1  59.7 
8  142.9  131.9 
9 6.91 dd (7.5, 1) 114.5 6.75 br d (8) 116.3 
10 6.99 t (7.5) 124.9 6.54 d (8) 103.8 
11 6.77 dd (7.5, 1) 111.6  148.4 
12  148.1  134.8 
13  129.2  124.1 
14 1.25 m 17.6 1.25 m 17.4 
 1.81 m  1.76 m  
15 1.25 m 35.7 1.46 m 30.3 
 1.64 m  1.70 m  
16  75.0  75.2 
17 1.41 dd (15, 1) 41.9 1.56 br d (15) 41.8 
 2.94 br d (15)  2.95 br d (15)  
18 1.47 ddd (13, 11, 8) 24.5 1.67 m 23.8 
 2.37 ddd (13, 11, 1.5)  2.29 m  
19 1.06 br t (11) 32.1 1.65 m 28.9 
 1.66 m  1.65 m  
20  32.4  36.4 
21 2.83 d (1.5)  67.9  90.6 
CO2Me 3.76 s 52.3 3.75 s 52.5 
CO2Me  173.2  173.0 
NCO2Me 3.88 s 53.0 3.88 s 53.2 
NCO2Me  157.3  155.9 
OCH2O   5.87 d (1.5) 100.3 
   5.93 d (1.5)  
12-OMe 3.82 s 56.2   
16-OH 6.66 s  6.98 s  
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13






















































































H NMR spectrum (CDCl3, 400 MHz) of paucifinine (83) 
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2.2.6 Kopsine Alkaloids 
 
2.2.6.1    Kopsanone (84), 11,12-Methylenedioxykopsine (85), 12-Methoxykopsine 
(86), Kopsifine (87), and N(1)-Decarbomethoxykopsifine (88) 
 














H NMR spectra of these compounds are 
shown in Figures 2.1132.117, while the NMR spectroscopic data of these compounds 






C NMR Spectroscopic Data of Kopsanone (84)
a 
Position H C  Position H C  
2  69.5 14 1.80 m 
3 3.03 m 46.7 15 1.30 m 15.4 
 3.03 m   1.30 m  
5 3.13 dd (10, 5) 54.3 16 2.69 br d (11) 52.3 
 3.50 t (10)  17 1.62 ddd (14, 11, 1) 33.6 
6 2.57 ddd (10, 5, 2) 57.3  2.03 d (14)  
7  63.1 18 1.30 m 33.9 
8  133.1  1.51 dt (14, 3)  
9 7.30 br d (8) 122.8 19 1.30 m 36.3 
10 6.79 td (8, 1) 119.6  1.30 m  
11 7.06 td (8, 1) 127.7 20  31.2 
12 6.67 br d (8) 110.9 21 3.37 d (1) 70.5 
13  150.8 22  218.2 
14 1.80 m 24.2 NH 3.60 br s  
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13






C NMR Spectroscopic Data of 11,12-Methylenedioxykopsine (85) 
and 12-Methoxykopsine (86)
a 
Position 85  86  
 H C H C 
2  75.3  76.6 
3 3.01 m 46.4 3.03 m 46.4 
 3.01 m  3.03 m  
5 3.13 dd (10, 5) 53.8 3.16 m 53.8 
 3.51 t (10)  3.58 m  
6 2.57 dd (10, 5) 53.5 2.70 dd (10, 5) 52.3 
7  59.7  61.0 
8  131.8  138.0 
9 7.04 d (8) 115.4 7.08 d (8) 115.0 
10 6.32 d (8) 105.1 7.14 t (8) 127.1 
11  149.0 6.68 dd (8, 1) 112.2 
12  135.7  150.5 
13  123.9  130.7 
14 1.26 m 15.3 1.30 m 15.4 
 1.79 m  1.80 m  
15 1.34 m 33.2 1.27 m 34.9 
 1.34 m  1.51 m  
16  82.2  82.0 
17 1.58 br d (15) 44.0 1.59 m 43.4 
 2.39 dd (15, 3)  2.38 dd (15, 4)  
18 1.68 ddd (14, 12, 5) 19.6 1.66 ddd (14, 12, 5) 20.4 
 2.51 ddd (14, 12, 4)  2.46 ddd (14, 12, 5)  
19 1.34 m 32.3 1.34 m 33.0 
 1.56 m  1.55 m  
20  34.9  31.9 
21 3.02 d (2) 69.6 3.18 s 69.2 
22  214.0  214.2 
NCO2Me 3.81 s 53.6 3.73 s 55.9 
NCO2Me  155.6  156.4 
OCH2O 5.90 d (1.5) 100.5  
 5.93 d (1.5)    
16-OH 7.09 s  7.00 s  
12-OMe   3.83 s 53.6 
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13






C NMR Spectroscopic Data of Kopsifine (87) and N(1)-
Decarbomethoxykopsifine (88)
a 
Position 87  88  
 H C H C 
2  74.9  71.9 
3 2.91 td (13, 4) 40.7 2.91 td (13, 4) 40.8 
 4.22 dd (13, 5)  4.23 dd (13, 5)  
5  164.3  164.7 
6 2.91 s 59.0 2.92 s 59.6 
7  52.6  53.6 
8  128.6  127.1 
9 6.72 d (8) 115.1 6.67 d (8) 115.2 
10 6.63 d (8) 105.2 6.35 d (8) 100.5 
11  149.9  148.9 
12  136.1  132.6 
13  123.9  132.4 
14 1.51 m 19.3 1.53 m 19.5 
 1.65 m  1.63 m  
15 1.46 m 32.6 1.46 m 33.0 
 1.65 m  1.63 m  
16  83.1  82.3 
17 1.61 br d (15) 39.3 1.50 br d (15) 37.6 
 2.13 dd (15, 3)  1.99 dd (15, 3)  
18 1.70 m 18.8 1.75 m 20.1 
 2.56 ddd (13.5, 12, 4.5)  2.09 td (13, 4.5)  
19 1.43 m 31.8 1.43 m 32.8 
 1.80 td (12, 4.5)  1.73 m  
20  32.8  34.7 
21 3.62 d (2) 65.4 3.66 br s 65.6 
22  202.5  204.6 
NCO2Me 3.82 s 53.8   
NCO2Me  155.3   
OCH2O 5.94 d (1.5) 100.9 5.86 d (1.5) 101.1 
 5.96 d (1.5)  5.91 d (1.5)  
16-OH 7.09 br s    
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13






































































H NMR spectrum (CDCl3, 400 MHz) of N(1)-decarbomethoxykopsifine (88)
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2.2.7 Strychnos Alkaloids 
 
2.2.7.1    Akuammicine (89) 
 





H NMR spectrum of this compound is shown in Figure 2.118, while the 
complete assignments of the NMR spectroscopic data of this compound are summarized 






C NMR Spectroscopic Data of Akuammicine (89)
a 
Position H C 
2  167.1 
3 4.25 br s 61.7 
5 3.11 dd (13, 7) 55.7 
 3.46 td (13, 6)  
6 1.93 dd (13, 6) 45.6 
 2.56 td (13, 7)  
7  57.0 
8  136.2 
9 7.30 br d (8) 120.9 
10 6.92 td (8, 1) 121.1 
11 7.18 td (8, 1) 128.0 
12 6.84 br d (8) 109.5 
13  143.3 
14 1.36 dt (14, 3) 29.5 
 2.50 ddd (14, 3, 2)  
15 4.03 m 30.5 
16  101.4 
18 1.63 d (7) 13.0 
19 5.46 br q (7) 122.4 
20  137.5 
21 3.08 d (14) 56.5 
 4.03 m  
NH 9.00 br s  
CO2Me 3.82 s 51.1 
CO2Me  167.7 
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13














H NMR spectrum (CDCl3, 400 MHz) of akuammicine (89)
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2.2.8 Aspidospermatan Alkaloids 
 
2.2.8.1    Andransinine (90) 
 
Andransinine (90) was obtained as an optically inactive alkaloid (light yellowish oil, 
[]D 0 (CHCl3, c 0.15)) It was subsequently obtained as light yellow crystals from 
CH2Cl2/hexanes, mp 186190 
o
C. The UV spectrum of 90 was characteristic of an 
indole chromophore with absorption maxima at 224 and 283 nm, while the IR spectrum 
indicated the presence of NH (3391 cm
1
), Wenkert-Bohlmann bands (2885 and 2840 
cm
1
), and ester carbonyl (1727 cm
1
) functions. The ESIMS of 90 showed an [M  H] 
peak at m/z 381 and the HRESIMS measurements yielded the molecular formula as 






H NMR spectrum (Figure 2.120) of 90 showed the presence of an unsubstituted 
indole moiety from the presence of four aromatic resonances (δ 7.51, br d, J = 7.7 Hz, 
H(9); 7.11, td, J = 7.7, 1 Hz, H(10); 7.17, td, J = 7.7, 1 Hz, H(11); 7.33, br d, J = 7.7 Hz, 
H(12)), an indolic NH as a broad singlet at δ 8.21, an isolated aminomethine at δ 3.79, a 
methoxy group associated with a methyl ester function at  3.63, a vinylic hydrogen at  
5.74, and an ethoxy group. The 
13
C NMR data of 90 (Table 2.61) indicated the presence 
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of 23 carbon resonances, comprising two methyl, seven methylene, seven methine, and 
seven quaternary carbon atoms, in agreement with the molecular formula.  
 




C NMR data (Table 2.61) of 90 revealed that the 
structure of compound 90 is identical to that of andransinine reported earlier (the small 
optical rotation observed previously was likely a result of racemate 
contamination).
313,378
 The structure was also confirmed by an X-ray diffraction analysis 
(crystals from CH2Cl2/hexanes) as shown in Figure 2.119, which also revealed the 









Figure 2.119: Top: X-ray crystal structure of 90; Bottom: Partial unit cell for crystals of 
90, obtained from CH2Cl2/hexanes solution. It can be seen that (±)-
andransinine are present in the unit cell.  
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2.2.8.2    Compound 91 
 
Compound 91 was also isolated as a racemate (light yellowish oil, []D 0 (CHCl3, c 
0.03)). The UV and IR spectra were similar to those of andransinine (90), suggesting an 
andranginine-type compound with similar functionalities. The ESIMS of 91 showed an 
[M  H] peak at m/z 367 and HRESIMS measurements yielded the molecular formula 




C NMR data (Table 
2.61) of 91 were very similar to those of 90, except for the absence of the ethoxy side 
chain and the presence instead of an OMe group in the 
1
H NMR spectrum of 91. The 
OMe substituent was readily deduced to be at C(15) since the chemical shifts of the 
other carbons were essentially unchanged. The COSY and HSQC data revealed partial 
structures that are similar to those of compound 90, providing additional support for the 
placement of the methoxy function at C(15). This was also supported by the observed 
three-bond correlation from the 15-OMe to C(15) in the HMBC spectrum. The relative 
configurations at the various stereogenic centers were deduced to be similar to 
compound 90 by examination of the NMR data as well as the NOE experiments. 
Compound 91 is therefore the C(15) methoxy analogue of andransinine (90). 
 
The lack of optical activity in 90 and 91 suggested that these compounds are in all 
probability artifacts formed during the isolation process. A non-enzymatic pathway 
(involving a 4 + 2 cycloaddition as the key step) was presented to account for the 
isolation of racemic andranginine (474) from Craspidospermum verticillatum which 
was supported by the observation that thermolysis of the putative precursor, 
precondylocarpine acetate (90a), at 100 
o
C in EtOAc solution, resulted in the formation 
 292 
of racemic andranginine (474), while carrying out the thermolysis in MeOH led to the 
formation of methoxyandranginine (Scheme 2.10).
379
 It is therefore likely that both 
ethoxyandranginine (90) and methoxyandranginine (91) are artifacts, formed by a 
similar pathway (Scheme 2.10) since compound 93 was present among the alkaloids 
isolated and denatured ethanol was used in the extraction of the plant materials. 













C NMR Spectroscopic Data of Andransinine (90) and Compound 
91
a 
Position 90  91  
 H C H C 
2  138.0  137.8 
3 2.74 m 50.0 2.72 m 49.8 
 3.23 m  3.18 m  
5 3.15 m 57.0 3.17 m 56.9 
 3.33 m  3.33 dd (14.5, 10.6)  
6 2.79 dd (16, 5.7) 18.6 2.78 dd (16.8, 5.5) 18.5 
 3.08 m  3.08 dd (16.8, 10.6)  
7  114.8  114.9 
8  127.7  127.6 
9 7.51 br d (7.7) 118.4 7.49 br d (7.7) 118.4 
10 7.11 td (7.7, 1) 119.5 7.10 td (7.7, 1) 119.5 
11 7.17 td (7.7, 1) 121.9 7.18 td (7.7, 1) 121.9 
12 7.33 br d (7.7) 110.8 7.33 br d (7.7) 110.7 
13  134.9  134.8 
14 1.95 br dd (13.6, 2.7) 32.4 1.96 br dd (13.6, 2.7) 32.4 
 2.07 m  2.10 m  
15 3.80 m 78.1 3.66 m 80.0 
16  48.6  48.5 
17 2.07 m 32.3 2.10 m 32.1 
 2.49 dd (12.7, 2.7)  2.51 br d (12)  
18 2.16 m 22.2 2.22 m 22.2 
 2.28 m  2.27 m  
19 5.74 d (5.4) 126.0 5.77 d (5.4) 126.7 
20  134.1  133.3 
21 3.79 s 63.5 3.76 s 63.3 
22 3.19 m 62.2   
 3.37 m    
23 1.12 t (7) 15.4  
NH 8.21 s  8.17 br s  
15-OMe   3.63 s 54.8 
CO2Me 3.63 s 52.3 3.12 s 52.4 
CO2Me  171.8  171.8 
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13





























H NMR spectrum (CDCl3, 400 MHz) of compound 91
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2.2.8.3    Condylocarpine (92), Precondylocarpine (93), and Stemmadenine (94) 
 










H NMR spectra of these compounds are shown in Figures 2.1222.124. The 1H 
and 
13
C NMR spectroscopic data are summarized in Tables 2.62 and 2.63. Other data 






C NMR Spectroscopic Data of Condylocarpine (92)
a 
Position H C Position H C 
2  169.2 13  144.4 
3 2.66 ddd (12.9, 7.6, 5.4) 45.9 14 1.88 m 28.2 
 3.03 ddd (12.9, 7.3, 5.6)   1.88 m  
5 2.97 ddd (11.5, 6.8, 3.4) 52.9 15 3.91 ddd (6.6, 3.4, 2) 28.9 
 3.09 ddd (11.5, 9.8, 6.8)  16  101.4 
6 1.97 ddd (12.9, 6.8, 3.4) 45.0 18 1.59 d (6.8) 13.0 
 2.77 ddd (12.9, 9.5, 6.8)  19 5.32 q (6.8) 117.4 
7  59.8 20  137.2 
8  135.2 21 4.13 br d (1.7) 68.7 
9 7.17 br d (7) 120.1 NH 8.67 br s  
10 6.89 td (7, 1) 121.0 CO2Me 3.79 s 51.2 
11 7.11 td (7, 1) 127.6 CO2Me  168.0 
12 6.78 br d (7) 109.6    
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13






C NMR Spectroscopic Data of Precondylocarpine (93) and 
Stemmadenine (94)
a 
Position 93  94  
 H C H C 
2  187.5  133.2 
3 2.68 dt (14, 4.6) 48.1 2.67 dd (14.5, 6.3) 45.5 
 3.08 m  2.84 m  
5 3.31 dd (12, 7.4) 58.2 3.03 m 55.9 
 3.51 td (12, 6.3)  3.03 m  
6 1.98 dd (14, 6.3) 38.9 3.01 m 27.2 
 3.03 m  3.17ddd (14.5, 10, 4)  
7  68.6  113.6 
8  146.0  127.9 
9 7.37 d (7.2) 120.6 7.42 br d (7.7) 118.0 
10 7.24 t (7.2) 126.7 6.99 td (7.7, 1) 119.0 
11 7.31 t (7.2) 127.8 7.04 td (7.7, 1) 121.6 
12 7.50 d (7.2) 120.6 7.22 br d (7.7) 111.1 
13  152.5  135.3 
14 2.08 m 30.3 1.96 ddd (14.5, 12, 5.4) 29.0 
 2.08 m  2.27 m  
15 3.03 m 34.5 3.47 dd (12, 3) 37.7 
16  61.9  61.1 
17 3.90 d (10.5) 70.9 4.16 d (10.4) 69.6 
 3.90 d (10.5)  4.27 d (10.4)  
18 1.56 d (7) 13.3 1.57 dd (7, 2.3) 14.2 
19 5.39 q (7) 123.8 5.25 q (7) 124.3 
20  133.1  134.4 
21 4.03 d (1.8) 75.0 2.80 m 55.4 
   3.08 m  
OH 5.56 br s   
NH   9.44 br s  
CO2Me 3.84 s 52.6 3.67 s 52.4 
CO2Me  172.9  174.1 
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13










































H NMR spectrum (CDCl3, 400 MHz) of stemmadenine (94)
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2.2.9 Methyl chanofruticosinate Alkaloids 
 
2.2.9.1    Methyl 11,12-methylenedioxy-N(1)-decarbomethoxychanofruticosinate 
(95), Methyl 11,12-methylenedioxychanofruticosinate (96), Methyl chano- 
fruticosinate (97), Methyl N(1)-decarbomethoxychanofruticosinate (98), 
and Methyl 12-methoxychanofruticosinate (99) 
 











 and methyl 12-methoxychanofruticosinate (99)
163
 were also 
obtained from K. pauciflora in the present study. The 
1
H NMR spectra of these 
compounds (9599) are shown in Figures 2.1252.129, while the complete assignments 
of the NMR spectroscopic data of compounds 9599 are summarized in Tables 













C NMR Spectroscopic Data of Methyl 11,12-methylenedioxy-
N(1)-decarbomethoxychanofruticosinate (95) and Methyl 11,12-
methylenedioxychanofruticosinate (96)
a 
Position 95  96  
 H C H C 
2  74.6  76.5 
3 2.92 m 46.6 3.03 m 46.3 
 2.92 m  3.03 m  
5 2.98 m 52.6 2.92 d (11) 52.2 
 3.71 dd (11, 6)  3.75 dd (11, 6)  
6 3.26 d (6) 55.3 3.02 d (6) 55.3 
7  57.6  58.2 
8  130.0  128.9 
9 6.62 d (8) 116.6 6.80 d (8) 116.7 
10 6.34 d (8) 100.3 6.57 d (8) 103.1 
11  148.1  148.8 
12  129.4  123.9 
13  131.6  133.7 
14 1.30 m 17.4 1.40 m 17.3 
 1.87 m  1.96 m  
15 1.30 m 34.9 1.46 m 35.5 
 1.87 m  1.46 m  
16  209.2  207.5 
17 2.02 d (19) 42.6 2.15 d (19) 43.0 
 2.83 d (19)  2.89 d (19)  
18 1.80 m 27.6 2.27 dd (16, 8) 23.3 
 1.92 m  3.00 m  
19 1.30 m 34.6 1.40 m 34.6 
 1.53 br d (13)  1.64 br d (14)  
20  36.3  35.8 
21 2.49 s 68.3 2.53 s 68.3 
CO2Me 3.64 s 52.3 3.66 s 52.4 
CO2Me  174.7  170.7 
NCO2Me   3.89 s 52.7 
NCO2Me    152.8 
OCH2O 5.89 d (1.5) 101.0 6.00 m 100.5 
 5.93 d (1.5)  6.00 m  
NH 4.47 br s    
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13




H NMR Spectroscopic Data of Methyl chanofruticosinate (97), Methyl 
N(1)-decarbomethoxychanofruticosinate (98), and Methyl 12-methoxy-
chanofruticosinate (99)
a 
H 97 98 99 
3 2.99 m 2.95 m 2.98 m 
 2.99 m 2.95 m 2.98 m 
5 2.81 d (11) 2.95 m 2.95 m 
 3.71 dd (11, 6) 3.76 dd (11, 6) 3.80 m 
6 2.84 d (6) 3.31 d (6) 3.22 d (6) 
9 7.31 d (7) 7.11 d (7) 6.88 d (8) 
10 7.00 t (7) 6.79 t (7) 7.05 t (8) 
11 7.13 t (7) 7.09 t (7) 6.84 d (8) 
12 7.74 d (7) 6.76 d (7) 
14 1.32 m 1.28 m 1.40 m 
 1.85 m 1.85 m 1.94 m 
15 1.56 m 1.28 m 1.37 m 
 1.56 m 1.85 m 1.57 m 
17 2.16 d (19) 2.04 d (19) 2.07 d (19) 
 2.77 d (19) 2.84 d (19) 2.90 d (19) 
18 2.50 m 1.70 m 1.98 m 
 2.67 m 1.90 m 3.29 dt (17, 4) 
19 m 1.28 m 1.36 m 
 m 1.54 br d (13) 1.36 m 
21 2.48 s 2.50 s 2.51 s 
NH  4.48 br s  
CO2Me 3.58 s 3.61 s 3.57 s 
NCO2Me 3.86 s  3.82 s 
12-OMe   3.85 s 
a




C NMR Spectroscopic Data of Methyl chanofruticosinate (97), Methyl 
N(1)-decarbomethoxychanofruticosinate (98), and Methyl 12-methoxy-
chanofruticosinate (99)
a 
C 97 98 99 
2 73.9 73.8 77.2 
3 46.3 46.5 46.3 
5 52.3 52.6 52.5 
6 56.2 55.1 54.6 
7 57.7 57.6 59.9 
8 132.8 133.1 130.0 
9 124.7 123.9 116.1 
10 122.9 119.8 124.9 
11 128.4 128.0 112.3 
12 114.2 110.1 148.6 
13 141.2 147.7 138.0 
14 17.3 17.4 17.4 
15 35.6 34.9 34.4 
16 207.9 209.3 208.5 
17 43.3 42.5 43.2 
18 24.3 27.4 23.4 
19 35.3 34.6 35.7 
20 34.8 36.1 36.6 
21 67.8 68.3 68.7 
12-OMe   56.1 
CO2Me 52.5 52.2 52.8 
CO2Me 170.9 175.0 171.3 
NCO2Me 52.8  52.8 
NCO2Me 154.1  153.2 
a









































































H NMR spectrum (CDCl3, 400 MHz) of methyl 12-methoxychanofruticosinate (99)
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2.2.10 Bisindole Alkaloids 
 
2.2.10.1    ()-Norpleiomutine (100) 
 





H NMR spectrum of 100 is shown in Figure 2.130, while the 
complete assignments of the NMR spectroscopic data of compound 100 are summarized 






C NMR Spectroscopic Data of ()-Norpleiomutine (100)a 
Position H C Position H C 
2  66.8 2′  133.9 
3 3.05 m 47.4 3′ 2.49 br t (13) 44.4 
 3.05 m   2.62 m  
5 3.05 m 50.8 5′ 3.35 m 50.9 
 3.35 m   3.35 m  
6 1.73 m 34.9 6′ 2.62 m 17.0 
 2.74 m   3.05 m  
7  58.1 7′  104.6 
8  141.4 8′  128.4 
9 7.17 s 120.0 9′ 7.44 d (8) 117.6 
10  134.5 10′ 7.00 t (8) 118.9 
11 6.90 d (8) 125.1 11′ 6.83 t (8) 120.0 
12 6.62 d (8) 111.0 12′ 6.54 d (8) 112.1 
13  148.5 13′  136.5 
14 1.27 m 16.6 14′ 1.38 m 20.7 
 1.90 m   1.77 m  
15 1.30 m 36.3 15′ 1.14 m 24.2 
 1.62 br d (13)   1.38 m  
16 2.91 t (10) 43.7 16′ 4.94 dd (11, 5) 55.9 
17 1.38 m 33.0 17′ 1.77 m 45.1 
 2.76 m   2.11 m  
18 1.26 m 33.7 18′ 0.87 t (7.5) 7.4 
 1.92 m     
19 1.26 m 33.8 19′ 1.49 m 28.7 
 1.41 m   2.17 m  
20  31.6 20′  34.9 
21 3.02 s 67.9 21′ 4.03 br s 59.5 
CO2Me 3.02 s 51.9    
CO2Me  174.7    
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13




















H NMR spectrum (CDCl3, 400 MHz) of ()-norpleiomutine (100) 
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2.3 Comparison of Alkaloid Composition of K. pauciflora from Peninsular 
Malaysia (Malaya) and K. pauciflora from Malaysian Borneo (Sabah) 
 
The present investigation of the stem-bark and leaves of K. pauciflora from Peninsular 
Malaysia (Malaya) has yielded a total of 50 alkaloids, of which 10 are new (6264, 
6971, 73, 77, 90, 91). Among the alkaloids obtained, eleven alkaloids are common in 
both the stem-bark and leave extracts (14, 25, 43, 63, 78, 79, 81, 83, 85, 95, 96). The 
alkaloids are constituted from 10 different subtypes, viz., six leuconoxine-leuconolam-
rhazinilam-type (1416, 19, 25, 62), 10 eburnane-type (29, 30, 33, 34, 6368), seven 
corynanthean-type (43, 47, 6973), seven aspidofractinine-type (7783), three 
Aspidosperma-type (7476), five kopsine-type (8488), one Strychnos-type (89), five 
aspidospermatan-type (9094), five methyl chanofruticosinate-type (9599), and one 
bisindole (100) alkaloids. The major alkaloids found from this plant include the 
corynanthean alkaloid, tetrahydroalstonine (43), the aspidofractinine alkaloids, 
kopsinine (79), kopsamine (80), N(1)-decarbomethoxykopsamine (81), and the methyl 
chanofruticosinate alkaloids, methyl 11,12-methylenedioxy-N(1)-decarbomethoxy-
chanofruticosinate (95), methyl 11,12-methylenedioxychanofruticosinate (96), methyl 
chanofruticosinate (97), methyl N(1)-decarbomethoxychanofruticosinate (98), and 
methyl 12-methoxychanofruticosinate (99).  
 
On the other hand, a total of 28 alkaloids were reported from K. pauciflora from Sabah, 
comprising six monoterpene-type (121126), four eburnane-type (29, 33, 34, 66), 12 
aspidofractinine-type (79, 80, 82, 83, 213, 218, 224226, 261, 274, 275), one 
kopsidasine-type (322), four pauciflorine-type (324326, 330), and one bisindole (100) 
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alkaloids. Alkaloids of the monoterpene-type (121), pauciflorine-type (324), and 
aspidofractinine-type (79) predominate in this plant. 
 
Alkaloids that are common to both plants include four of the eburnane-type (29, 3334, 
66), four aspidofractinine-type (7980, 82, 83), and one bisindole (100) alkaloids. It is 
therefore apparent from the above comparison that the alkaloidal composition varies 
with the different locality, a feature which is becoming increasingly apparent from our 
ongoing investigation of the phytochemistry of the Malaysian Apocynaceae. 
 
Table 2.68: Comparison of the Alkaloid Composition of K. pauciflora from Peninsular 







Bark Leaves Bark Leaves 
Monoterpene Alkaloids     
Kinabalurine A (121)    + 
Kinabalurine B (122)    + 
Kinabalurine C (123)    + 
Kinabalurine D (124)    + 
Kinabalurine E (125)    + 
Kinabalurine F (126)    + 
     
Leuconoxine-Leuconolam-Rhazinilam Alkaloids     
Leuconoxine (14) + +   
Leuconodine F (6-oxoleuconoxine) (15)  +   
Mersicarpine (16)  +   
Leuconolam (19)   +   
Rhazinilam (25) + +   
Compound 62 (New)  +   
     
Eburnane Alkaloids     
()-Eburnamonine (29) +  +  
()-Eburnamenine (30) +    
()-Isoeburnamine (33) +  +  
()-Eburnamine (34)   +  
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Bark  Leaves Bark  Leaves 
Eburnane Alkaloids     
Compound 63 (New) + +   
Compound 64 (New) +    
Larutenine (65)  +   
()-19-Oxoeburnamine (66) +  +  
()-19(R)-Hydroxyisoeburnamine (67) +    
()-19(R)-Hydroxyeburnamine (68) +    
     
Corynanthe Alkaloids     
Tetrahydroalstonine (43)  + +   
16(R)-19,20-E-Isositsirikine (47)  +   
Compound 69 (New)  +   
Compound 70 (New)  +   
Compound 71 (New)  +   
()-Catharinensine (72)  +   
Tetrahydroalstonine pseudoindoxyl (73) (New)  +   
     
Aspidofractinine Alkaloids     
11,12-Dimethoxykopsinaline (77) (New) +    
Pseudokopsinine (78) + +   
Kopsinine (79) + + +  
Kopsamine (80) +  + + 
N(1)-Decarbomethoxykopsamine (81) + +   
Kopsilongine (82) +  +  
Paucifinine (83) + +  + 
Kopsamine N-oxide (213)    + + 
11-Methoxykopsilongine (N-methoxycarbonyl-11,12-
dimethoxykopsinaline (218) 
  + + 
Paucifinine N-oxide (224)    + 
Lahadinine A (225)     + 
Lahadinine B (226)      + 
N(1)-Methoxycarbonyl-12-methoxy-16,17-kopsinine 
(261) 
  +  
Paucidactine A (274)    + 
Paucidactine B (275)     + 
     
Aspidosperma Alkaloids     
()-Aspidospermidine (74)  +   
()-1,2-Dehydroaspidospermidine (75)   +   
()-Quebrachamine (76)  +   
     
Kopsine Alkaloids     
Kopsanone (84) +    
11,12-Methylenedioxykopsine (85) + +   
12-Methoxykopsine (86)  +   
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Bark  Leaves Bark  Leaves 
Kopsine Alkaloids     
Kopsifine (87) +    
N(1)-Decarbomethoxykopsifine (88) +    
     
Kopsidasinine Alkaloids     
12-Methoxy-10-demethoxykopsidasinine (322)   +  
     
Pauciflorine Alkaloids     
Pauciflorine A (324)     + + 
Pauciflorine B (325)    + 
Pauciflorine C (326)    + 
Paucifoline (330)    + 
     
Strychnos Alkaloids     
Akuammicine (89)  +   
     
Aspidospermatan Alkaloids     
Andransinine (90) (New)  +   
Compound 91 (New)  +   
Condylocarpine (92)  +   
Precondylocarpine (93)  +   
Stemmadenine (94)  +   
     
Methyl chanofruticosinate Alkaloids     
Methyl 11,12-methylenedioxy-N(1)-
decarbomethoxychanofruticosinate (95) 
+ +   
Methyl 11,12-methylenedioxychanofruticosinate (96) + +   
Methyl chanofruticosinate (97)  +   
Methyl N(1)-decarbomethoxychanofruticosinate (98)  +   
Methyl 12-methoxychanofruticosinate (99)  +   
     
Bisindole Alkaloids     







2.4 Alkaloids from Penicillium sp. (CDA p48.3) 
 
During this study many soil samples were collected from various locations, which were 
then cultured in order to isolate pure strains of microbes, including actinobacteria and 
fungi. The pure strains thus obtained, were then extracted and screened for the presence 
of potentially interesting secondary metabolites. Unfortunately however, despite a 
considerable number of sampling carried out, the chemical screening results were not 
encouraging, furnishing mainly long chain fatty acids and known diketopiperazines in 
most cases.   
 
In one instance, a total of 15 different Penicillium strains were screened for their 
chemical constituents, of which only one of the strains (CDA p48.3) was found to 
produce a number of compounds. Seven alkaloids were subsequently obtained, of which 
three are new. These three new alkaloids are the variotin derivatives (101103), which 
consist of a pyrrolidone moiety and a C12 side chain. The alkaloid composition of 





Table 2.69: Alkaloid Composition of Penicillium sp. (CDA p48.3) 
Fungi  Alkaloid Yield (g L
1
) 
Broth extract Compound 101 0.00177 
(0.857 g) Compound 102  0.00040 
 Compound 103  0.00107 
 Variotin (104) 0.00567 
 Viriditin (105)  0.00253 
 cyclo (L-Phenylalanine-trans-4-hydroxy-L-proline) (106) 0.00107 




2.4.1 Variotin Alkaloids 
 
2.4.1.1    Compound 101 
 
Compound 101 was isolated as a light yellowish oil in minute amounts, with []D 2 
(CHCl3, c 0.24). The UV spectrum of 101 showed absorption maxima at 225, 287, and 
332 nm, while the IR spectrum indicated the presence of OH (3368 cm
1
) and lactam 
(1738 and 1679 cm
1
) functions. The carbon resonances observed at  167.3 and 176.3 
in the 
13
C NMR data (Table 2.71) confirmed the presence of two lactam carbonyl 
functions in 101. The LSIMS of 101 showed an [M  H] peak at m/z 308 and the 
HRLSIMS measurements gave the formula C17H25NO4. The 
13
C NMR data (Table 2.71) 
gave a total of 17 carbon resonances (two methyl, five methylene, seven methine, and 
three quaternary carbons) in agreement with the molecular formula.  
 
The NMR data (Tables 2.70 and 2.71) of 101 were very similar to those of variotin 
(104),
385-387
 except for some minor changes. The 
1
H NMR spectrum (Figure 2.134) of 
101 showed the presence of signals due to H(3) ( 2.62, td, J = 8, 1.7 Hz), H(4) ( 2.05, 
qu, J = 8 Hz), and H(5) ( 3.87, td, J = 8, 1.7 Hz), indicating that the pyrrolidone moiety 
in variotin (104) was also present in compound 101. Thus, the changes in 101 when 
compared to those of 104, must be associated with the side chain branched from the 
nitrogen atom of the pyrrolidone ring. Detailed examination of the 
13
C NMR data of 101 
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revealed that the C(15) methylene carbon signal in 104 ( 27.3) has shifted downfield to 
73.4 in 101, indicating that oxygenation has occurred at C(15) in 101. This was 
supported by the COSY and HMQC data, which revealed a CHCHCH2CH fragment 
corresponding to the C(12)C(13)C(14)C(15) unit in 101, instead of a 
CHCHCH2CH2 unit in 104. 
  
 
Figure 2.131: Selected HMBCs of 101 
 
The placement of the hydroxy group at C(15) was further supported by the HMBC data 
(Figure 2.131), which showed three-bond correlation from H(17) to C(15). The structure 
deduced is entirely consistent with the rest of the HMBC data. Compound 101 is 
therefore 15-hydroxyvariotin. 
 
2.4.1.2    Compound 102 
 
Compound 102 was isolated as a light yellowish oil in minute amounts, []D 6 (CHCl3, 
c 0.04). The UV and IR spectra were similar to those of 101, suggesting a variotin-type 
compound with similar functionalities. The LSIMS of 102 showed an [M  H] peak at 









C NMR data (Tables 2.70 and 2.71) of 102 were generally similar to those 
of 101, except for changes involving H(12), H(13), H(14), and H(15). Examination of 
the 
13
C NMR data (Table 2.71) of 102 indicated the absence of signals due to the 
trisubstituted double bond corresponding to C(11)C(12) in 101, instead, two higher 
field signals were observed at  84.8 and 77.1, suggesting that the C(11)C(12) double 
bond has been reduced and oxygenation had occured at C(11) and C(12), respectively. 
The observed downfield shift of the C(14) carbon signal from  42.0 in 101 to 76.3 in 
102, indicated the placement of the third hydroxyl group at C(14) in 102.  
 
Figure 2.132: Selected HMBCs of 102 
 
The location of the hydroxy functions at C(11), C(12), and C(14) in 102 were further 
supported by the HMBC data (Figure 2.132), which showed three-bond correlations 
from H(9) and H(13) to C(11), and from H(18) to C(12). The structure proposed is in 




2.4.1.3    Compound 103 
 
Compound 103 was obtained in minute amounts as a light yellowish oil, []D 7 
(CHCl3, c 0.09). The UV and IR spectra of 103 were similar to those of 101 and 102, 
suggesting a variotin-type compound with similar functionalities. The LSIMS of 103 
showed an [M  H] peak at m/z 324, 16 mass units higher than that of 101, and the 
HRLSIMS measurements established the molecular formula as C17H25NO5. The NMR 
data (Tables 2.70 and 2.71) of 103 is very similar to those of 101, except for changes 
involving H(12), C(11),and C(12) in 103. As in the case of 102, two higher field signals 
were observed in 103 at  76.9 and 73.0, corresponding to C(11) and C(12), 
respectively, indicating that the trisubstituted C(11)C(12) double bond present in 101, 
was absent in 103. Thus, the additional oxygen atom must be attached to C(11) and 
C(12) to form an epoxide ring in 103. The placement of the epoxide function at 
C(11)C(12) was further confirmed by the HMBC data (Figure 2.133), which showed 
three-bond correlations from H(9) to C(11), and from H(18) to C(12). 
 
Figure 2.133: Selected HMBCs of 103 
 
The relative configurations at the various stereogenic centers in compounds 101103 






H NMR Spectroscopic Data of Compounds 101103a 
H 101 102 103 
3 2.62 td (8, 1.7) 2.62 t (8) 2.63 t (8) 
4 2.05 qu (8) 2.05 qu (8) 2.05 qu (8) 
5 3.87 td (8, 1.7) 3.87 t (8) 3.87 t (8) 
7 7.36 dd (15, 1.5) 7.32 d (15) 7.31 d (15) 
8 7.49 ddd (15, 11, 1.5) 7.42 ddd (15, 11, 0.5) 7.47 dd (15, 10) 
9 6.45 ddd (15, 11, 1.5) 6.49 dd (15, 11) 6.44 dd (15, 10) 
10 6.60 d (15) 6.14 d (15) 6.37 d (15) 
12 5.68 d (8.3) 4.10 m 3.53 br d (3.7) 
13 4.77 m 1.67 m 4.07 br q (3.7) 
  2.31 ddd (13, 7.6, 6)  
14 1.59 m 3.96 q (7) 1.52 m 
 1.64 m  1.76 ddd (14, 11.5, 3.5) 
15 3.80 m 1.61 m 3.76 m 
  1.67 m  
16 1.50 m 1.45 m 1.45 m 
 1.50 m 1.45 m 1.60 m 
17 0.93 t (7.3) 0.95 t (7) 0.98 t (7) 
18 1.85 s 1.32 s 1.29 s 
a




C NMR Spectroscopic Data of Compounds 101103a 
C 101 102 103 
2 176.3 175.7 176.0 
3 33.8 34.0 34.1 
4 17.0 17.3 17.2 
5 45.7 45.9 46.0 
6 167.3 166.4 167.0 
7 121.5 122.3 121.9 
8 145.7 145.0 145.6 
9 126.6 126.9 127.0 
10 145.5 147.3 146.8 
11 134.2 84.8 76.9 
12 138.9 77.1 73.0 
13 69.1 40.1 69.2 
14 42.0 76.3 33.1 
15 73.4 39.5 67.6 
16 30.6 19.4 29.1 
17 9.5 14.2 10.2 
18 12.6 21.3 26.4 
a























































H NMR spectrum (CDCl3, 400 MHz) of compound 103 
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2.4.1.4    Variotin (104) and Viriditin (105) 
 
Two known alkaloids belonging to this group, viz., variotin (104)
385-387
 and viriditin 
(105)
388
 were also isolated. The 
1
H NMR spectra of these compounds are shown in 
Figures 2.137 and 2.138, while the NMR spectroscopic data are summarized in Table 






C NMR Spectroscopic Data of Variotin (104) and Viriditin (105)
a 
Position 104  105  
 H C H C 
1   3.66 m 66.9 
   3.66 m  
2  175.5 4.32 m 61.2 
3 2.62 t (8) 33.8 1.67 m 28.1 
   2.05 m  
4 2.04 qu (8) 17.0 4.00 m 24.3 
5 3.87 t (8) 45.7 3.60 m 48.0 
6  166.2  167.4 
7 7.36 d (15) 121.4 6.23 d (15) 120.8 
8 7.50 dd (15, 11) 145.7 7.38 dd (15, 11) 143.4 
9 6.45 dd (15, 11) 126.4 6.37 dd (15, 11) 125.9 
10 6.61 d (15) 145.8 6.57 d (15) 144.6 
11  134.4  134.5 
12 5.67 d (8.5) 139.8 5.65 d (8.6) 139.2 
13 4.49 dd (15, 7) 68.2 4.50 dd (15, 7) 68.4 
14 1.49 m 36.9 1.49 m 37.1 
 1.64 m  1.63 m  
15 1.33 m 27.3 1.33 m 27.4 
 1.33 m  1.33 m  
16 1.33 m 22.5 1.33 m 22.6 
 1.33 m  1.33 m  
17 0.90 t (7) 13.9 0.90 t (7) 14.0 
18 1.84 s  12.6 1.85 s  12.7 
OH 2.44 br s  5.34 br s  
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13




































H NMR spectrum (CDCl3, 400 MHz) of viriditin (105) 
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2.4.2 Diketopiperazine Alkaloids 
 
2.4.2.1    cyclo (L-Phenylalanine-trans-4-hydroxy-L-proline) (106) and cyclo (L-
Leucine-trans-4-hydroxy-L-proline) (107) 
 
Two known alkaloids belonging to this group, viz., cyclo (L-phenylalanine-trans-4-
hydroxy-L-proline) (106)
389,390
 and cyclo (L-leucine-trans-4-hydroxy-L-proline) 
(107)
390-392
 were isolated. The 
1
H NMR spectra of these compounds are shown in 
Figures 2.139 and 2.140, while the NMR spectroscopic data are summarized in Table 






C NMR Spectroscopic Data of cyclo (L-Phenylalanine-trans-4-
hydroxy-L-proline) (106) and cyclo (L-Leucine-trans-4-hydroxy-L-
proline) (107)
a 
Position 106  107  
 H C H C 
2  165.2  166.5 
3 4.32 dd (11, 3) 56.1 4.06 dd (9, 3.5) 53.3 
5  169.8  170.9 
6 4.47 dd (11, 6) 57.4 4.49 dd (13, 6) 57.3 
7 2.04 ddd (13, 11, 4) 37.6 2.11 td (13, 4) 37.1 
 2.36 dd (13, 6)  2.36 dd (13, 6)  
8 4.57 t (4) 68.0 4.51 m 68.0 
9 3.62 dd (13, 4) 54.4 3.53 d (13) 54.2 
 3.78 dd (13, 4.6)  3.66 dd (13, 4)  
10 2.79 dd (14, 11) 36.6 1.53 ddd (14, 10, 5) 38.3 
 3.58 d (14)  2.01 ddd (14, 10, 4)  
11  135.7 1.80 m 24.5 
12 7.36 m 129.2 0.96 d (6.6) 21.2 
12′   1.00 d (6.6)  
13 7.24 m 129.2   
14 7.29 m 127.5   
15 7.24 m 129.2   
16 7.36 m 129.2   
NH 5.70 br s  6.68 br s  
a
 CDCl3, 400 MHz (
1
H), 100 MHz (
13




































H NMR spectrum (CDCl3, 400 MHz) of cyclo (L-leucine-trans-4-hydroxy-L-proline) (107) 
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Alkaloids are interesting substances due to their multiple pharmacological activities. 
Thus, alkaloids isolated from the present study were screened for their biological 
activity, in particular for their cytotoxic effects, including their potential in reversing 
multidrug resistance (MDR) in drug-resistant tumor cells. This part of the work was 
carried out by Dr. K. Komiyama (Kitasato University, Japan) and his associates (Iwaki 
Meisei University, Japan). 
 
2.5.2 Cytotoxicity and Reversal of Multidrug Resistance (MDR) 
 
Cancer represents one of the major causes of deaths worldwide. The development of 
new anticancer drugs as well as more effective treatment strategies, are therefore of 
great importance in drug discovery and clinical therapy. However, multidrug resistance 
(MDR) of cancer cells is one of the major obstacles to successful chemotherapeutic 
treatment of cancer. MDR is typically defined as the ability of a living cell to show 
resistance to a wide variety of structurally and functionally unrelated compounds, e.g., 
taxanes (paclitaxel and docetaxel), Vinca alkaloids (vincristine and vinblastine), 
anthracyclines (doxorubicin and daunorubicin), and epipodophyllotoxins (etoposide and 
teniposide). MDR is usually associated with the over expression of P-glycoprotein (a 
multidrug resistant protein or ATP-dependent membrane transporter that acts as a drug 




approach to counteract the mechanisms of drug resistance is to develop pharmacological 
agents (modulators of MDR, also known as chemosensitizers) that are devoid of 
cytotoxicities but are capable of inhibiting the functions of these membrane-bound 
proteins in tumor cells. When a modulator is present in the growth medium the 
sensitivity of the resistant cells to the oncolytic can be enhanced by inhibiting the efflux 
mechanism so that cells accumulate a higher intracellular concentration of the drug, 
thereby becoming more drug-sensitive. The Tsuruo group was the first to demonstrate 
that the sensitivity of P-gp-expressing multidrug-resistant cells was enhanced by the 
presence of the calcium channel blocker, verapamil.
395
 Nowadays, one of the most 
promising P-gp inhibitors is the anthranilic acid derivative, tariquidar
396,397
 (third-
generation agent), which binds with high affinity to the P-gp transporter and potently 
inhibits its activity. The inhibitory effects of tariquidar on the P-gp transporter pump 
greatly exceed those of the phenylalkylamine derivative, verapamil (first-generation 
agent) and the cyclosporin derivative, valspodar (second-generation agent) with respect 
to potency and duration of action.
394
 However, the mechanisms by which these drugs 
reverse MDR is not fully understood, and to date there are no MDR reversal agents 
available clinically (due to their toxicity), although several are currently undergoing 





As part of the group’s ongoing search for new bioactive principles from plants and 
microorganisms, alkaloids obtained from the present study were screened for their 
cytotoxic effects against several cancer cell lines (KB and Jurkat) as well as their 
potential in reversing multidrug resistance (MDR) in drug-resistant KB cells. KB and 
Jurkat refer to the human oral epidermoid carcinoma and human T-cell-leukemia cell 
lines, respectively. The alkaloids were tested at an initial concentration of 25 µg/mL and 
the IC50 values were then determined for the more active compounds and the results are 
presented in Table 2.74. 
 
5,21-Dihydrorhazinilam N-oxide (23), leucophyllidine (36),
137
 and leucoridine A (39)
138
 
isolated from the stem-bark extract of L. griffithii, were found to display strong 
cytotoxicity toward drug-sensitive and drug-resistant KB cells. Other alkaloids such as 





 and leucoridines BD (4042)138 showed moderate cytotoxicity 
toward KB cells. Leuconicines AB (23)134 showed strong activity in reversing MDR 
in vincristine-resistant KB cells, while leuconicines CE (46),134 and leuconodine E 
(13) showed only moderate activity. Among the new alkaloids, leucolusine (1),
136
 
leuconicines FG (78), leuconodine A (9), leuconodine C (11), 3,14-
dehydroleuconolam (18), and ()-eburnamaline (28),134 did not show any appreciable 
bioactivity against KB cells. Leuconicines AB (23) and leuconodine F (15) were 
found to be inactive when tested against Jurkat cells. 
 
The stem-bark extract of K. pauciflora has yielded two new eburnane alkaloids 
(compounds 63 and 64) and one new aspidofractinine derivative (11,12-
 336 
dimethoxykopsinaline (77)). Compound 64 showed weak ability in reversing multidrug 
resistance in vincristine-resistant KB cells while compounds 63 and 77 are inactive 
toward KB cells. 
 
The corynanthean oxindole compound, 71, and andransinine (90) isolated from the leaf 
extract of K. pauciflora were found to be highly effective in circumventing MDR in 
vincristine-resistant KB cells, while compounds 62 and 91 showed moderate activity in 
reversing multidrug resistance in vincristine-resistant KB cells. The only corynanthean-
type pseudoindoxyl obtained from this plant, tetrahydroalstonine pseudoindoxyl (73) is 
inactive towards KB cells.  
 
Variotin (104), isolated from Penicillium sp. (CDA p48.3) is inactive towards KB cells. 
The variotin derivatives, compounds 101103, were not evaluated due to the limited 











Table 2.74: Cytotoxic Effects of Alkaloids Isolated from L. griffithii, K. pauciflora, and Penicillium sp. (CDA p48.3) 
Compound IC50, g/mL (M) 
 KB/S KB/VJ300 KB/VJ300
a
 Jurkat 
Alkaloids from L. griffithii (stem-bark)     
Leucolusine (1) >25 >25 >25  
Leuconicine A (2) >25 >25 2.57 (7.12) >25 
Leuconicine B (3) >25 >25 1.98 (5.27) >25 
Leuconicine C (4) >25 >25 3.86 (10.75)  
Leuconicine D (5) >25 >25 4.62 (12.35)  
Leuconicine E (6) >25 >25 13.52 (37.56)  
Leuconicine F (7) >25 >25 >25  
Leuconicine G (8) >25 >25 >25  
Leuconodine A (9) >25 >25 >25  
Leuconodine B (scholarisine G) (10) 13.96 (42.82) 17.81 (54.63) 16.21 (49.72)  
Leuconodine C (11) >25 >25 >25  
Leuconodine D (12) 17.90 (60.47) 11.50 (38.85) 3.95 (13.34) 19.80 (66.89) 
Leuconodine E (13) >25 >25 9.34 (29.94)  
Leuconoxine (14) >25 >25 >25  
Leuconodine F (6-oxoleuconoxine) (15) >25 >25 >25 >25 
3,14-Dehydroleuconolam (18) >25 >25 >25  
Nor-rhazinicine (22) 12.51 (42.55) 7.06 (24.01) 4.81 (16.36)  
5,21-Dihydrorhazinilam N-oxide (23) 1.14 (3.65) 1.53 (4.90) 1.75 (5.61)  
Rhazinilam (25) 0.19 (0.65) 0.25 (0.85) 0.34 (1.16)  
Rhazinal (26) 0.24 (0.75) 0.25 (0.78) 0.30 (0.93)  
Rhazinicine (27) 1.25 (4.06) 2.50 (8.12) 1.85 (6.01)  
()-Eburnamaline (28) >25 >25 >25  
Leucophyllidine (36) 2.95 (5.16) 2.92 (5.10) 0.91 (1.59)  
Leuconoline (37) 11.46 (17.74) 12.17 (18.84) 9.33 (14.44)  
Leucofoline (38) 12.90 (23.20) 13.15 (23.65) 0.59 (1.06)  
Leucoridine A (39) 0.57 (1.03) 2.39 (4.30) 0 (0)  
Leucoridine B (40) 11.59 (20.92) 12.05 (21.75) 12.41 (22.40)  











Table 2.74, continued 
Compound IC50, g/mL (M) 
 KB/S KB/VJ300 KB/VJ300
a
 Jurkat 
Leucoridine D (42) 12.53 (22.46) 13.29 (23.82) 1.50 (2.69)  
16(S)-19,20-E-Isositsirikine (48) >25 >25 12.08 (34.12)  
()-Isovallesiachotamine (53) 3.94 (11.73) 5.01 (14.91) 3.16 (9.40)  
Tubotaiwine N-oxide (58) >25 >25 >25  
N(4)-Chloromethyltubotaiwine chloride (59) >25 >25 >25  
     
Alkaloids from K. pauciflora (stem-bark)     
Compound 63 >25 >25 >25  
Compound 64 >25 >25 18.13 (58.48)  
11,12-Dimethoxykopsinaline (77) >25 >25 >25  
     
Alkaloids from K. pauciflora (leaves)     
Compound 62 >25 >25 10.80 (30.51)  
Compound 63 >25 >25 >25  
Larutenine (65) >25 >25 4.63 (15.75)  
Compound 70 >25 >25 2.75 (7.81)  
()-Catharinensine (72) 2.77 (7.82) 2.42 (6.84) 0.05 (0.14)  
Tetrahydroalstonine pseudoindoxyl (73) >25 >25 >25  
Andransinine (90) >25 >25 1.61 (4.24)  
Compound 91 >25 >25 8.06 (22.02)  
Stemmadenine (94) >25 >25 >25  
     
Alkaloids from Penicillium sp. (CDA p48.3)     
Variotin (104) >25 >25 >25  
     
Control     
Vincristine 1.4 ng/mL (1.70 nM) 0.8 g/mL (0.97 M)  1.8 ng/mL (2.18 nM) 
Verapamil >1.0 (> 2.20) >1.0 (> 2.2)  0.33 (0.73) 
a 






3.1 Source and Authentication of Plant and Fungi Samples 
 
The plant materials were collected from various locations in Malaysia and were 
identified by Dr. Richard C. K. Chung (Forest Research Institute, Malaysia). All plant 
materials were screened for their alkaloidal constituents before any chemical analysis 
was carried out. Voucher specimens are deposited at the Herbarium, University of 
Malaya (UM). The details are given in Table 3.1.  
 
Table 3.1: Source and Authentication of Plant Materials 
Herbarium 
Specimen No. 
Locality Species Date of 
Collection 
Herbarium 
K 672 Pahang L. griffithii Sept 2005 University of Malaya 
K 678 Terengganu K. pauciflora May 2008 University of Malaya 
 
The fungi samples were collected by Professor Dr. Noorlidah Abdullah 
(Biotechnology), from the Institute of Biological Sciences, University of Malaya. The 





Melting points were determined on Mel-Temp melting point apparatus and were 
uncorrected. Optical rotations were determined on a Jasco P-1020 digital polarimeter. 
UV spectra were obtained on a Shimadzu UV-3101PC spectrophotometer. IR spectra 
were recorded on a Perkin-Elmer 1600 Series or a Perkin-Elmer RX1 FT-IR 
spectrophotometer.  
ESIMS and HRESIMS were obtained on an Agilent 6530 Q-TOF mass spectrometer. 
HREIMS and HRLSIMS were obtained at Organic Mass Spectrometry, Central Science 




C NMR spectra were recorded in CDCl3 using TMS as internal standard on a 
JEOL JNM-LA 400 and JNM-ECA 400 spectrometers at 400 and 100 MHz, 
respectively. Coupling constants (J) are reported in Hz and  in ppm.  
X-ray diffraction analysis was carried out on a Bruker SMART APEX II CCD area 
detector system equipped with a graphite monochromator and a Mo K fine-focus 
sealed tube (= 0.71073 Å), at 100K, or, on an Agilent Technologies SuperNova Dual 
CCD area detector system equipped with mirror monochromator and a SuperNova (Cu 
K) X-ray source (=1.50352 Å). The structure was solved by direct methods 
(SHELXS-97) and refined with full-matrix least-squares on F
2
 (SHELXL-97). I thank 
Mr. Low Yun Yee and Professor Ward Robinson for carrying out X-ray diffraction 
analyses. 
All solvents were distilled prior to use with the exception of diethyl ether, which was 
passed through activated neutral alumina before use. 
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3.3 Chromatographic Methods 
 
3.3.1 Column Chromatography 
 
Flash chromatography was performed using Merck silica gel 9385 (230-400 Mesh 
ASTM). The ratio of silica gel to the sample was approximately 30:1 for crude samples 
and 100:1 for semi-pure fractions. The gel was made into a slurry with chloroform 
before it was packed onto the column and was allowed to equilibrate for at least an hour 
before use. When diethyl ether was used as an eluting solvent, the column was packed 
by the dry packing method. The solvent systems normally used as eluents were 
chloroform with increasing methanol gradient or diethyl ether with increasing ethyl 
acetate gradient. Fractions were monitored by thin layer chromatography (TLC) and 
appropriate fractions were combined and where necessary subjected to further 
separation by re-chromatography or preparative centrifugal TLC. 
 
3.3.2 Sephadex LH-20 
 
The dried powder of Sephadex LH-20 was allowed to swell in methanol for at least 3 
hours before use. The slurry was poured onto the column and allowed to equilibrate to 
room temperature. The sample was filtered with a 0.45 m nylon membrane before it 
was loaded into the column to ensure a longer column life. The column can be re-
generated by washing of the Sephadex LH-20 gel with 23 column volumes of eluent, 
followed by re-equilibration.  
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3.3.3 High Performance Liquid Chromatography (HPLC) 
 
High performance liquid chromatography (HPLC) was use for the separation of fungi 
and bacteria samples. The instruments were: Waters 600 (analytical and semi-
preparative HPLC) and Waters Autopurification System (semi- and preparative HPLC). 
Several C18 reverse phase HPLC columns of different dimensions were use during this 
study, including, a Merck Chromolith semi-preparative column (10 x 100 mm), Waters 
X-Bridge (4.6 x 50 mm), and the Waters RCM-100 radial compression module. All 
samples were filtered with 0.45 m nylon membrane before use. The solvent systems 
normally used as eluents were acetonitrile, methanol, and water.         
 
3.3.4 Thin Layer Chromatography (TLC) 
 
Thin layer chromatography (TLC) was routinely used to detect and separate the various 
alkaloids. The crude alkaloidal extracts, fractions from chromatography, and isolated 
pure alkaloids were examined by TLC using pre-coated 5 x 10 cm aluminium plates, 
0.25 mm thickness, silica gel 60 F254 (Merck, Darmstadt, G.F.R.). The TLC plates were 
spotted with a piece of fine glass capillary tube and then developed in saturated 
chromatographic tanks with various solvent systems at room temperature. The 
alkaloidal spots were visualized by examination of the TLC plates under UV light (254 
nm), followed by spraying with Dragendorff’s reagent, which formed orange spots. The 
hRf values of the alkaloids are tabulated in Table 3.2. 
 
 343 
Table 3.2: The hRf Values of Alkaloids Isolated from Leuconotis griffithii, Kopsia 
pauciflora, and Penicillium sp. (CDA p48.3) 




Leucolusine (1)  14 53 40 80 56 
Leuconicine A (2) 6 4 0 66 7 
Leuconicine B (3) 9 3 0 76 6 
Leuconicine C (4) 20 37 16 84 48 
Leuconicine D (5) 35 41 24 88 48 
Leuconicine E (6) 27 41 18 84 42 
Leuconicine F (7) 0 0 0 22 0 
Leuconicine G (8) 0 0 0 22 0 
Leuconodine A (9) 14 49 22 73 52 
Leuconodine B (10) 8 51 21 69 54 
Leuconodine C (11) 4 30 3 55 40 
Leuconodine D (12)  35 62 66 81 62 
Leuconodine E (13) 22 63 61 74 60 
Leuconoxine (14) 22 63 25 77 49 
Leuconodine F (15) 38 55 24 82 58 
Mersicarpine (16) 7 65 75 70 70 
Arboloscine (17) 35 65 79 81 70 
3,14-Dehydroleuconolam (18)  0 33 6 69 41 
Leuconolam (19) 0 16 2 63 27 
O-Methylleuconolam (20) 43 67 53 79 66 
6,7-Dehydroleuconoxine (21a) 42 58 43 96 51 
Nor-rhazinicine (22)  14 54 33 94 53 
5,21-Dihydrorhazinilam N-oxide (23)  0 0 0 12 0 
5,21-Dihydrorhazinilam (24) 3 12 9 43 24 
Rhazinilam (25) 14 57 40 74 61 
Rhazinal (26) 11 42 20 94 49 
Rhazinicine (27) 11 51 29 70 55 
Eburnamaline (28)  0 12 9 54 23 
(+)-Eburnamonine (29) 18 24 35 79 26 
(+)-Eburnamenine (30) 9 31 39 77 36 
O-Methylisoeburnamine (31) 5 24 24 67 29 
O-Methyleburnamine (32) 10 28 31 76 34 
(+)-Isoeburnamine (33) 0 14 12 49 25 
()-Eburnamine (34) 4 21 18 51 29 
()-Vincamine (35) 5 21 14 70 30 
Leucophyllidine (36)  4 9 3 50 22 
Leuconoline (37)  0 5 2 29 11 
Leucofoline (38)  0 2 1 33 4 
Leucoridine A (39) 2 1 0 26 4 
Leucoridine B (40) 4 4 3 40 5 
Leucoridine C (41) 0 2 0 26 2 
Leucoridine D (42) 2 2 2 37 4 
Tetrahydroalstonine (43) 22 76 73 84 76 
17(S)-Ajmalicinial (44) and 17(R)-
ajmalicinial (45) 
0 27 14 36 37 
Akuammidine (46) 3 38 26 50 53 
16(R)-19,20-E-Isositsirikine (47) 3 12 9 43 24 
16(S)-19,20-E-Isositsirikine (48) 0 9 6 30 17 
Z-Geissoschizol (49) 0 19 6 27 29 
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Table 3.2, continued 




Fluorocarpamine (50) 6 15 10 54 24 
Pleiocarpamine (51) 6 17 13 43 6 
16-Hydroxymethylpleiocarpamine (52) 0 24 3 31 35 
()-Isovallesiachotamine (53) 5 65 45 75 62 
()-Isovallesiachotamine (53) and  
()-vallesiachotamine (54) 
6 66 45 72 65 
Norfluorocurarine (55) 4 4 3 49 8 
12-Hydroxynorfluorocurarine (56) 0 3 1 32 4 
Tubotaiwine (57) 0 5 4 46 5 
Tubotaiwine N-oxide (58) 0 3 0 29 3 
N(4)-Chloromethyltubotaiwine chloride 
(59)  
0 0 0 15 1 
Venoterpine (60) 0 20 10 42 25 
Syringaresinol (61) 5 55 19 73 52 
Compound 62 15 59 72 79 55 
Compound 63 9 33 47 73 38 
Compound 64  22 59 71 79 61 
Larutenine (65) 9 25 31 70 31 
()-19-Oxoeburnamine (66) 1 20 10 44 33 
()-19(R)-Hydroxyisoeburnamine (67) 0 0 0 36 14 
()-19(R)-Hydroxyeburnamine (68) 0 0 0 37 14 
Compound 69 39 76 69 98 80 
Compound 70  4 63 52 77 61 
Compound 71 0 23 0 45 30 
()-Catharinensine (72) 8 65 61 72 60 
Tetrahydroalstonine pseudoindoxyl (73) 5 62 51 81 63 
()-Aspidospermidine (74) 5 30 35 55 34 
()-1,2-Dehydroaspidospermidine (75) 7 31 33 75 37 
()-Quebrachamine (76)  5 61 72 52 56 
11,12-Dimethoxykopsinaline (77)  1 12 6 41 22 
Pseudokopsinine (78)  4 8 6 41 13 
Kopsinine (79) 17 57 60 52 34 
Kopsamine (80) 26 72 48 75 59 
N(1)-Decarbomethoxykopsamine (81) 5 33 28 52 45 
Kopsilongine (82) 18 50 46 76 59 
Paucifinine (83) 5 33 44 73 49 
Kopsanone (84) 24 40 32 74 45 
11,12-Methylenedioxykopsine (85) 23 54 35 75 56 
12-Methoxykopsine (86) 5 13 4 64 24 
Kopsifine (87) 8 73 30 63 73 
N(1)-Decarbomethoxykopsifine (88) 2 45 7 49 67 
Akuammicine (89) 2 11 12 58 35 
Andransinine (90)  4 16 16 42 23 
Compound 91  2 15 8 35 21 
Condylocarpine (92) 10 13 7 65 21 
Precondylocarpine (93) 8 6 6 39 10 
Stemmadenine (94) 0 3 1 25 4 
Methyl 11,12-methylenedioxy-N(1)-
decarbomethoxychanofruticosinate (95) 
34 53 48 68 68 
Methyl 11,12-
methylenedioxychanofruticosinate (96) 
28 66 49 79 70 
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Table 3.2, continued 




Methyl chanofruticosinate (97) 36 86 82 94 90 
Methyl N(1)-decarbomethoxychanofruticosinate (98) 32 63 52 76 66 
Methyl 12-methoxychanofruticosinate (99) 34 61 35 74 63 
()-Norpleiomutine (100)  4 8 6 44 9 
Compound 101    54 
Compound 102    67 
Compound 103    54 
Variotin (104)    72 
Viriditin (105)    38 
cyclo (L-Phenylalanine-trans-4-hydroxy-L-proline) 
(106) 
   32 
cyclo (L-Leucine-trans-4-hydroxy-L-proline) (107)    20 
 
 
3.3.5 Preparative Centrifugal TLC 
 
Preparative centrifugal TLC was carried out using a round chromatographic plate 
measuring 24 cm in diameter. To prepare the chromatographic plate, the edge of the 
plate is secured with cellophane tape to form a mould. Silica gel (Merck 7749, 50 g) is 
added to about 110 ml of cold distilled water to give a slurry. The slurry is shaken and is 
then quickly poured onto the circular glass plate before setting commences. The circular 
glass plate is rotated while the gel is being poured to obtain an even setting. The plate is 
then left to air-dry for about an hour before being dried in an oven at 80 °C for about 12 
hours. The sample was dissolved in a minimum volume of a suitable solvent and loaded 
at the centre of the plate while the plate is spinning to form a thin band. Elution is then 
carried with the appropriate solvent system. The fractions are collected, concentrated by 
rotary-evaporation, examined by TLC, and combined where appropriate. Some of the 
solvent systems used as eluents were: 
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1. Chloroform 
2. Chloroform: Hexanes 
3. Chloroform with added 1% of liquid ammonia 
4. Chloroform: Methanol  
5. Diethyl ether  
6. Diethyl ether: Hexanes 
7. Diethyl ether: Methanol 
8. Diethyl ether with added 1% of liquid ammonia 
9. Ethyl acetate 
10. Ethyl acetate: Hexanes 
11. Ethyl acetate: Methanol  
12. Ethyl acetate with added 1% of liquid ammonia 
13. Acetone: Hexanes 
 
3.4 Spray Reagent (Dragendorff’s Reagent) 
 
Solution A: 0.85 g of bismuth nitrate was dissolved in a mixture of 10 mL glacial acetic 
acid and 40 mL of distilled water. 
Solution B: 8 g of potassium iodide was dissolved in 20 mL of distilled water. 
A stock solution was prepared by mixing equal volumes of solutions A and B. 
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Dragendorff”s reagent was prepared by mixing 1 mL of stock solution with 2 mL of 
glacial acetic acid and 10 mL of distilled water. Orange spots on the developed TLC 
plates indicate the presence of alkaloids. 
 
3.5 Cultivation and Fermentation of Fungi Strains 
 
The pure fungi strain was grown on GYMP (glucose 1.5 %yeast 0.8 %malt extract 
0.8 %peptone 0.8 %) agars. Ten plugs of 7 days old culture were cut from the 
periphery of the colony and transferred into 100 mL sterile liquid GYMP in 500 mL 
Erlenmeyer flasks (thirty 500 mL Erlenmeyer flask, containing 100 mL of liquid GYMP 
each) and incubated under static conditions at 27°C for 14 days. 
 
3.6 Extraction of Alkaloids 
 
3.6.1 Extraction of Alkaloids from Plant 
 
The plant materials were dried and ground before extracting with 95% ethanol for 23 
days at room temperature. The ethanol extract was filtered and the residue was then re-
extracted with a fresh portion of distilled ethanol. This procedure was repeated 5 or 6 
times. The combined extract was then concentrated by distillation under reduced 
pressure using a rotary-evaporator to about a tenth of the original volume. The 
concentrated extract was then added slowly into 5% hydrochloric acid with constant 
stirring. The acidic solution was then filtered through kieselguhr to remove the non-
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alkaloidal substances. The filtrate was then basified with concentrated ammonia 
solution to about pH 10 with cooling and the liberated alkaloids were extracted 
exhaustively with chloroform. The chloroform extract was then washed with distilled 
water and dried over anhydrous sodium sulfate. Finally, the solvent was removed by 
evaporation under reduced pressure to furnish the crude alkaloidal mixture. 
 
3.6.2 Extraction of Alkaloids from Fungi  
 
The culture broth was centrifuged, followed by filtration through kieselguhr to separate 
the supernatant and mycelia. The supernatant or the liquid broth was extracted 
exhaustively with ethyl acetate, followed by washing of the ethyl acetate extract with 
distilled water and drying over anhydrous sodium sulfate. The solvent was removed 
under reduced pressure to yield the crude extract. The mycelia were extracted 
exhaustively with methanol. The methanol extract was dried over anhydrous sodium 
sulfate, followed by removal of solvent under reduced pressure to furnish the crude 
mixture. 
 
3.7 Isolation of Alkaloids 
 
3.7.1 General Procedure 
 
The crude mixture obtained from the extraction procedure described above was initially 
fractionated by vacuum chromatography over silica gel. The column was eluted with 
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chloroform, followed by a stepwise increase of methanol gradient. Based on TLC, the 
many fractions collected were pooled into several major fractions, which were then 
subjected to further fractionation by flash chromatography, vacuum chromatography, 
HPLC, Sephadex LH-20, or preparative centrifugal TLC until pure compounds are 
obtained. 
 
3.7.2 Isolation of Alkaloids from Leuconotis griffithii 
 
Extraction of 13.8 kg of stem-bark material yielded ca. 31 g of crude alkaloidal mixture. 
This mixture was then subjected to chromatography as summarized in the flow diagram 
shown in Figure 3.1 to yield 60 pure alkaloids and 1 lignan. 
 
3.7.3 Isolation of Alkaloids from Kopsia pauciflora 
 
Extraction of 19 kg of the stem-bark of K. pauciflora gave ca. 58 g of crude alkaloidal 
mixture. By utilizing various chromatographic methods, a total of 26 alkaloids were 
isolated. The flow diagram depicting the isolation of the alkaloids from the stem-bark of 
K. pauciflora is shown in Figure 3.2. 
 
The leaves of the same plant gave 45 g of crude material from the extraction of ca. 9 kg 
of plant material. From this mixture, 35 alkaloids were separated. The isolation of 
alkaloids from the leaves of K. pauciflora is summarized in Figure 3.3. 
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3.7.4 Isolation of Alkaloids from Penicillium sp. (CDA p48.3) 
 
Extraction of 3 L of the liquid broth of Penicillium sp. gave ca. 0.86 g of crude mixture. 
From this mixture, a total of 7 alkaloids were isolated. The isolation of alkaloids from 







































































Figure 3.4: Isolation of alkaloids from the culture broth extract of Penicillium sp. (CDA p48.3)
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3.8 Compound Data 
 
Alkaloids from L. griffithii 
Leucolusine (1): light yellowish oil; [α]D 55 (c 0.12, CHCl3); UV (EtOH) max nm 





H NMR and 
13
C NMR data, see Table 2.2; EIMS m/z 330 [M]

 
(7), 312 (2), 302 (8), 285 (12), 271 (35), 257 (2), 231 (2), 205 (4), 182 (47), 168 (100), 
154 (19), 140 (40), 110 (16), 96 (11), 81 (8), 69 (11), 55 (15); HREIMS m/z 330.1942 
(calcd for C19H26N2O3, 330.1943). HMBC: 
2
J NH to C(13); H(3) to C(14); H(17) to 
C(16); H(16) to C(17); H(19) to C(18); H(18) to C(19); H(19) to C(20). 
3
J H(6) to C(2); 
H(15), H(21) to C(3); H(21) to C(5); NH, H(9) to C(7); NH, H(10), H(12) to C(8); 
H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); H(9), H(11) to C(13); 
H(3), H(17), H(19), H(21) to C(15); H(21) to C(16); H(19), H(21) to C(17); H(17), 
H(21) to C(19); H(14), H(18) to C(20); H(3), H(5), H(15), H(16), H(17), H(19) to 
C(21). NOE: H(5)/H(21); H(12)/NH; H(18)/H(21); H(21)/H(5), H(18); NH/H(12). 
 
Leuconicine A (2): light yellowish oil; []D 473 (c 0.24, CHCl3); UV (EtOH) max nm 
(log ) 211 (4.28), 282 (3.55), 369 (3.82) nm; IR (dry film) max 3361, 1672, 1614 cm
1
; 




H NMR and 
13
C 
NMR data, see Tables 2.3 and 2.4, respectively; EIMS m/z 361 [M]

 (100), 344 (8), 332 
(13), 316 (7), 288 (18), 277 (33), 260 (44), 246 (63), 218 (17), 204 (40), 190 (28), 166 
(7), 135 (4), 123 (68), 94 (22); HREIMS m/z 361.1791 (calcd for C22H23N3O2, 
361.1790). HMBC: 
2
J H(6) to C(5); H(6) to C(7); H(15) to C(16); H(19) to C(18); 
H(18) to C(19); H(19), H(21) to C(20); H(20) to C(21); H(17) to C(23); NH to CONH2. 
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3
J H(3), H(6), H(15), H(17) to C(2); H(5), H(6), H(15), H(21) to C(3); H(3), H(21) to 
C(5); H(5), H(9), H(14) to C(7); H(3), H(6), H(10), H(12) to C(8); H(11) to C(9); H(12) 
to C(10); H(9) to C(11); H(10) to C(12); H(9), H(11) to C(13); H(3), H(17), H(19), 
H(21) to C(15); H(14) to C(16); H(15) to C(17); H(20) to C(18); H(18) to C(20); H(3), 
H(5), H(15), H(19) to C(21); H(17) to C(22); NH to C(23); H(17) to CONH2. NOESY: 
H(3)/H(5), H(9), H(14R), H(14S); H(5)/H(3); H(6)/H(9); H(9)/H(3), H(6); 
H(11)/H(12); H(12)/H(11); H(14R)/H(3), H(14S); H(14S)/H(3), H(14R), H(20); 
H(15)/H(17), H(18), H(20); H(17)/H(15), H(18), H(19), NH; H(18)/H(15), H(17), 
H(20), H(21); H(19)/H(17); H(20)/H(14S), H(15), H(18), H(21); H(21)/H(18), 
H(20); NH/H(17). NOE: H(9)/H(3); H(15)/H(17); H(17)/H(15); H(18)/H(15), H(20).   
 
Leuconicine B (3): light yellowish oil; []D 720 (c 1.55, CHCl3); UV (EtOH) max nm 







C NMR data, see Tables 2.3 and 2.4, respectively; EIMS m/z 376 [M]

 
(100), 361 (7), 347 (19), 317 (6), 305 (9), 292 (40), 274 (15), 260 (59), 246 (79), 218 
(24), 204 (51), 190 (35), 167 (8), 135 (5), 123 (91), 110 (21); HREIMS m/z 376.1784 
(calcd for C23H24N2O3, 376.1787). HMBC: 
2
J H(6) to C(5); H(6) to C(7); H(15) to 
C(16); H(19) to C(18); H(18) to C(19); H(19), H(21) to C(20); H(20) to C(21); H(17) to 
C(23). 
3
J H(3), H(6), H(15), H(17) to C(2); H(5), H(6), H(15), H(21) to C(3); H(3), 
H(21) to C(5); H(5), H(9), H(14) to C(7); H(3), H(6), H(10), H(12) to C(8); H(11) to 
C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); H(9), H(11) to C(13); H(3), H(17), 
H(19), H(21) to C(15); H(14) to C(16); H(15) to C(17); H(20) to C(18); H(18) to C(20); 
H(3), H(5), H(15), H(19) to C(21); H(17) to C(22); CO2Me, H(17) to CO2Me. NOESY: 
H(3)/H(5), H(9), H(14R), H(14S); H(5)/H(3); H(6)/H(9); H(9)/H(3), H(6); 
H(11)/H(12); H(12)/H(11); H(14R)/H(3), H(14S); H(14S)/H(3), H(14R), H(20); 
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H(15)/H(17), H(18), H(20); H(17)/H(15), H(18), H(19); H(18)/H(15), H(17), H(20), 
H(21); H(19)/H(17); H(20)/H(14S), H(15), H(18), H(21); H(21)/H(18), H(20). 
NOE: H(3)/H(5), H(9), H(14R), H(14S); H(5)/H(3), H(5); H(14S)/H(3), H(14R), 
H(15), H(20); H(17)/H(15); H(18)/H(15); H(20)/H(21); H(21)/H(20), H(21); 
H(21)/ H(21).   
  
Leuconicine C (4): light yellowish oil; []D 374 (c 0.22, CHCl3); UV (EtOH) max nm 




H NMR and 
13
C NMR data, see Tables 2.3 and 2.4, respectively; EIMS m/z 359 [M]

 
(100), 341 (15), 330 (5), 313 (11), 289 (12), 275 (16), 257 (7), 246 (10), 204 (8), 170 
(14), 156 (6), 121 (7); HREIMS m/z 359.1629 (calcd for C22H21N3O2, 359.1634). 
HMBC: 
2
J H(6) to C(5); H(6) to C(7); H(15) to C(16); H(19) to C(18); H(18) to C(19); 
H(19), H(21) to C(20); H(17) to C(23); NH to CONH2. 
3
J H(3), H(6), H(15), H(17) to 
C(2); H(5), H(6), H(15), H(21) to C(3); H(3), H(21) to C(5); H(5), H(9), H(14) to C(7); 
H(3), H(6), H(10), H(12) to C(8); H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) 
to C(12); H(9), H(11) to C(13); H(3), H(17), H(19), H(21) to C(15); H(14) to C(16); 
H(15) to C(17); H(18) to C(20); H(3), H(5), H(15), H(19) to C(21); H(17) to C(22); NH 
to C(23); H(17) to CONH2. NOESY: H(3)/H(5), H(9), H(14R), H(14S); H(5)/H(3); 
H(6)/H(9); H(9)/H(3), H(6); H(11)/H(12); H(12)/H(11); H(14R)/H(3), H(14S); 
H(14S)/H(3), H(14R), H(15)/H(17), H(18); H(17)/H(15), H(18), H(19), NH; 
H(18)/H(15), H(17), H(21); H(19)/H(17); H(21)/H(18), H(19); NH/H(17).  
 
Catalytic hydrogenation of 4: leuconicine C (4) (10.2 mg, 0.028 mmol) was dissolved 
in CH2Cl2 (15 mL) and then stirred over 10% Pd/C (5.8 mg) under a hydrogen 
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atmosphere at room temperature for 2 h. The catalyst was then removed by filtration 
over silica gel. Evaporation of the solvent under vacuo, followed by chromatography of 
the resulting residue (silica gel, MeOH/CHCl3) provided 2 (7.8 mg, 76%).  
  
Leuconicine D (5): light yellowish oil; []D 501 (c 0.42, CHCl3); UV (EtOH) max nm 







C NMR data, see Tables 2.3 and 2.4, respectively; EIMS m/z 374 [M]

 
(100), 359 (9), 331 (5), 290 (17), 272 (7), 247 (14), 231 (11), 217 (7), 190 (7), 171 (3), 
121 (5), 108 (2); HREIMS m/z 374.1632 (calcd for C23H22N2O3, 374.1630). HMBC: 
2
J 
H(6) to C(5); H(6) to C(7); H(15) to C(16); H(19) to C(18); H(18) to C(19); H(19), 
H(21) to C(20); H(17) to C(23). 
3
J H(3), H(6), H(15), H(17) to C(2); H(5), H(6), H(15), 
H(21) to C(3); H(3), H(21) to C(5); H(5), H(9), H(14) to C(7); H(3), H(6), H(10), H(12) 
to C(8); H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); H(9), H(11) to 
C(13); H(3), H(17), H(19), H(21) to C(15); H(14) to C(16); H(15) to C(17); H(18) to 
C(20); H(3), H(5), H(15), H(19) to C(21); H(17) to C(22); CO2Me, H(17) to CO2Me. 
NOESY: H(3)/H(5), H(9), H(14R), H(14S); H(5)/H(3); H(6)/H(9); H(9)/H(3), 
H(6); H(11)/H(12); H(12)/H(11); H(14R)/H(3), H(14S); H(14S)/H(3), H(14R); 
H(15)/H(17), H(18); H(17)/H(15), H(18), H(19); H(18)/H(15), H(17), H(21); 
H(19)/H(17); H(21)/H(18), H(19).    
 
Catalytic hydrogenation of 5: leuconicine D (5) (10.5 mg, 0.028 mmol) was dissolved 
in CH2Cl2 (15 mL) and then stirred over 10% Pd/C (5.8 mg) under a hydrogen 
atmosphere at room temperature for 2 h. The catalyst was then removed by filtration 
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over silica gel. Evaporation of the solvent under vacuo, followed by chromatography of 
the resulting residue (silica gel, MeOH/CHCl3) provided 3 (7.5 mg, 71%).  
 
Leuconicine E (6): light yellowish oil; []D 193 (c 0.04, CHCl3); UV (EtOH) max nm 







C NMR data, see Tables 2.5 and 2.6, respectively; EIMS m/z 360 [M]

 
(100), 345 (4), 316 (29), 287 (25), 259 (12), 232 (29), 217 (13), 204 (22), 191 (13), 163 
(4), 121 (10), 108 (7); HREIMS m/z 360.1473 (calcd for C22H20N2O3, 360.1474). 
HMBC: 
2
J H(6) to C(5); H(6) to C(7); H(15) to C(16); H(19) to C(18); H(18) to C(19); 
H(19), H(21) to C(20); H(17) to C(23). 
3
J H(3), H(6), H(15), H(17) to C(2); H(5), H(6), 
H(15), H(21) to C(3); H(3), H(21) to C(5); H(5), H(9), H(14) to C(7); H(3), H(6), 
H(10), H(12) to C(8); H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); 
H(9), H(11) to C(13); H(3), H(17), H(19), H(21) to C(15); H(14) to C(16); H(15) to 
C(17); H(18) to C(20); H(3), H(5), H(15), H(19) to C(21); H(17) to C(22). NOESY: 
H(3)/H(5), H(9), H(14R), H(14S); H(5)/H(3); H(6)/H(9); H(9)/H(3), H(6); 
H(11)/H(12); H(12)/H(11); H(14R)/H(3), H(14S); H(14S)/H(3), H(14R); H(15)/H(17), 
H(18); H(17)/H(15), H(18), H(19); H(18)/H(15), H(17), H(21); H(19)/H(17); 
H(21)/H(18), H(19).    
 
Leuconicine F (7): light yellowish oil; []D 353 (c 0.19, CHCl3); UV (EtOH) max nm 




H NMR and 
13
C NMR data, see Tables 2.5 and 2.6, respectively; EIMS m/z 361 [M 
O]

 (100), 344 (7), 332 (12), 316 (7), 289 (15), 277 (30), 260 (33), 246 (50), 232 (11), 




; HRESIMS m/z 378.1825 (calcd for C22H23N3O3 + H, 378.1812). HMBC: 
2
J 
H(6) to C(5); H(6) to C(7); H(15) to C(16); H(19) to C(18); H(18) to C(19); H(19), 
H(21) to C(20); H(20) to C(21); H(17) to C(23); NH to CONH2. 
3
J H(3), H(6), H(15), 
H(17) to C(2); H(5), H(6), H(15), H(21) to C(3); H(3), H(21) to C(5); H(5), H(9), H(14) 
to C(7); H(3), H(6), H(10), H(12) to C(8); H(11) to C(9); H(12) to C(10); H(9) to C(11); 
H(10) to C(12); H(9), H(11) to C(13); H(3), H(17), H(19), H(21) to C(15); H(14) to 
C(16); H(15) to C(17); H(20) to C(18); H(18) to C(20); H(3), H(5), H(15), H(19) to 
C(21); H(17) to C(22); NH to C(23); H(17) to CONH2.    
 
Leuconicine G (8): light yellowish oil; []D 265 (c 0.06, CHCl3); UV (EtOH) max nm 







C NMR data, see Tables 2.5 and 2.6, respectively; EIMS m/z 376 [M O] 
(100), 361 (6), 347 (17), 322 (10), 292 (36), 260 (42), 246 (58), 232 (18), 204 (27), 190 
(19), 167 (7), 151 (4), 123 (53), 94 (13), 69 (9), 41 (6); ESIMS m/z 393 [MH]

; 
HRESIMS m/z 393.1815 (calcd for C23H24N2O4 + H, 393.1809). HMBC: 
2
J H(6) to 
C(5); H(6) to C(7); H(15) to C(16); H(19) to C(18); H(18) to C(19); H(19), H(21) to 
C(20); H(20) to C(21); H(17) to C(23). 
3
J H(3), H(6), H(15), H(17) to C(2); H(5), H(6), 
H(15), H(21) to C(3); H(3), H(21) to C(5); H(5), H(9), H(14) to C(7); H(3), H(6), 
H(10), H(12) to C(8); H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); 
H(9), H(11) to C(13); H(3), H(17), H(19), H(21) to C(15); H(14) to C(16); H(15) to 
C(17); H(20) to C(18); H(18) to C(20); H(3), H(5), H(15), H(19) to C(21); H(17) to 
C(22); CO2Me, H(17) to CO2Me. 
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Leuconodine A (9): light yellowish oil and subsequently colorless needles from EtOH; 
mp 135138 oC; []D 20 (c 0.26, CHCl3); UV (EtOH) max (log ) 242 (3.90), 277 




H NMR and 
13
C NMR data, see Tables 
2.7 and 2.8; EIMS m/z: 326 [M]

 (100), 298 (46), 283 (34), 252 (18), 237 (3), 212 (11), 
171 (9), 145 (13), 117 (7); HREIMS [M]
+
 326.1633 (calcd for C19H22N2O3, 326.1630); 
ESIMS m/z 327 [MH]

; HRESIMS m/z 327.1699 (calcd for C19H22N2O3 + H, 
327.1703). HMBC: 
2
J H(16) to C(2); H(14) to C(3); H(7) to C(6); H(6) to C(7); H(7) to 
C(8); H(12) to C(13); H(14) to C(15); H(17) to C(16); H(16) to C(17); H(19) to C(18); 
H(15), H(19) to C(20). 
3
J H(17) to C(2); H(7) to C(5); H(9) to C(7); H(10), H(12) to 
C(8); H(7), H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); H(7), H(9), 
H(11) to C(13); H(3), H(17), H(19) to C(15); H(15), H(19) to C(17); H(15), H(17) to 
C(19); H(7), H(16), H(18) to C(20); H(3), H(6), H(15), H(17), H(19) to C(21).  
 
Crystallographic data of 9: colorless needles, C19H22N2O3.C2H6O, Mr = 372.45, 
orthorhombic, space group P212121, a = 7.3486(4) Å, b = 15.0738(7) Å, c = 16.6740(8) 
Å;  =  =  = 90o, V = 1847.0(16) Å3, T = 100 K, Z = 4, Dcalc = 1.339 gcm
3
, crystal 
size 0.04 x 0.17 x 0.63 mm
3
, F(000) = 800. The final R1 value is 0.0512 (wR2 = 0.1263) 
for 1975 reflections [I > 2(I)].  
 
Leuconodine B (scholarisine G) (10): light yellowish amorphous solid and 
subsequently colourless block crystals from CH2Cl2MeOH; mp 198200 
o
C; []D 48 





H NMR and 
13
C NMR data, see Tables 2.7 and 2.8, respectively; 
EIMS m/z 326 [M]
+
 (69), 270 (100), 255 (68), 181 (45), 152 (30), 55 (32); HREIMS m/z 
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326.1635 (calcd for C19H22N2O3, 326.1630). HMBC: 
2
J H(16) to C(2); H(6) to C(5); 
H(6) to C(7); H(17) to C(16); H(16) to C(17); H(19) to C(18); H(18) to C(19); H(17), 
H(19) to C(20). 
3
J H(17) to C(2); H(9) to C(7); H(6), H(10), H(12) to C(8); H(11) to 
C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); H(9), H(11) to C(13); H(17), 
H(19) to C(15); H(15), H(19) to C(17); H(16), H(18) to C(20); H(6), H(15), H(17) to 
C(21).  
 
Crystallographic data of 10: colorless block crystals, C19H22N2O3.CH4O, Mr = 358.43, 
orthorhombic, space group P212121, a = 8.0382(5) Å, b = 14.5281(9) Å, c = 15.2187(8) 
Å;  =  =  = 90o, V = 1777.24(18) Å3, T = 100 K, Z = 4, Dcalc = 1.340 gcm
3
, crystal 
size 0.04 x 0.15 x 0.17 mm
3
, F(000) = 768. The final R1 value is 0.0491 (wR2 = 0.1091) 
for 1540 reflections [I > 2(I)].  
 
Leuconodine C (11): light yellowish oil; []D 71 (c 0.24, CHCl3); UV (EtOH) max 




H NMR and 
13
C 
NMR data, see Tables 2.7 and 2.8, respectively; ESIMS m/z 327 [MH]

; HRESIMS m/z 
327.1710 (calcd for C19H22N2O3 + H, 327.1703). HMBC: 
2
J H(16) to C(2); H(6) to 
C(5); H(6) to C(7); H(7), H(9) to C(8); H(9) to C(10); H(12) to C(13); H(17) to C(16); 
H(19) to C(18); H(18) to C(19); H(15), H(17), H(19) to C(20). 
3
J H(17) to C(2); H(3), 
H(7) to C(5); H(9) to C(7); H(6), H(12) to C(8); H(11) to C(9); H(12) to C(10); H(9) to 
C(11); H(7) to C(13); H(17), H(19) to C(15); H(15), H(19) to C(17); H(16), H(18) to 
C(20); H(6), H(15), H(17), H(19) to C(21). NOESY: H(6)/H(9); H(7)/H(19); 
H(9)/H(6); H(11)/H(12); H(12)/H(11); H(19)/H(7).  
 365 
Leuconodine D (12): light yellowish oil and subsequently light yellowish crystals; mp 
100105 oC; []D 37 (c 0.10, CHCl3); UV (EtOH) max (log ) 210 (3.86), 253 (3.68), 




H NMR and 
13
C NMR data, 
see Table 2.9; EIMS m/z 296 [M]
+
 (15), 268 (45), 253 (100), 151 (15), 136 (7); 
HREIMS m/z 296.1884 (calcd for C19H24N2O, 296.1889). HMBC: 
2
J H(16) to C(2); 
H(14) to C(3); H(7) to C(6); H(6) to C(7); H(7) to C(8); H(3) to C(14); H(17) to C(16); 
H(16) to C(17); H(19) to C(18); H(18) to C(19); H(17), H(19) to C(20). 
3
J H(17) to 
C(2); H(5) to C(3); H(3), H(7) to C(5); H(5), H(9) to C(7); H(6) to C(8); H(7), H(11) to 
C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); H(7), H(9), H(11) to C(13); H(17) 
to C(15); H(15), H(19) to C(17); H(17) to C(19); H(16), H(18) to C(20); H(5), H(6), 
H(17), H(19) to C(21).  
 
Leuconodine E (13): light yellowish amorphous solid and subsequently colorless 
crystals from CH2Cl2MeOH; mp >230 
o
C; []D 13 (c 0.03, CHCl3); UV (EtOH) max 





H NMR and 
13
C NMR data, see Table 2.9; EIMS m/z 312 [M]
+
 (52), 284 (53), 
269 (100), 255 (11), 228 (37), 213 (24), 207 (19), 181 (23), 132 (44); HREIMS m/z 
312.1835 (calcd for C19H24N2O2, 312.1838). HMBC: 
2
J H(16) to C(2); H(5) to C(6); 
H(6) to C(7); H(3) to C(14); H(12) to C(13); H(14) to C(15); H(16) to C(17); H(19) to 
C(18); H(18) to C(19); H(15), H(19) to C(20). 
3
J H(17) to C(2); H(3) to C(5); H(5), 
H(9) to C(7); H(6), H(10), H(12) to C(8); H(11) to C(9); H(12) to C(10); H(9) to C(11); 
H(10) to C(12); H(9), H(11) to C(13); H(15), H(19) to C(17); H(14), H(18) to C(20); 
H(3), H(5), H(6), H(15), H(17) to C(21).  
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Crystallographic data of 13: colorless flake crystals, C19H24N2O2, Mr = 312.40, 
orthorhombic, space group P212121, a = 8.1326(7) Å, b = 10.6116(9) Å, c = 18.2366(17) 
Å;  =  =  = 90o, V = 1573.80(2) Å3, T = 100 K, Z = 4, Dcalc = 1.318 gcm
3
, crystal 
size 0.03 x 0.17 x 0.80 mm
3
, F(000) = 672. The final R1 value is 0.0403 (wR2 = 0.0966) 
for 1051 reflections [I > 2(I)].  
 
Leuconoxine (14): colorless oil; []D 71 (c 0.08, CHCl3); UV (EtOH) max (log ) 205 




H NMR and 
13
C 





Leuconodine F (6-oxoleuconoxine) (15): colorless oil; []D 75 (c 0.03, CHCl3); UV 





H NMR and 
13





Mersicarpine (16): colorless oil; []D 18 (c 0.28, CHCl3); UV (EtOH) λmax (log ε) 204 





H NMR and 
13
C NMR data, see Tables 2.12 and 2.13, respectively; 
EIMS m/z 284 (M
+
, C17H20N2O2).  
 
 367 
Arboloscine (17): colorless oil; []D +137 (c 0.15, CHCl3); UV (EtOH) max (log ) 210 




H NMR and 
13
C NMR data, see Table 2.14; LSIMS m/z 341 (MH
+
, C20H24N2O3 + H). 
 
3,14-Dehydroleuconolam (18): light yellowish oil; []D 385 (c 0.17, CHCl3); UV 





H NMR and 
13
C NMR data, see Table 2.10; EIMS m/z 324 [M]
+
 (100), 306 (9), 
295 (18), 277 (28), 240 (55), 212 (29), 184 (53), 145 (60), 117 (54), 95 (27); HREIMS 
m/z 324.1473 (calcd for C19H20N2O3, 324.1474). HMBC: 
2
J NH, H(16) to C(2); H(14), 
H(15) to C(3); H(6) to C(5); H(6) to C(7); H(15) to C(14); H(16) to C(17); H(19) to 
C(18); H(18) to C(19); H(15), H(19) to C(20); OH to C(21). 
3
J H(17) to C(2); H(9) to 
C(7); NH, H(6), H(10), H(12) to C(8); H(11) to C(9); H(12) to C(10); H(9) to C(11); 
H(10) to C(12); H(9), H(11) to C(13); H(3), H(19) to C(15); NH to C(16); H(15), H(19) 
to C(17); OH, H(14), H(16), H(18) to C(20); H(3), H(6), H(15), H(17), H(19) to C(21).  
 
Leuconolam (19): light yellowish oil; []D 476 (c 0.23, CHCl3); UV (EtOH) max (log 











O-Methylleuconolam (20): light yellowish oil; []D 242 (c 0.06, CHCl3); UV (EtOH) 







C NMR data, see Table 2.15; ESIMS m/z 341 (MH
+
, C20H24N2O3 + H). 
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Epi-leuconolam (21) or 6,7-dehydroleuconoxine (21a): light yellowish oil; []D 271 
(c 0.11, CHCl3); UV (EtOH) max (log ) 202 (4.33), 252 (4.31), 349 (3.68) nm; IR (dry 




H NMR and 
13
C NMR data, see Table 2.15; 
ESIMS m/z 309 (MH
+
, C19H20N2O2 + H). 
 
Nor-rhazinicine (22): light yellowish oil and subsequently light yellowish needles from 
CH2Cl2-hexanes; mp 190192 
o
C; []D 285 (c 0.13, CHCl3); UV (EtOH) max (log ) 




H NMR and 
13
C 
NMR data, see Table 2.11; EIMS m/z 294 [M]
+
 (82), 265 (60), 237 (100), 223 (15), 209 
(24), 195 (29), 182 (25), 167 (20), 154 (15); HREIMS m/z 294.1366 (calcd for 
C18H18N2O2, 294.1368). HMBC: 
2
J H(16) to C(2); H(6) to C(5); H(5) to C(6); H(6) to 
C(7); H(10), H(12) to C(11); H(15) to C(14); H(17) to C(16); H(16) to C(17); H(19) to 
C(18); H(18) to C(19); H(15), H(17), H(19) to C(20). 
3
J H(17) to C(2); H(5), H(9) to 
C(7); H(12) to C(8); H(9), H(11) to C(13); H(19) to C(15); H(15), H(19) to C(17); 
H(15) to C(19); H(18) to C(20); H(5), H(6), H(15), H(17), H(19) to C(21).  
 
Crystallographic data of 22: light yellowish needles, C18H18N2O2, Mr = 294.34, 
monoclinic, space group P21, a = 13.646(3) Å, b = 8.3619(17) Å, c = 14.658(3) Å;  = 
=  = 90o,  = 115.775(11)o, V = 1506.2(5) Å3, T = 100 K, Z = 4, Dcalc = 1.298 gcm
3
, 
crystal size 0.52 x 0.32 x 0.05 mm
3
, F(000) = 624. The final R1 value is 0.1262 (wR2 = 




5,21-Dihydrorhazinilam N-oxide (23): light yellowish oil; []D 370 (c 0.07, CHCl3); 




H NMR and 
13
C NMR data, see Table 2.11; EIMS m/z 294 [M H2O]
+
 (13), 265 
(100), 237 (65), 222 (14), 209 (50), 195 (7), 167 (6), 130 (5); ESIMS m/z 313 [MH]

; 
HRESIMS m/z 313.1912 (calcd for C19H24N2O2 + H, 313.1911). HMBC: 
2
J NH, H(16) 
to C(2); H(6) to C(5); H(5) to C(6); H(6), H(21) to C(7); NH, H(12) to C(13); H(17) to 
C(16); H(19) to C(18); H(18) to C(19); H(15), H(17), H(21) to C(20). 
3
J H(17) to C(2); 
H(5), H(15) to C(3); H(3), H(21) to C(5); H(21) to C(6); H(5) to C(7); NH, H(6), H(10), 
H(12) to C(8); H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); H(9), 
H(11) to C(13); H(3), H(19) to C(15); NH to C(16); H(19), H(21) to C(17); H(15), 
H(17), H(21) to C(19); H(16), H(18) to C(20); H(3), H(5), H(6), H(19) to C(21). NOE: 
H(9)/H(21); H(18)/H(19); H(19)/H(18), H(21); H(21)/H(3 H(9), H(19).  
 
5,21-Dihydrorhazinilam (24): light yellowish oil; []D 296 (c 0.19, CHCl3); UV 
(EtOH) max (log ) 213 (4.31), 227 (4.21), 261 (3.50) nm; 
1
H NMR and 
13
C NMR data, 




Rhazinilam (25): colorless prisms (CHCl3-MeOH); mp 204206 
o
C; []D 396 (c 0.12, 
CHCl3); UV (EtOH) max (log ) 205 (4.17), 222 (3.86), 270 (3.10) nm; IR (dry film) 




H NMR and 
13






Rhazinal (26): light yellowish oil; []D 187 (c 0.19, CHCl3); UV (EtOH) max (log ) 
203 (4.55), 234 (3.80), 302 (3.96) nm; 
1
H NMR and 
13
C NMR data, see Table 2.17; 




Rhazinicine (27): light yellowish oil; []D 208 (c 0.13, CHCl3); UV (EtOH) max (log 











()-Eburnamaline (28): light yellowish oil; []D 49 (c 0.21, CHCl3); UV (EtOH) max 




H NMR and 
13
C NMR 
data, see Table 2.18; EIMS m/z 312 [M]

 (100), 294 (23), 283 (20), 265 (76), 242 (26), 
224 (38), 208 (18), 196 (12), 180 (8), 144 (5); HREIMS m/z 312.1827 (calcd for 
C19H24N2O2, 312.1838); ESIMS m/z 313 [MH]

; HRESIMS m/z 313.1926 (calcd for 
C19H24N2O2 + H, 313.1911). HMBC: 
2
J H(21) to C(2); H(6) to C(5); H(6) to C(7); 
H(19) to C(18); H(18) to C(19); H(19), H(21) to C(20). 
3
J H(6) to C(2); H(5), H(21) to 
C(3); H(5), H(9), H(21) to C(7); H(10), H(12) to C(8); H(11) to C(9); H(12) to C(10); 
H(9) to C(11); H(10) to C(12); H(9), H(11) to C(13); H(3), H(19), H(21) to C(15); 
H(19) to C(17); H(18) to C(20); H(3), H(5), H(17) to C(21). NOE: H(5)/H(21); 
H(5)/H(21); H(11)/H(12); H(12)/H(11), H(16); H(15)/H(16); H(15)/H(17); 
H(16)/H(12), H(15), H(17); H(17)/H(15), H(16), H(18); H(18)/H(17); H(19)/H(21); 
H(21)/H(5), H(5), H(19). 
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()-Eburnamonine (29): colorless oil; []D 82 (c 0.05, CHCl3); UV (EtOH) λmax (log 







C NMR data, see Tables 2.19 and 2.20, respectively; ESIMS m/z 295 (MH
+
, 
C19H22N2O + H). 
  
()-Eburnamenine (30): colorless oil; []D 216 (c 0.07, CHCl3); UV (EtOH) λmax (log 
ε) 223 (3.95), 259 (3.98), 303 (3.42), 310 (3.44), 362 (2.48) nm; 1H NMR and 13C NMR 




O-Methylisoeburnamine (31): light yellowish oil; []D 36 (c 0.12, CHCl3); UV 
(EtOH) λmax (log ε) 226 (4.34), 275 (3.76), 289 (3.68) nm; 
1
H NMR and 
13
C NMR data, 




O-Methyleburnamine (32): light yellowish oil; []D 75 (c 0.64, CHCl3); UV (EtOH) 
λmax (log ε) 229 (4.37), 280 (3.79), 290 (3.70) nm; 
1
H NMR and 
13
C NMR data, see 




()-Isoeburnamine (33): light yellow oil; []D 93 (c 0.12, CHCl3); UV (EtOH) λmax 




H NMR and 
13
C NMR data, see Tables 2.22 and 2.23, respectively; ESIMS m/z 297 
(MH
+
, C19H24N2O + H). 
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()-Eburnamine (34): colorless oil; []D 52 (c 0.08, CHCl3); UV (EtOH) λmax (log ε) 
205 (4.13), 229 (4.30), 282 (3.79), 292 (3.67) nm; 
1
H NMR and 
13
C NMR data, see 




()-Vincamine (35): light yellowish oil; []D 0 (c 0.09, CHCl3); UV (EtOH) λmax (log 
ε) 232 (3.85), 295 (3.75), 326 (3.91) nm; 1H NMR and 13C NMR data, see Tables 2.22 
and 2.23, respectively; ESIMS m/z 355 (MH
+
, C21H26N2O3 + H). 
 
Leucophyllidine (36): pale yellowish crystals from Et2OEtOAc; mp 215217 

C; [α]D 
138 (c 0.18, CHCl3); UV (EtOH) max nm (log ) 230 (4.81), 288 (3.92), 354 (3.97) 




H NMR and 
13
C NMR data, see Table 2.24; 
EIMS m/z 572 [M]

 (100), 543 (13), 502 (28), 473 (4), 400 (2), 359 (1), 307 (19), 271 
(11), 252 (72), 208 (9), 156 (3), 111 (4); HREIMS m/z 572.3510 (calcd for C38H44N4O, 
572.3515). HMBC: 
2
J H(5) to C(6); H(6) to C(7); H(12) to C(11); H(12) to C(13); 
H(17) to C(16); H(19) to C(18); H(18) to C(19); H(17), H(19) to C(20); H(21') to C(2'); 
H(6') to C(5'); H(6') to C(7'); H(9') to C(8'); H(3') to C(14'); H(19') to C(18'); H(18') to 
C(19'); H(17'), H(19'), H(21') to C(20'). 
3
J H(3), H(17), H(21) to C(2); H(21) to C(3); 
H(5), H(9) to C(7); H(12) to C(8); H(12) to C(10); H(9) to C(11); H(9) to C(13); H(16), 
H(19), H(21) to C(15); H(21) to C(17); H(18) to C(20); H(19) to C(21); H(6') to C(2'); 
H(5'), H(15'), H(21') to C(3'); H(5'), H(9'), H(21') to C(7'); H(10'), H(12') to C(8'); 
H(11') to C(9'); H(12') to C(10'); H(9') to C(11'); H(10') to C(12'); H(9'), H(11') to 
C(13'); H(3'), H(21') to C(15'); H(9) to C(16'); H(19') to C(17'); H(21') to C(19'); H(18') 
to C(20'); H(5'), H(19') to C(21'). NOE: H(5)/H(6), H(16'); H(16')/H(5); H(18')/H(19'). 
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Crystallographic data of 36: a single crystal of 36 was obtained from Et2OEtOAc; 
C38H44N4O, Mr = 572.35, monoclinic, space group P21, a = 12.7151(3) Å, b = 8.5294(3) 
Å, c = 17.2463(5) Å; V = 1770.50(9) Å
3
, Z = 2, Dcalc = 1.240 g cm
3
. The structure was 
solved by direct methods and refined by the least-square method. The final R value is 
0.0489. 
 
Leuconoline (37): light yellowish oil and subsequently light yellowish crystals from 
EtOH; mp 223–224 oC; []D +142 (c 0.49, CHCl3); UV (EtOH) max (log ) 230 (4.72), 






C NMR data, see Table 
2.25; EIMS m/z 646 [M]

 (100), 615 (12), 543 (12), 463 (10), 433 (3), 393 (6), 323 (4), 
252 (45), 197 (7), 156 (4), 124 (15); HREIMS m/z 646.3510 (calcd for C40H46N4O4, 
646.3519).
 2
J NH, H(3) to C(2); H(6) to C(5); H(6) to C(7); H(11) to C(10); NH to 
C(13); H(19) to C(18); H(18) to C(19); H(21') to C(2'); H(6') to C(7'); H(9') to C(8'); 
H(10') to C(11'); H(14') to C(15'); H(18') to C(19'); H(15'), H(19'), H(21') to C(20'). 
3
J 
H(6), H(14) to C(2); H(21) to C(3); H(3), H(17), H(21) to C(5); NH, H(3), H(5) to C(7); 
NH, H(12) to C(8); H(11) to C(9); H(12), H(16') to C(10); H(11) to C(13); H(19) to 
C(15); H(18) to C(20); H(19) to C(21); CO2Me, H(17) to CO2Me; H(21') to C(3'); H(9'), 
H(21') to C(7'); H(10'), H(12') to C(8'); H(11') to C(9'); H(12') to C(10'); H(9') to C(11'); 
H(10') to C(12'); H(9'), H(11') to C(13'); H(19'), H(21') to C(15'); H(19') to C(17'); 
H(21') to C(19'); H(14'), H(18') to C(20'); H(5'), H(17'), H(19') to C(21'). NOE: 
H(11)/H(12); H(12)/NH; NH/H(3), H(12); H(10')/H(9'); H(12')/H(11'). 
 
Acetylation of leuconoline (37): to a stirred solution of 37 (9.6 mg, 0.015 mmol), 
CH2Cl2 (2 mL) and 4-(dimethylamino)pyridine (DMAP, 4.5 mg, 0.037 mmol) was 
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added dropwise acetic anhydride (7 L, 0.075 mmol), and the mixture was stirred at 
room temperature for 2 h. The mixture was quenched with 10% Na2CO3 (5 mL) and 
extracted with CH2Cl2 (3 10 mL). The combined organic layers were dried (Na2SO4), 
the solvent evaporated in vacuo, and the residue purified by preparative centrifugal TLC 
(SiO2, Et2O/hexanes 1:1) to give 7.2 mg (67%) of the diacetate derivative 37a as light 
yellowish amorphous solids; mp >224 
o
C dec; []D 113 (c 0.07, CHCl3); UV (EtOH), 





H NMR (CDCl3, 400 MHz):  0.96 (3H, t, J = 7 Hz, Me(18′)), 1.20 (1H, m, 
H(15′a)), 1.42 (1H, m, H(14′a)), 1.58 (3H, d, J = 7 Hz, H(18)), 1.61 (1H, m, H(19′a)), 
1.63 (1H, m, H(15′b)), 1.72 (3H, s, COMe), 1.83 (1H, m, H(14′b)), 1.91 (1H, m, 
H(14a)), 1.98 (3H, s, COMe), 2.14 (1H, m, H(19′b)), 2.23 (1H, m, H(17′a)), 2.46 (1H, 
m, H(3′a)), 2.50 (1H, m, H(17′b)), 2.59 (1H, m, H(3′b)), 2.62 (1H, m, H(6′a)), 2.63 (1H, 
m, H(14b)), 2.89 (1H, m, H(5)), 3.01 (1H, m, H(6′b)), 3.03 (3H, s, CO2Me), 3.14 (1H, 
m, H(6a)), 3.21 (1H, m, H(15)), 3.29 (1H, td, J = 11 and 5 Hz, H(5′a)), 3.38 (1H, dd, J = 
13.6 and 6.3 Hz, H(5′b)), 3.46 (1H, m, H(6b)), 3.54 (1H, d, J = 17 Hz, H(21a)), 3.65 
(1H, d, J = 17 Hz, H(21b)), 4.04 (1H, s, H(21′)), 4.13 (1H, d, J = 10.5 Hz, H(17a)), 4.28 
(1H, d, J = 10.5 Hz, H(17b)), 4.25 (1H, d, J = 12 Hz, H(3)), 5.39 (1H, q, J = 7 Hz, 
H(19)), 5.79 (1H, dd, J = 11 and 5.2 Hz, H(16′)), 6.42 (1H, d, J = 8 Hz, H(12′)), 6.68 
(1H, t, J = 7.6 Hz, H(11′)), 6.70 (1H, d, J = 9 Hz, H(11)), 6.93 (1H, t, J = 7.6 Hz, 
H(10′)), 7.08 (1H, d, J = 9 Hz, H(12)), 7.39 (1H, d, J = 7.6 Hz, H(9′)), 8.38 (1H, br s, 
NH); ESIMS m/z 731 [MH]

; HRESIMS m/z 731.3813 (calcd for C44H50N4O6  H, 
731.3803). 
 
Crystallographic data of 37: a single crystal of 37 was obtained from EtOH; 
C40H46N4O4, Mr = 646.81, orthorhombic, space group P212121, a = 7.0778(2) Å, b = 
 375 
13.0650(4) Å, c = 37.7977(12) Å; V = 3495.2(12) Å
3
, Z = 4, Dcalc = 1.229 g cm
3
. The 
structure was solved by direct methods and refined by the least-square method. The 
final R value is 0.0644 (Rw = 0.1387) for 3119 reflections [I > 2(I)].  
 
Leucofoline (38): light yellowish oil; []D 113 (c 0.28, CHCl3); UV (EtOH) max (log 
) 214 (4.26), 273 (3.82) nm; 1H and 13C NMR data, see Table 2.26; ESIMS m/z 557 
[MH]
+
; HRESIMS m/z 557.3642 (calcd for C38H44N4 + H, 557.3644). HMBC: 
2
J H(21) 
to C(7); H(22'a) to C(16); H(19) to C(18); H(18) to C(19); H(19), H(21) to C(20); H(6') 
to C(5'); H(21') to C(7'); H(10') to C(11'); H(20') to C(15'); H(22'a) to C(16'); H(19') to 
C(18'); H(18'), H(20') to C(19'). 
3
J H(21) to C(2); H(21) to C(5); H(5), H(9) to C(7); 
H(10), H(12), H(21) to C(8); H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) to 
C(12); H(9), H(11) to C(13); H(21) to C(19); H(18) to C(20); H(3), H(5), H(6), H(19) to 
C(21); H(22') to C(22); H(6'), H(21'), H(22') to C(2'); H(5'), H(21') to C(3'); H(21') to 
C(6'); H(9') to C(7'); H(6'), H(10'), H(12'), H(21') to C(8'); H(11') to C(9'); H(12') to 
C(10'); H(9') to C(11'); H(10') to C(12'); H(9'), H(11') to C(13'); H(18') to C(20'); H(5'), 
H(19') to C(21'). NOESY: H(9)/H(21); H(18)/H(21); H(19)/H(18), H(20); H(21)/H(9), 
H(18), H(19), H(20); H(9')/H(10'), H(21'); H(10')/H(9'); H(11')/H(12'); H(12')/H(22a), 
H(22b), H(11'); H(18')/H(20'); H(19')/H(18'), H(21'); H(20')/H(18'); H(21')/H(9'), H(19'); 
H(22'a)/H(20), H(12'); H(22'b)/H(12').  
 
Leucoridine A (39): light yellowish oil; []D 29 (c 0.26, CHCl3); UV (EtOH) λmax 
(log ε) 213 (3.89), 267 (3.52) nm; 1H NMR and 13C NMR data, see Tables 2.27 and 
2.28, respectively; ESIMS m/z 557 [MH]
+
; HRESIMS m/z 557.3643 (calcd for 
C38H44N4 + H, 557.3644). HMBC: 
2
J H(6) to C(5); H(6) to C(7); H(22) to C(16); H(19) 
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to C(18); H(18), H(20) to C(19); H(19), H(21) to C(20); H(14') to C(3'); H(6') to C(7'); 
H(15'), H(22') to C(16'); H(19') to C(18'); H(18') to C(19'); H(21') to C(20'). 
3
J H(3), 
H(22), H(22') to C(2); H(15), H(21) to C(3); H(5), H(9), H(14) to C(7); H(6), H(10), 
H(12) to C(8); H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); H(9), 
H(11) to C(13); H(3), H(19), H(21), H(22') to C(15); H(15), H(21) to C(19); H(14), 
H(18) to C(20); H(3), H(5), H(19) to C(21); H(22), H(6'), H(15'), H(22') to C(2'); H(5'), 
H(6'), H(15'), H(21') to C(3'); H(5'), H(9') to C(7'); H(3'), H(6'), H(10'), H(12') to C(8'); 
H(11') to C(9'); H(12') to C(10'); H(9') to C(11'); H(10') to C(12'); H(9'), H(11') to 
C(13'); H(3'), H(21') to C(15'); H(20') to C(18'); H(18') to C(20'); H(3') to C(21'); H(22) 
to C(22'). NOESY: H(3)/H(5), H(9), H(14R), H(14S); H(5)/H(3); H(9)/H(3), H(6); 
H(14R)/H(3); H(14S)/H(3); H(15)/H(18); H(18)/H(15), H(20); H(19)/H(22b); 
H(20)/H(18); H(22a)/H(12'); H(22b)/H(19); H(3')/H(9'); H(9')/H(3'); H(12')/H(22a); 
H(15')/H(18'); H(18')/H(15'). NOE: H(3)/H(5), H(9), H(14R), H(14S); H(14S)/H(14R); 
H(21)/H(21); H(22a)/H(22b), H(12'); H(3')/H(9'), H(21'); H(5')/H(5'); 
H(12')/H(22a), H(11'); H(14'S)/H(14'R), H(21'); H(15')/H(14'R), H(18'), H(20'), 
H(22'b); H(22'a)/H(22'b); H(22'b)/H(22'a). 
 
Leucoridine B (40): light yellowish oil; []D 56 (c 0.29, CHCl3); UV (EtOH) λmax 
(log ε) 215 (4.45), 268 (4.06), 329 (3.50) nm; 1H NMR and 13C NMR data, see Tables 
2.27 and 2.28, respectively; ESIMS m/z 555 [MH]

; HRESIMS m/z 555.3487 (calcd for 
C38H42N4 + H, 555.3488). HMBC: 
2
J H(6) to C(5); H(6) to C(7); H(22) to C(16); H(19) 
to C(18); H(18) to C(19); H(19), H(21) to C(20); H(14') to C(3'); H(6') to C(7'); H(15'), 
H(22') to C(16'); H(19') to C(18'); H(18') to C(19'); H(21') to C(20'). 
3
J H(3), H(22), 
H(22') to C(2); H(5), H(15), H(21) to C(3); H(21) to C(5); H(5), H(9), H(14) to C(7); 
H(6), H(10), H(12) to C(8); H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) to 
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C(12); H(9), H(11) to C(13); H(3), H(19), H(21), H(22') to C(15); H(15), H(21) to 
C(19); H(18) to C(20); H(3), H(5), H(19) to C(21); H(22), H(6'), H(15'), H(22') to C(2'); 
H(5'), H(6'), H(15'), H(21') to C(3'); H(5'), H(9') to C(7'); H(3'), H(6'), H(10'), H(12') to 
C(8'); H(11') to C(9'); H(12') to C(10'); H(9') to C(11'); H(10') to C(12'); H(9'), H(11') to 
C(13'); H(3'), H(21') to C(15'); H(18') to C(20'); H(3') to C(21'); H(22) to C(22'). 
NOESY: H(5)/H(21); H(21)/H(5); H(22a)/H(22b); H(22b)/H(22a); H(3')/H(9'); 
H(9')/H(3').  
 
Leucoridine C (41): light yellowish oil; []D 61 (c 0.26, CHCl3); UV (EtOH) λmax 




H NMR and 
13
C NMR data, see Tables 2.27 and 2.28, respectively; ESIMS m/z 575 
[MH]

; HRESIMS m/z 575.3751 (calcd for C38H46N4O + H, 575.3750). HMBC: 
2
J H(6) 
to C(5); H(6) to C(7); H(22) to C(16); H(18), H(20) to C(19); H(21) to C(20); H(14') to 
C(3'); H(6') to C(7'); H(15'), H(22') to C(16'); H(19') to C(18'); H(18') to C(19'); H(19'), 
H(21') to C(20'). 
3
J H(3), H(22), H(22') to C(2); H(15), H(21) to C(3); H(5), H(9), 
H(14) to C(7); NH, H(6), H(10), H(12) to C(8); H(11) to C(9); H(12) to C(10); H(9) to 
C(11); NH, H(10) to C(12); H(9), H(11) to C(13); H(3), H(21), H(22') to C(15); H(15), 
H(21) to C(19); H(18) to C(20); H(3), H(5) to C(21); H(22), H(6'), H(15'), H(22') to 
C(2'); H(5'), H(6'), H(15'), H(21') to C(3'); H(5'), H(9') to C(7'); H(3'), H(6'), H(10'), 
H(12') to C(8'); H(11') to C(9'); H(12') to C(10'); H(9') to C(11'); H(10') to C(12'); H(9'), 
H(11') to C(13'); H(3'), H(19'), H(21') to C(15'); H(20') to C(18'); H(18') to C(20'); 
H(3'), H(19') to C(21'); H(22) to C(22'). NOESY: H(6)/H(6); H(6)/H(6); 
H(14R)/H(14S), H(15), H(22'b); H(14S)/H(14R); H(15)/H(14R); H(21)/H(21); 
H(21)/H(21); H(22a)/H(22b); H(22b)/H(22a); H(18')/H(19'); H(19')/H(18'); 
H(22'a)/H(22'b); H(22'b)/H(22'a). 
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Leucoridine D (42): light yellowish oil; []D 6 (c 0.40, CHCl3); UV (EtOH) λmax (log 




H NMR and 
13
C 
NMR data, see Tables 2.27 and 2.28, respectively; ESIMS m/z 559 [MH]
+
; HRESIMS 
m/z 559.3794 (calcd for C38H46N4 + H, 559.3795). HMBC: 
2
J H(16) to C(2); H(6) to 
C(7); H(16) to C(15); H(22) to C(16); H(19) to C(18); H(18) to C(19); H(19) to C(20); 
H(2'), H(6') to C(7'); H(10') to C(11'); H(15'), H(22') to C(16'); H(19') to C(18'); H(18') 
to C(19'); H(15'), H(19'), H(21') to C(20'). 
3
J H(3), H(6), H(22) to C(2); H(5), H(6) to 
C(3); H(5), H(9), H(14) to C(7); H(3), H(6), H(10), H(12) to C(8); H(11) to C(9); H(12) 
to C(10); H(9) to C(11); H(10) to C(12); H(9), H(11) to C(13); H(3), H(21) to C(15); 
H(21) to C(19); H(18) to C(20); H(3), H(5), (19) to C(21); H(11') to C(22); H(6'), 
H(22') to C(2'); H(2') to C(3'); H(21') to C(5'); H(2') to C(6'); NH', H(5'), H(9') to C(7'); 
NH', H(3'), H(6'), H(10') to C(8'); H(11') to C(9'); H(22), H(9') to C(11'); H(16), H(10') 
to C(12'); H(22), H(9'), H(11') to C(13'); H(2'), H(3'), H(21'), H(22') to C(15'); H(15') to 
C(18'); H(14'), H(18') to C(20'); H(3'), H(5'), H(19') to C(21'); H(2'), H(15') to C(22'). 
NOESY: H(3)/H(9), H(14R), H(14S); H(9)/H(3); H(12)/H(22'a); H(14R)/H(3); 
H(14S)/H(3); H(16)/H(21); H(18)/H(21); H(21)/H(18); H(21)/H(16); H(22a)/NH'; 
H(2')/NH', H(6'), H(22'a); H(3')/H(9'); H(6')/H(9'); H(6')/H(2'); H(9')/H(3'), H(6'); 
H(15')/H(18'), H(22'b); H(18')/H(15'); H(19')/H(22'b); H(22'a)/H(2'); H(22'b)/H(15'), 
H(18'), H(19'); NH'/H(22a), H(2'). NOE: H(3)/H(9), H(14R), H(14S), H(21); 
H(6)/H(6); H(12)/H(22'a); H(15)/H(14R), H(14S), H(18), H(20), H(22b); 
H(21)/H(16), H(21); H(22a)/H(22b); H(22b)/H(15), H(16), H(22a); H(2')/NH', 
H(6'), H(22'a); H(9')/H(3'); H(10')/H(9'), H(11'); H(14'S)/H(14'R); H(21')/H(21'); 
H(22'a)/H(12), H(2'), H(22'b); H(22'b)/H(15'), H(22'a); NH'/H(2').   
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Tetrahydroalstonine (43): colorless oil; []D 53 (c 0.10, CHCl3); UV (EtOH) max 





H NMR and 
13
C NMR data, see Tables 2.29 and 2.30, respectively; ESIMS m/z 
353 (MH
+
, C21H24N2O3 + H). 
 
17(S)-Ajmalicinial (44) and 17(R)-Ajmalicinial (45): light yellowish oil; IR (dry film) 




H NMR and 
13
C NMR data, see Tables 2.29 and 2.30, 
respectively; ESIMS m/z 313 (MH
+
, C19H24N2O2 + H). 
 
Akuammidine (46): colorless crystals (CHCl3-MeOH); mp 250252 
o
C; []D +25 (c 
0.10, CHCl3); UV (EtOH) max (log ) 227 (4.18), 282 (3.51), 291 (3.39) nm; IR (dry 




H NMR and 
13
C NMR data, see Tables 2.31 and 2.32, 
respectively; ESIMS m/z 353 (MH
+
, C21H24N2O3 + H). 
 
16(R)-19,20-E-Isositsirikine (47): light yellowish oil; []D 21 (c 0.05, CHCl3); UV 
(EtOH) max (log ) 225 (4.27), 286 (3.96), 295 (3.65) nm; 
1
H NMR and 
13
C NMR data, 
see Tables 2.31 and 2.32, respectively; ESIMS m/z 355 (MH
+
, C21H26N2O3 + H). 
 
16(S)-19,20-E-Isositsirikine (48): light yellowish oil; []D 77 (c 0.10, CHCl3); UV 
(EtOH) max (log ) 225 (4.51), 282 (3.88), 318 (3.42) nm; 
1
H NMR and 
13
C NMR data, 
see Tables 2.31 and 2.32, respectively; ESIMS m/z 355 (MH
+
, C21H26N2O3 + H). 
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Z-Geissoschizol (49): light yellowish oil; []D 42 (c 0.06, CHCl3); UV (EtOH) max 







C NMR data, see Table 2.33; ESIMS m/z 297 (MH
+
, C19H24N2O + H). 
 
Fluorocarpamine (50): light yellowish oil; []D +243 (c 1.64, CHCl3); UV (EtOH) 




H NMR and 
13
C NMR data, see Table 2.33; ESIMS m/z 339 (MH
+
, C20H22N2O3 + H). 
 
Pleiocarpamine (51): colorless oil; []D +87 (c 0.08, CHCl3); UV (EtOH) max (log ) 




H NMR and 
13
C NMR data, 
see Table 2.34; ESIMS m/z 323 (MH
+
, C20H22N2O2 + H). 
 
16-Hydroxymethylpleiocarpamine (52): light yellowish oil; []D +102 (c 0.21, 





H NMR and 
13
C NMR data, see Table 2.34; ESIMS m/z 353 (MH
+
, 
C21H24N2O3 + H). 
 
()-Isovallesiachotamine (53): light yellowish oil; []D 63 (c 0.25, CHCl3); UV 





H NMR and 
13






()-Isovallesiachotamine (53) and ()-Vallesiachotamine (54): light yellowish oil; IR 




H NMR and 
13
C NMR data, see Table 2.35; 




Norfluorocurarine (55): colorless crystals (acetone); mp 181183 oC; []D 900 (c 
0.32, CHCl3); UV (EtOH) max (log ) 232 (4.27), 296 (3.86), 364 (4.33) nm; IR (dry 




H NMR and 
13





12-Hydroxynorfluorocurarine (56): light yellowish oil; []D 645 (c 0.06, CHCl3); 
UV (EtOH) max (log ) 215 (4.09), 236 (3.86), 292 (3.19), 379 (3.72) nm; IR (dry film) 




H NMR and 
13
C NMR data, see Table 2.36; ESIMS m/z 309 
(MH
+
, C19H20N2O2 + H). 
 
Tubotaiwine (57): light yellow oil; []D 609 (c 0.19, CHCl3); UV (EtOH) max (log ) 




H NMR and 
13
C NMR data, see Tables 2.37 and 2.38, respectively; ESIMS m/z 325 (MH
+
, 
C20H24N2O2  H). 
 
Tubotaiwine N-oxide (58): light yellowish oil; []D 360 (c 0.04, CHCl3); UV (EtOH) 






H NMR and 
13
C NMR data, see Tables 2.37 and 2.38, respectively; ESIMS 
m/z 341 (MH
+
, C20H24N2O3  H). 
 
N(4)-Chloromethyltubotaiwine chloride (59): light yellowish oil; []D 323 (c 0.08, 
CHCl3); UV (EtOH) max (log ) 229 (3.89), 293 (3.75), 329 (3.84) nm; IR (dry film) 




H NMR and 
13
C NMR data, see Tables 2.37 and 2.38, 




); ESIMS m/z 373 [M]

; HRESIMS 
m/z 373.1677 (calcd for C21H26ClN2O2
+
, 373.1683).  
 
Venoterpine (60): light yellowish oil; []D 2 (c 0.11, CHCl3); UV (EtOH) max (log ) 







data, see Table 2.39; ESIMS m/z 150 (MH
+
, C9H11NO  H). 
 
Syringaresinol (61): colourless oil; []D 9 (c 0.07, CHCl3); UV (EtOH) max (log ) 











Alkaloids from K. pauciflora 
Compound 62: yellowish oil; []D 72 (c 0.87, CHCl3); UV (EtOH) λmax (log ε) 246 







C NMR data, see Table 2.41; ESIMS m/z 355 [MH]
+
; HRESIMS m/z 355.2021 
(calcd for C21H26N2O3 + H, 355.2016). HMBC: 
2
J H(16) to C(2); H(6) to C(7); H(3) to 
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C(14); H(17) to C(16); H(18) to C(19); H(23) to C(22); H(22) to C(23). 
3
J H(17) to 
C(2); H(22) to C(5); H(6), H(10) to C(8); H(11) to C(9); H(12) to C(10); H(9) to C(11); 
H(10) to C(12); H(9), H(11) to C(13); H(3), H(17), H(19) to C(15); H(19) to C(17); 
H(18) to C(20); H(3), H(6), H(15), H(17), H(19) to C(21). NOE: H(6)/H(9); H(9)/H(6), 
H(10); H(10)/H(9), H(11); H(11)/H(10), H(12); H(12)/H(11); H(18)/H(19); 
H(19)/H(18); H(22)/H(23); H(23)/H(22). 
 
Compound 63: light yellowish oil; []D 5 (c 0.10, CHCl3); UV (EtOH) max (log ) 




H NMR and 
13
C 
NMR data, see Table 2.42; ESIMS m/z 295 [MH]
+
; HRESIMS m/z 295.1811 (calcd for 
C19H22N2O + H, 295.1805). HMBC: 
2
J H(21) to C(2); H(6) to C(5); H(5) to C(6); H(6) 
to C(7); H(15) to C(14); H(14) to C(15); H(18) to C(19); H(21) to C(20). 
3
J H(6), H(16) 
to C(2); H(15) to C(3); H(3), H(21) to C(5); H(5), H(21) to C(7); H(10), H(12) to C(8); 
H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); H(9), H(11) to C(13); 
H(3), H(19) to C(15); H(19) to C(16); H(21) to C(17); H(16), H(17), H(21) to C(19); 
H(18) to C(20); H(3), H(5), H(17), H(19) to C(21). NOESY: H(9)/H(10); H(10)/H(9); 
H(12)/H(16); H(15)/H(19); H(15)/H(19); H(16)/H(12), H(17); H(17)/H(16); 
H(18)/H(19), H(21); H(19)/H(15), H(15), H(18); H(21)/H(18). NOE: H(16)/H(9), 
H(17), H(17); H(18)/H(19), H(21); H(19)/H(15), H(15), H(17), H(18); 
H(21)/H(18). 
 
Compound 64: light yellowish oil and subsequently light yellowish crystals from 
CH2Cl2MeOH; mp 190–192 
o
C; []D 381 (c 0.16, CHCl3); UV (EtOH) max (log ) 






H NMR and 
13
C NMR data, see Table 2.42; ESIMS m/z 311 [MH]
+
; 
HRESIMS m/z 311.1756 (calcd for C19H22N2O2 + H, 311.1754). HMBC: 
2
J H(6) to 
C(2); H(6) to C(5); H(5) to C(6); H(10) to C(11); H(15) to C(14); H(14) to C(15); H(17) 
to C(16); H(16) to C(17); H(18) to C(19); H(15), H(17), H(19) to C(20). 
3
J H(5), H(16) 
to C(2); H(5), H(15) to C(3); H(21) to C(5); H(6), H(9), H(21) to C(7); H(10), H(12) to 
C(8); H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); H(9), H(11) to 
C(13); H(3), H(17), H(19) to C(15); H(15), H(21) to C(17); H(16), H(17) to C(19); 
H(14), H(16), H(18) to C(20); H(3), H(5), H(6), H(15), H(17), H(19) to C(21). NOE: 
H(3)/H(3), H(5), H(14), H(21); H(5)/H(3), H(5); H(6))/H(5); H(9)/H(10); H(10)/H(9); 
H(11)/H(12); H(12)/H(11), H(16); H(14)/H(3), H(15); H(15)/H(14), H(19); 
H(16)/H(17); H(17)/H(16), H(17), H(19); H(17)/H(16), H(17); H(18)/H(19), 
H(21); H(19)/H(15), H(17), H(18); H(21)/H(3), H(18). 
 
Larutenine (65): light yellowish oil; []D 0 (c 0.03, CHCl3); UV (EtOH) max (log ) 
207 (4.17), 228 (4.25), 275 (3.64), 292 (3.55), 356 (3.21) nm; 
1
H NMR and 
13
C NMR 




()-19-Oxoeburnamine (66): light yellowish oil; []D +83 (c 0.06, CHCl3); UV 
(EtOH) max (log ) 229 (4.00), 282 (3.39), 292 (3.25) nm; 
1
H NMR and 
13
C NMR data, 





()-19(R)-Hydroxyisoeburnamine (67): yellowish oil; []D 16 (c 0.18, CHCl3); UV 
(EtOH) max (log ) 203 (4.39), 229 (4.53), 282 (3.74), 292 (3.83) nm; 
1
H NMR and 
13
C 




()-19(R)-Hydroxyeburnamine (68): light yellowish oil; []D 111 (c 0.09, CHCl3); 
UV (EtOH) max (log ) 201 (3.86), 229 (4.02), 283 (3.42), 291 (3.31) nm; 
1
H NMR and 
13





Compound 69: light yellowish oil; []D 13 (c 0.02, CHCl3); UV (EtOH) max (log ) 





H NMR and 
13
C NMR data, see Tables 2.46 and 2.47, respectively; ESIMS m/z 
353 [MH]
+
; HRESIMS m/z 353.1863 (calcd for C21H24N2O3 + H, 353.1860). HMBC: 
2
J 
H(14) to C(3); H(6) to C(5); H(5) to C(6); NH to C(13); H(14) to C(15); H(17) to 
C(16); H(19) to C(18); H(18) to C(19); H(21) to C(20). 
3
J H(6) to C(2); H(5), H(21) to 
C(3); NH, H(9) to C(7); NH, H(6), H(10), H(12) to C(8); H(11) to C(9); H(12) to C(10); 
H(9) to C(11); H(10) to C(12); H(9), H(11) to C(13); H(17), H(19), H(21) to C(15); 
H(21) to C(19); H(18) to C(20); H(5), H(19) to C(21); CO2Me, H(17) to CO2Me. 
NOESY: H(3)/H(14), H(14), H(15), H(21); H(5)/H(5), H(6), H(21); 
H(5)/H(5), H(6), H(9); H(6)/H(5), H(6); H(6)/H(5); H(9)/H(5), H(6), 
H(10), H(14); H(10)/H(9), H(11); H(11)/H(10), H(12); H(12)/H(11); H(14)/H(3), 
H(15); H(14)/H(3), H(9), H(17a); H(15)/H(3), H(14), H(18); H(17a)/H(17b), 
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H(14); H(17b)/H(17a); H(18)/H(15), H(19); H(19)/H(18), H(21); H(21)/H(3), 
H(5), H(21H(21)/H(5), H(19), H(21).  
 
Compound 70: light yellowish oil; []D 38 (c 0.08, CHCl3); UV (EtOH) max (log ) 





H NMR and 
13
C NMR data, see Tables 2.46 and 2.47, respectively; ESIMS 
m/z 353 [MH]
+
; HRESIMS m/z 353.1866 (calcd for C21H24N2O3 + H, 353.1860). 
HMBC: 
2
J H(6) to C(5); H(5) to C(6); H(17) to C(16); H(19) to C(18); H(18) to C(19); 
H(21) to C(20). 
3
J H(6) to C(2); H(5), H(21) to C(3); H(9) to C(7); NH, H(6), H(10), 
H(12) to C(8); H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); H(9), 
H(11) to C(13); H(17), H(19), H(21) to C(15); H(21) to C(19); H(18) to C(20); H(5), 
H(19) to C(21); CO2Me, H(17) to CO2Me. NOESY: H(3)/H(14), H(14); H(9)/H(10), 
H(14); H(10)/H(9); H(11)/H(10), H(12); H(12)/H(11); H(14)/H(3); H(14)/H(3), 
H(9); H(15)/H(14), H(18); H(17a)/H(17b), H(21); H(17b)/H(17a); H(18)/H(15), 
H(19); H(19)/H(18), H(21); H(21)/H(3), H(5), H(17a), H(21H(21)/H(19), 
H(21). NOE: H(3)/H(14), H(21); H(5)/H(5; H(5)/H(5H(6) 
H(6); H(6)/H(6); H(6)/H(6), H(9); H(9)/H(6), H(10); H(12)/NH, H(11); 
H(15)/H(14), H(18); H(17a)/H(17b), H(21); H(17b)/H(17a); H(18)/H(15), H(19); 
H(19)/H(18), H(21); H(21)/H(3), H(5), H(17a), H(21H(21)/H(19), H(21); 
/H(12). 
 
Compound 71: light yellowish oil; []D 42 (c 0.41, CHCl3); UV (EtOH) max (log ) 





H NMR and 
13
C NMR data, see Tables 2.46 and 2.47, respectively; ESIMS m/z 353 
[MH]
+
; HRESIMS m/z 353.1869 (calcd for C21H24N2O3 + H, 353.1860). HMBC: 
2
J 
H(6) to C(5); H(5) to C(6); H(17) to C(16); H(19) to C(18); H(18) to C(19); H(21) to 
C(20). 
3
J H(6) to C(2); H(5), H(21) to C(3); H(9) to C(7); NH, H(6), H(10), H(12) to 
C(8); H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); H(9), H(11) to 
C(13); H(17), H(19), H(21) to C(15); H(21) to C(19); H(18) to C(20); H(5), H(19) to 
C(21); CO2Me, H(17) to CO2Me. NOESY: H(3)/H(9), H(14); H(5)/H(3), H(21); 
H(6)/H(9); H(9)/H(3), H(6), H(10); H(10)/H(9); H(11)/H(10), H(12); H(12)/H(11); 
H(14)/H(3); H(15)/H(14), H(14), H(18); H(17a)/H(17b), H(21); H(17b)/H(17a); 
H(18)/H(15), H(19); H(19)/H(18), H(21); H(21)/H(3), H(5), H(17a)H(21)/H(19). 
NOE: H(5)/H(5; H(5)/H(5; H(6)/H(6); H(9)/H(3), H(6), H(10); 
H(11)/H(10); H(12)/H(11); H(14)/H(14; H(15)/H(14), H(14), H(18); 
H(17a)/H(17b), H(21); H(17b)/H(17a); H(18)/H(15), H(19); H(19)/H(18), H(21); 
H(21)/(21H(21)/H(19), H(21). 
 
()-Catharinensine (72): light yellowish oil; []D 6 (c 0.05, CHCl3); UV (EtOH) max 





H NMR and 
13
C NMR data, see Table 2.48; ESIMS m/z 355 [MH]
+
; 
HRESIMS m/z 355.2023 (calcd for C21H26N2O3 + H, 355.2016). HMBC: 
2
J H(14) to 
C(3); H(6) to C(5); H(5) to C(6); NH to C(13); H(17) to C(16); H(19) to C(18); H(18) 
to C(19); H(21) to C(20). 
3
J H(6) to C(2); H(5), H(6), H(21) to C(3); H(9) to C(7); NH, 
H(6), H(10), H(12) to C(8); H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) to 
C(12); H(9), H(11) to C(13); H(17), H(19), H(21) to C(15); H(21) to C(19); H(18) to 
C(20); H(3), H(5) to C(21); CO2Me, H(17) to CO2Me. NOESY: H(3)/H(15), H(21); 
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H(5)/H(21); H(6)/H(9); H(9)/H(6), H(10); H(10)/H(9); H(11)/H(12); H(12)/NH, 
H(11); H(15)/H(3), H(21); H(17a)/H(17b); H(17b)/H(17a); H(18)/H(20), H(21); 
H(20)/H(18); H(21)/H(3), H(5), H(15); H(21)/H(18); NH/H(12). 
 
Tetrahydroalstonine pseudoindoxyl (73): light yellowish oil; []D 196 (c 0.16, 





H NMR and 
13
C NMR data, see Table 2.49; ESIMS m/z 369 [MH]
+
; 
HRESIMS m/z 369.1803 (calcd for C21H24N2O4 + H, 369.1809). HMBC: 
2
J H(14) to 
C(3); H(6) to C(5); H(5) to C(6); H(17) to C(16); H(18) to C(19); H(21) to C(20). 
3
J 
H(5) to C(2); H(5), H(21) to C(3); H(3), H(6), H(9) to C(7); H(10) to C(8); H(11) to 
C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); H(9), H(11) to C(13); H(17), 
H(21) to C(15); H(17) to C(19); H(18) to C(20); CO2Me, H(17) to CO2Me. NOE: 
H(3)/H(15); H(5)/H(5); H(6)/NH; H(9)/H(10); H(10)/H(9); H(11)/H(12); 
H(12)/NH, H(11); H(14)/H(15); H(14)/H(19); H(15)/H(3), H(14), H(20), H(21); 
H(18)/H(20), H(21); H(19)/H(14), H(18); H(20)/H(15), H(18), H(21), H(21); 
H(21)/H(20), H(21); H(21)/H(18), H(21); NH/H(6), H(12). 
 
()-Aspidospermidine (74): light yellowish oil; []D 19 (c 0.05, CHCl3); UV (EtOH) 







C NMR data, see Tables 2.50 and 2.51, respectively; ESIMS m/z 283 (MH
+
, 
C19H26N2 + H). 
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()-1,2-Dehydroaspidospermidine (75): light yellowish oil; []D 148 (c 0.37, 





H NMR and 
13
C NMR data, see Tables 2.50 and 2.51, respectively; ESIMS m/z 
281 (MH
+
, C19H24N2 + H). 
 
()-Quebrachamine (76): light yellowish oil; []D 180 (c 0.19, CHCl3); UV (EtOH) 




H NMR and 
13
C 
NMR data, see Tables 2.50 and 2.51, respectively; ESIMS m/z 283 (MH
+
, C19H26N2 + 
H). 
 
11,12-Dimethoxykopsinaline (77): light yellowish oil; []D 18 (c 0.11, CHCl3); UV 





H NMR and 
13
C NMR data, see Table 2.52; ESIMS m/z 415 [MH]
+
; 
HRESIMS m/z 415.2220 (calcd for C23H30N2O5 + H, 415.2227). HMBC: 
2
J H(18) to 
C(2); H(6) to C(5); H(5) to C(6); H(6), H(21) to C(7); H(10) to C(11); NH to C(13); 
H(17) to C(16); H(17) to C(20). 
3
J H(6) to C(2); H(5) to C(3); H(21) to C(6); NH, H(9) 
to C(7); NH, H(10) to C(8); 11-OMe, H(9) to C(11); 12-OMe, H(10) to C(12); H(9) to 
C(13); H(17) to C(15); H(18) to C(16); H(15), H(19) to C(17); H(17) to C(19); H(18) to 
C(20); H(5), H(17) to C(21); CO2Me, H(17) to CO2Me.  
 
Pseudokopsinine (78): light yellowish oil; []D 20 (c 0.22, CHCl3); UV (EtOH) max 








C NMR data, see Tables 2.53 and 2.54, respectively; ESIMS m/z 339 (MH
+
, 
C21H26N2O2 + H).  
 
Kopsinine (79): colorless oil; []D 68 (c 0.24, CHCl3); UV (EtOH) max (log ) 205 




H NMR and 
13
C 
NMR data, see Tables 2.53 and 2.54, respectively; ESIMS m/z 339 (MH
+
, C21H26N2O2 + 
H). 
 
Kopsamine (80): colorless crystals (CHCl3Et2O); mp 200201 
o
C; []D 47 (c 0.21, 
CHCl3); UV (EtOH) max (log ) 227 (4.36), 248 (3.92), 286 (2.92) nm; IR (dry film) 




H NMR and 
13
C NMR data, see Table 2.55; ESIMS m/z 
457 (MH
+
, C24H28N2O7 + H). 
 
N(1)-Decarbomethoxykopsamine (81): colorless oil; []D 9 (c 0.19, CHCl3); UV 





H NMR and 
13
C NMR data, see Table 2.55; ESIMS m/z 399 (MH
+
, 
C22H26N2O5 + H). 
 
Kopsilongine (82): colorless oil; []D 21 (c 0.09, CHCl3); UV (EtOH) max (log ) 217 







C NMR data, see Table 2.56; ESIMS m/z 443 (MH
+
, C24H30N2O6 + H). 
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Paucifinine (83): light yellowish oil; []D 91 (c 0.08, CHCl3); UV (EtOH) max (log ) 





H NMR and 
13





Kopsanone (84): colorless oil; []D +126 (c 0.20, CHCl3); UV (EtOH) max (log ) 207 




H NMR and 
13
C 
NMR data, see Table 2.57; ESIMS m/z 323 (MH
+
, C20H22N2O + H). 
 
11,12-Methylenedioxykopsine (85): colorless oil; []D 13 (c 0.18, CHCl3); UV 
(EtOH) max (log ) 225 (4.61), 244 (4.24), 287 (3.41), 294 (3.39) nm; IR (dry film) max 




H NMR and 
13





12-Methoxykopsine (86): colorless oil; []D +310 (c 0.11, CHCl3); UV (EtOH) max 











Kopsifine (87): colorless oil; []D +97 (c 0.04, CHCl3); UV (EtOH) max (log ) 223 




H NMR and 
13





N(1)-Decarbomethoxykopsifine (88): colorless oil; []D +52 (c 0.07, CHCl3); UV 
(EtOH) max (log ) 220 (4.72), 243 (4.23), 288 (3.51) nm; 
1
H NMR and 
13
C NMR data, 




Akuammicine (89): light yellowish oil; []D 466 (c 0.07, CHCl3); UV (EtOH) max 
(log ) 225 (3.74), 298 (3.68), 328 (3.83) nm; 1H NMR and 13C NMR data, see Table 
2.60; ESIMS m/z 323 (MH
+
, C20H22N2O2 + H). 
 
Andransinine (90): light yellowish oil and subsequently light yellowish crystals from 
CH2Cl2-hexanes; mp 186190 
o
C; []D 0 (c 0.15, CHCl3); UV (EtOH) max (log ) 224 




H NMR and 
13
C NMR data, see Table 2.61; ESIMS m/z 381 [MH]
+
; HRESIMS m/z 381.2178 (calcd 
for C23H28N2O3 + H, 381.2173). HMBC: 
2
J NH to C(2); H(6) to C(5); H(6) to C(7); NH 
to C(13); H(14) to C(15); H(17) to C(16); H(17), H(19) to C(18); H(23) to C(22); H(22) 
to C(23). 
3
J H(6), H(21) to C(2); H(5), H(15) to C(3); NH, H(5), (9) to C(7); NH, H(6), 
H(10) to C(8); H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); H(9), 
H(11) to C(13); H(19), H(22) to C(15); H(19) to C(17); H(17) to C(19); H(14) to C(20); 
H(3), H(5), H(15), H(17), H(19) to C(21); CO2Me, H(21) to CO2Me. NOE: 
H(3)/H(3); H(5)/H(5); H(6)/H(6), H(9); H(6)/H(6); H(12)/NH; H(15)/H(19); 




Crystallographic data of 90: colorless block crystals, C23H28N2O3, Mr = 380.47, 
monoclinic, space group P21, a = 8.5064(2) Å, b = 9.1496(2) Å, c = 12.5255(2) Å;  =  
= 90
o
,  = 96.007(10)o, V = 969.51(3) Å3, T = 100 K, Z = 2, Dcalc = 1.303 gcm
3
, crystal 
size 0.17 x 0.21 x 0.44 mm
3
, F(000) = 408. The final R1 value is 0.0302 (wR2 = 0.0774) 
for 2259 reflections [I > 2(I)]. 
 
Compound 91: light yellowish oil; []D 0 (c 0.03, CHCl3); UV (EtOH) max (log ) 224 




H NMR and 
13
C NMR data, see Table 2.61; ESIMS m/z 367 [MH]
+
; HRESIMS m/z 367.2018 (calcd 
for C22H26N2O3 + H, 367.2016). HMBC: 
2
J NH to C(2); H(6) to C(5); H(6) to C(7); NH 
to C(13); H(14) to C(15); H(17) to C(16); H(17), H(19) to C(18). 
3
J H(6), H(21) to 
C(2); H(5), H(15) to C(3); NH, H(5), H(9) to C(7); NH, H(6), H(10) to C(8); H(11) to 
C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); H(9), H(11) to C(13); 15-OMe, 
H(19) to C(15); H(19) to C(17); H(17) to C(19); H(14) to C(20); H(3), H(5), H(15), 
H(17), H(19) to C(21); CO2Me, H(21) to CO2Me. NOE: H(3)/H(3); H(5)/H(5); 
H(6)/H(6); H(6)/H(6); H(9)/H(10); H(12)/NH, H(11); H(15)/CO2Me; H(19)/15-
OMe; 15-OMe/H(19). 
 
Condylocarpine (92): colorless oil; []D +619 (c 0.13, CHCl3); UV (EtOH) max (log ) 




H NMR and 
13
C NMR data, see Table 2.62; ESIMS m/z 323 (MH
+
, C20H22N2O2 + H). 
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Precondylocarpine (93): light yellowish oil; []D 407 (c 0.10, CHCl3); UV (EtOH) 




H NMR and 
13
C NMR data, see Table 2.63; ESIMS m/z 353 (MH
+
, C21H24N2O3 + H). 
 
Stemmadenine (94): light yellowish oil and subsequently light yellowish crystals; mp 
187190 oC; []D 270 (c 0.14, CHCl3); UV (EtOH) max (log ) 209 (4.43), 228 (4.64), 




H NMR and 
13
C NMR data, see 
Table 2.63; ESIMS m/z 355 (MH
+
, C21H26N2O3 + H). 
 
Methyl 11,12-methylenedioxy-N(1)-decarbomethoxychanofruticosinate (95): 
colorless oil; []D +89 (c 0.06, CHCl3); UV (EtOH) max (log ) 215 (3.26), 248 (2.71), 
285 (1.83) nm; 
1
H NMR and 
13
C NMR data, see Table 2.64; ESIMS m/z 397 (MH
+
, 
C22H24N2O5 + H). 
 
Methyl 11,12-methylenedioxychanofruticosinate (96): colorless oil; []D +51 (c 0.26, 
CHCl3); UV (EtOH) max (log ) 202 (4.02), 226 (3.60), 278 (2.94) nm; 
1
H NMR and 
13
C NMR data, see Table 2.64; ESIMS m/z 455 (MH
+
, C24H26N2O7 + H). 
 
Methyl chanofruticosinate (97): light yellowish oil; []D +97 (c 0.51, CHCl3); UV 
(EtOH) max (log ) 205 (4.26), 237 (3.88), 280 (3.14) nm; 
1
H NMR and 
13
C NMR data, 
see Tables 2.65 and 2.66, respectively; ESIMS m/z 411 (MH
+
, C23H26N2O5 + H). 
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Methyl N(1)-decarbomethoxychanofruticosinate (98): colorless oil; []D +258 (c 





C NMR data, see Tables 2.65 and 2.66, respectively; ESIMS m/z 353 (MH
+
, 
C21H24N2O3 + H). 
 
Methyl 12-methoxychanofruticosinate (99): colorless oil; []D +194 (c 0.18, CHCl3); 





H NMR and 
13
C NMR data, see Tables 2.65 and 2.66, respectively; ESIMS 
m/z 441 (MH
+
, C24H28N2O6 + H). 
 
()-Norpleiomutine (100): light yellowish oil; []D 49 (c 1.21, CHCl3); UV (EtOH) 
max (log ) 208 (4.69), 229 (4.51), 255 (4.09), 287 (3.97), 293 (3.97) nm; IR (dry film) 




H NMR and 
13
C NMR data, see Table 2.67; ESIMS m/z 617 
(MH
+
, C40H48N4O2 + H).  
 
Alkaloids from Penicillium sp. (CDA p48.3) 
Compound 101: light yellowish oil; []D 2 (c 0.24, CHCl3); UV (EtOH) max (log ) 







C NMR data, see Tables 2.70 and 2.71, respectively; LSIMS m/z 308 
[MH]
+
; HRLSIMS m/z 308.1859 (calcd for C17H25NO4 + H, 308.1856). HMBC: 
2
J H(3) 
to C(2); H(4) to C(3); H(3), H(5) to C(4); H(4) to C(5); H(7) to C(6); H(8) to C(7); H(7) 
to C(8); H(10) to C(9); H(10), H(18) to C(11); H(14) to C(13); H(14), H(16) to C(15); 
H(17) to C(16); H(16) to C(17). 
3
J H(4), H(5) to C(2); H(5) to C(3); H(3) to C(5); H(8) 
 396 
to C(6); H(10) to C(8); H(12), H(18) to C(10); H(9) to C(11); H(10), H(18) to C(12); 
H(12), H(16) to C(14); H(17) to C(15); H(10), H(12) to C(18).  
 
Compound 102: light yellowish oil; []D 6 (c 0.04, CHCl3); UV (EtOH) max (log ) 




H NMR and 
13
C NMR data, 
see Tables 2.70 and 2.71, respectively; LSIMS m/z 326 [MH]
+
; HRLSIMS m/z 
326.1962 (calcd for C17H27NO5 + H, 326.1962). HMBC: 
2
J H(3) to C(2); H(4) to C(3); 
H(3), H(5) to C(4); H(4) to C(5); H(7) to C(6); H(7) to C(8); H(10), H(18) to C(11); 
H(13) to C(12); H(15) to C(14); H(17) to C(16). 
3
J H(4), H(5) to C(2); H(5) to C(3); 
H(3) to C(5); H(8) to C(6); H(10) to C(8); H(7) to C(9); H(18) to C(10); H(9), H(13) to 
C(11); H(18) to C(12); H(17) to C(15).  
 
Compound 103: light yellowish oil; []D 7 (c 0.09, CHCl3); UV (EtOH) max (log ) 




H NMR and 
13
C NMR data, 
see Tables 2.70 and 2.71, respectively; LSIMS m/z 324 [MH]
+
; HRLSIMS m/z 
324.1809 (calcd for C17H25NO5 + H, 324.1805). HMBC: 
2
J H(3) to C(2); H(4) to C(3); 
H(3), H(5) to C(4); H(4) to C(5); H(7) to C(6); H(7) to C(8); H(10) to C(9); H(10), 
H(18) to C(11); H(16) to C(15); H(17) to C(16); H(16) to C(17). 
3
J H(4), H(5) to C(2); 
H(5) to C(3); H(3) to C(5); H(8) to C(6); H(10) to C(8); H(7) to C(9); H(18) to C(10); 
H(9) to C(11); H(18) to C(12); H(16) to C(14); H(17) to C(15). 
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Variotin (104): light yellowish oil; []D 6 (c 1.0, MeOH); UV (EtOH) max (log ) 320 




H NMR and 
13
C NMR data, see 
Table 2.72; ESIMS m/z 292 (MH
+
, C17H25NO3 + H).  
 
Viriditin (105): light yellowish oil; []D 28 (c 0.35, CHCl3); UV (EtOH) max (log ) 




H NMR and 
13
C 
NMR data, see Table 2.72; ESIMS m/z 308 (MH
+
, C18H29NO3 + H).  
 
cyclo (L-Phenylalanine-trans-4-hydroxy-L-proline) (106): light yellowish oil; []D 





H NMR and 
13
C NMR data, see Table 2.73; ESIMS m/z 261 (MH
+
, 
C14H16N2O3 + H). 
 
cyclo (L-Leucine-trans-4-hydroxy-L-proline) (107): light yellowish oil; []D 99 (c 




H NMR and 
13
C NMR data, 
see Table 2.73; ESIMS m/z 227 (MH
+






3.9 Cytotoxicity Assays 
 
Cytotoxicity assays were carried out on KB (human oral epidermoid carcinoma cell 
line), or Jurkat (human T-cell-leukemia cell line) cells. The cells were maintained in 
culture flasks in Eagle’s MEM, supplemented with 10% fetal calf serum and kanamycin 
(60 µg/mL). The KB or Jurkat cells (1.5×10
5
/mL) were seeded in 0.2 mL of culture 
medium/well in 96-well plates (Corning Glass Works). The cells were treated in 
triplicate with graded concentrations of 5 µL test samples and were then incubated in a 
5% carbon dioxide atmosphere at 37 °C for 72 h. The MTT assay was used to measure 
the cytotoxicity effect.
409
 The activity was shown as the IC50 value, which was the 
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